
<html lang="en"     class="pb-page"  data-request-id="725d7108-5153-4d22-b0f0-c99520dfb83f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2015.58.issue-22;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/acs.jmedchem.5b01208;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Hit Optimization of 5-Substituted-N-(piperidin-4-ylmethyl)-1H-indazole-3-carboxamides: Potent Glycogen Synthase Kinase-3 (GSK-3) Inhibitors with in Vivo Activity in Model of Mood Disorders" /></meta><meta name="dc.Creator" content="Guido  Furlotti" /></meta><meta name="dc.Creator" content="Maria Alessandra  Alisi" /></meta><meta name="dc.Creator" content="Nicola  Cazzolla" /></meta><meta name="dc.Creator" content="Patrizia  Dragone" /></meta><meta name="dc.Creator" content="Lucia  Durando" /></meta><meta name="dc.Creator" content="Gabriele  Magarò" /></meta><meta name="dc.Creator" content="Francesca  Mancini" /></meta><meta name="dc.Creator" content="Giorgina  Mangano" /></meta><meta name="dc.Creator" content="Rosella  Ombrato" /></meta><meta name="dc.Creator" content="Marco  Vitiello" /></meta><meta name="dc.Creator" content="Andrea  Armirotti" /></meta><meta name="dc.Creator" content="Valeria  Capurro" /></meta><meta name="dc.Creator" content="Massimiliano  Lanfranco" /></meta><meta name="dc.Creator" content="Giuliana  Ottonello" /></meta><meta name="dc.Creator" content="Maria  Summa" /></meta><meta name="dc.Creator" content="Angelo  Reggiani" /></meta><meta name="dc.Description" content="Novel treatments for bipolar disorder with improved efficacy and broader spectrum of activity are urgently needed. Glycogen synthase kinase 3β (GSK-3β) has been suggested to be a key player in the ..." /></meta><meta name="Description" content="Novel treatments for bipolar disorder with improved efficacy and broader spectrum of activity are urgently needed. Glycogen synthase kinase 3β (GSK-3β) has been suggested to be a key player in the ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 13, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b01208" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01208" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b01208" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01208" /></link>
        
    
    

<title>Hit Optimization of 5-Substituted-N-(piperidin-4-ylmethyl)-1H-indazole-3-carboxamides: Potent Glycogen Synthase Kinase-3 (GSK-3) Inhibitors with in Vivo Activity in Model of Mood Disorders | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b01208" /></meta><meta property="og:title" content="Hit Optimization of 5-Substituted-N-(piperidin-4-ylmethyl)-1H-indazole-3-carboxamides: Potent Glycogen Synthase Kinase-3 (GSK-3) Inhibitors with in Vivo Activity in Model of Mood Disorders" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0014.jpeg" /></meta><meta property="og:description" content="Novel treatments for bipolar disorder with improved efficacy and broader spectrum of activity are urgently needed. Glycogen synthase kinase 3β (GSK-3β) has been suggested to be a key player in the pathophysiology of bipolar disorder. A series of novel GSK-3β inhibitors having the common N-[(1-alkylpiperidin-4-yl)methyl]-1H-indazole-3-carboxamide scaffold were prepared taking advantage of an X-ray cocrystal structure of compound 5 with GSK-3β. We probed different substitutions at the indazole 5-position and at the piperidine-nitrogen to obtain potent ATP-competitive GSK-3β inhibitors with good cell activity. Among the compounds assessed in the in vivo PK experiments, 14i showed, after i.p. dosing, encouraging plasma PK profile and brain exposure, as well as efficacy in a mouse model of mania. Compound 14i was selected for further in vitro/in vivo pharmacological evaluation, in order to elucidate the use of ATP-competitive GSK-3β inhibitors as new tools in the development of new treatments for mood disorders." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b01208"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b01208">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b01208&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b01208&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b01208&amp;href=/doi/10.1021/acs.jmedchem.5b01208" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 8920-8937</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b01200" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b01254" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Hit Optimization of 5-Substituted-<i>N</i>-(piperidin-4-ylmethyl)-1<i>H</i>-indazole-3-carboxamides: Potent Glycogen Synthase Kinase-3 (GSK-3) Inhibitors with in Vivo Activity in Model of Mood Disorders</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guido++Furlotti">Guido Furlotti</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria+Alessandra++Alisi">Maria Alessandra Alisi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicola++Cazzolla">Nicola Cazzolla</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrizia++Dragone">Patrizia Dragone</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lucia++Durando">Lucia Durando</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gabriele++Magar%C3%B2">Gabriele Magarò</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Francesca++Mancini">Francesca Mancini</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giorgina++Mangano">Giorgina Mangano</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rosella++Ombrato">Rosella Ombrato</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marco++Vitiello">Marco Vitiello</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrea++Armirotti">Andrea Armirotti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Valeria++Capurro">Valeria Capurro</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Massimiliano++Lanfranco">Massimiliano Lanfranco</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giuliana++Ottonello">Giuliana Ottonello</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria++Summa">Maria Summa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Angelo++Reggiani">Angelo Reggiani</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Angelini S.p.A., Angelini Research Center, P.le della Stazione s.n.c., Santa Palomba-Pomezia, 00071 Rome, Italy</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Drug Discovery and Development Department, Istituto Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy</span></div><div class="corresp-info"><strong>*</strong>(G.F.) Phone: +390691045265. E-mail: <a href="/cdn-cgi/l/email-protection#65024b031017090a11110c25040b0200090c0b0c4b0c114b"><span class="__cf_email__" data-cfemail="13743d7566617f7c67677a53727d74767f7a7d7a3d7a673d">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>(A.G.) Phone: +3901071781571. E-mail: <a href="/cdn-cgi/l/email-protection#f0b19e97959c9fdea295979799919e99b0999984de9984"><span class="__cf_email__" data-cfemail="d796b9b0b2bbb8f985b2b0b0beb6b9be97bebea3f9bea3">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01208&amp;href=/doi/10.1021%2Facs.jmedchem.5b01208" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 8920–8937</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 20, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>31 July 2015</li><li><span class="item_label"><b>Published</b> online</span>13 November 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 November 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b01208" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01208</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8920%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DGuido%2BFurlotti%252C%2BMaria%2BAlessandra%2BAlisi%252C%2BNicola%2BCazzolla%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D22%26contentID%3Dacs.jmedchem.5b01208%26title%3DHit%2BOptimization%2Bof%2B5-Substituted-N-%2528piperidin-4-ylmethyl%2529-1H-indazole-3-carboxamides%253A%2BPotent%2BGlycogen%2BSynthase%2BKinase-3%2B%2528GSK-3%2529%2BInhibitors%2Bwith%2Bin%2BVivo%2BActivity%2Bin%2BModel%2Bof%2BMood%2BDisorders%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8937%26publicationDate%3DNovember%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b01208"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1854</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">21</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b01208" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Hit Optimization of 5-Substituted-N-(piperidin-4-ylmethyl)-1H-indazole-3-carboxamides: Potent Glycogen Synthase Kinase-3 (GSK-3) Inhibitors with in Vivo Activity in Model of Mood Disorders&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Guido&quot;,&quot;last_name&quot;:&quot;Furlotti&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Alessandra Alisi&quot;},{&quot;first_name&quot;:&quot;Nicola&quot;,&quot;last_name&quot;:&quot;Cazzolla&quot;},{&quot;first_name&quot;:&quot;Patrizia&quot;,&quot;last_name&quot;:&quot;Dragone&quot;},{&quot;first_name&quot;:&quot;Lucia&quot;,&quot;last_name&quot;:&quot;Durando&quot;},{&quot;first_name&quot;:&quot;Gabriele&quot;,&quot;last_name&quot;:&quot;Magarò&quot;},{&quot;first_name&quot;:&quot;Francesca&quot;,&quot;last_name&quot;:&quot;Mancini&quot;},{&quot;first_name&quot;:&quot;Giorgina&quot;,&quot;last_name&quot;:&quot;Mangano&quot;},{&quot;first_name&quot;:&quot;Rosella&quot;,&quot;last_name&quot;:&quot;Ombrato&quot;},{&quot;first_name&quot;:&quot;Marco&quot;,&quot;last_name&quot;:&quot;Vitiello&quot;},{&quot;first_name&quot;:&quot;Andrea&quot;,&quot;last_name&quot;:&quot;Armirotti&quot;},{&quot;first_name&quot;:&quot;Valeria&quot;,&quot;last_name&quot;:&quot;Capurro&quot;},{&quot;first_name&quot;:&quot;Massimiliano&quot;,&quot;last_name&quot;:&quot;Lanfranco&quot;},{&quot;first_name&quot;:&quot;Giuliana&quot;,&quot;last_name&quot;:&quot;Ottonello&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Summa&quot;},{&quot;first_name&quot;:&quot;Angelo&quot;,&quot;last_name&quot;:&quot;Reggiani&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;8920-8937&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b01208&quot;},&quot;abstract&quot;:&quot;Novel treatments for bipolar disorder with improved efficacy and broader spectrum of activity are urgently needed. Glycogen synthase kinase 3β (GSK-3β) has been suggested to be a key player in the pathophysiology of bipolar disorder. A series of novel GSK-3β inhibitors having the common N-[(1-alkylpiperidin-4-yl)methyl]-1H-indazole-3-carboxamide scaffold were prepared taking advantage of an X-ray cocrystal structure of compound 5 with GSK-3β. We probed different substitutions at the indazole 5-position and at the piperidine-nitrogen to obtain potent ATP-competitive GSK-3β inhibitors with good cell activity. Among the compounds assessed in the in vivo PK experiments, 14i showed, after i.p. dosing, encouraging plasma PK profile and brain exposure, as well as efficacy in a mouse model of mania. Compound 14i was selected for further in vitro/in vivo pharmacological evaluation, in order to elucidate the use of ATP-competitive GSK-3β inhibitors as new tools in the development of new treatments for mood disorders.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01208&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01208" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01208&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01208" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01208&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01208" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01208&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01208&amp;href=/doi/10.1021/acs.jmedchem.5b01208" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b01208" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b01208" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b01208%26sid%3Dliteratum%253Aachs%26pmid%3D26486317%26genre%3Darticle%26aulast%3DFurlotti%26date%3D2015%26atitle%3DHit%2BOptimization%2Bof%2B5-Substituted-N-%2528piperidin-4-ylmethyl%2529-1H-indazole-3-carboxamides%253A%2BPotent%2BGlycogen%2BSynthase%2BKinase-3%2B%2528GSK-3%2529%2BInhibitors%2Bwith%2Bin%2BVivo%2BActivity%2Bin%2BModel%2Bof%2BMood%2BDisorders%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D22%26spage%3D8920%26epage%3D8937%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290982" title="Diseases and disorders">Diseases and disorders</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/jmcmar.2015.58.issue-22/20151125/jmcmar.2015.58.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/medium/jm-2015-01208k_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01208&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Novel treatments for bipolar disorder with improved efficacy and broader spectrum of activity are urgently needed. Glycogen synthase kinase 3β (GSK-3β) has been suggested to be a key player in the pathophysiology of bipolar disorder. A series of novel GSK-3β inhibitors having the common <i>N</i>-[(1-alkylpiperidin-4-yl)methyl]-1<i>H</i>-indazole-3-carboxamide scaffold were prepared taking advantage of an X-ray cocrystal structure of compound <b>5</b> with GSK-3β. We probed different substitutions at the indazole 5-position and at the piperidine-nitrogen to obtain potent ATP-competitive GSK-3β inhibitors with good cell activity. Among the compounds assessed in the <i>in vivo</i> PK experiments, <b>14i</b> showed, after i.p. dosing, encouraging plasma PK profile and brain exposure, as well as efficacy in a mouse model of mania. Compound <b>14i</b> was selected for further <i>in vitro</i>/<i>in vivo</i> pharmacological evaluation, in order to elucidate the use of ATP-competitive GSK-3β inhibitors as new tools in the development of new treatments for mood disorders.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02450" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02450" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Bipolar disorder is a severe psychiatric condition characterized by swings between depressive episodes (anhedonia, cognitive disorders, and suicidal thoughts) and periods of elevated mood (hyperarousal, irritability, and hallucinations). Bipolar disorder affects about 1% of the world’s population, with symptoms generally emerging in young adults with comparable prevalence in males and females. According to the current literature, lithium remains the best available mood stabilizer, but efficacy is primarily during the manic phase, while additional supportive therapy is required to control the depressive phase.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Anticonvulsant agents, such as valproic acid and lamotrigine, or atypical antipsychotic drugs, such as olanzapine and quetiapine, have some efficacy, although limited to particular patient subgroups. Moreover, current medications have little efficacy in preventing relapse (low remission rate) and have significant side effects. For these reasons, there is a significant medical need to identify more effective and safer drugs, acting on both the acute and global course of the illness.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><div class="NLM_p">Recent literature has pointed out a significant role for glycogen synthase kinase 3β (GSK-3β) in the pathophysiology of bipolar disorder.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Dysregulation of the enzyme has been proposed as a potential driver of the disease, and strong support for this has been the discovery of an inherited mutation of the GSK-3 gene which leads to overactivation of the enzyme, causing psychiatric illnesses in humans.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Moreover, both lithium and, to a lesser extent, valproic acid are inhibitors of the GSK-3β signaling cascade.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3-5)</a></div><div class="NLM_p">GSK-3 is a constitutively active multifunctional serine/threonine protein kinase discovered in the late 1970s.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> In humans, GSK-3 is encoded by two different and independent genes, generating GSK-3α and GSK-3β proteins, with molecular weights of about 51 and 47 kDa, respectively. The two isoforms share nearly identical sequences in their kinase domains (95% homology of the catalytic domain) while differing substantially in sequence elsewhere in the protein.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Like other kinases, GSK-3β transfers phosphate groups from ATP to specific substrates, usually proteins. After phosphorylation, the substrate undergoes a functional change, by which kinases can mediate various biological functions. In the central nervous system, GSK-3β is widely expressed and has a fundamental role, in neuronal signaling, regulating the Wnt pathway (by β-catenin deactivation) and tau protein function.<a onclick="showRef(event, 'ref3 ref8'); return false;" href="javascript:void(0);" class="ref ref3 ref8">(3, 8)</a></div><div class="NLM_p">In the past decade, several novel classes of adenosine triphosphate (ATP) competitive and non-ATP competitive GSK-3β inhibitors have been reported.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Among the non-ATP competitive inhibitors, 4-benzyl-1,2,4-thiadiazolidine-3,5-diones such as TDZD-8 or tideglusib (<a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>) showed good kinase inhibition (IC<sub>50</sub> = 2 μM and 0.06 μM, respectively) and good efficacy in many animal models but failed to exhibit clinical benefit in Alzheimer’s disease clinical trials.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Reported ATP competitive inhibitors such as <i>N</i>-(1,3-thiazol-2-yl)urea (<b>1</b>),<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> 3,4-diaryl-maleimides and derivatives (<b>2</b>),<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> 6-heteroaryl pyridones (<b>3a</b>), and pyrimidinones (<b>3b</b>),<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> 5-aryl-4-carboxamide-1,3-oxazoles (<b>4</b>),<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> shared a standard H-bond pattern interaction with the hinge region of the binding site, involving one hydrogen bond acceptor and one or two hydrogen bond donor sites. Despite good <i>in vitro</i> potency and in some cases favorable PK properties, few of these GSK-3β inhibitors have showed efficacy in preclinical <i>in vivo</i> models, and none of them have progressed to the clinical phase for mood-disorder related indications.<a onclick="showRef(event, 'ref15 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17">(15-17)</a></div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/medium/jm-2015-01208k_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0016.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Structures of GSK-3β Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01208&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In the present article, our effort to identify novel GSK-3β inhibitors acting as mood-stabilizers in animal models is described. The chemical program was initiated, following the identification of the 1<i>H</i>-indazole-3-carboxamide hit compound <b>5</b> (after a virtual screening campaign described in a separate paper).<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> The X-ray structure of GSK-3β cocrystallized with this ligand helped us to design novel <i>N</i>-[(1-alkylpiperidin-4-yl)methyl]-1<i>H</i>-indazole-3-carboxamides as potent GSK-3β enzyme inhibitors. Compounds demonstrated robust activity in a cell-based model, while selected compounds showed appropriate pharmacokinetic properties for <i>in vivo</i> efficacy studies. In the absence of rodent <i>in vivo</i> models of bipolar disorder, the most promising compounds were tested in the low-dose amphetamine hyper-motility test, a well-established preclinical model of mania. Early results of these efficacy experiments are reported here.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82740" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82740" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Initial Hit Finding Results</h3><div class="NLM_p">Following a structure-based hit discovery program,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> we identified a series of <i>N</i>-[(1-alkylpiperidin-4-yl)methyl]-1<i>H</i>-indazole-3-carboxamides showing GSK-3β inhibition with low micromolar IC<sub>50</sub>s. One of these preliminary hits (<b>5</b>, <a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>) with IC<sub>50</sub> = 0.64 μM was successfully cocrystallized with GSK-3β revealing key interaction features between the enzyme and inhibitor (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/medium/jm-2015-01208k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0001.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. X-ray crystal structure of compound <b>5</b> in the GSK-3β ATP binding site: (A) view of the hinge region interactions; (B) view from the inner cavity toward the hinge region and solvent accessible area.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01208&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A and B shows the key interactions between compound <b>5</b> and amino acid residues of the enzyme ATP binding pocket. The indazole moiety is located at the adenine binding site, and its two nitrogen atoms form hydrogen bonds with the backbone carbonyl group of Asp133 and with the backbone NH of Val135 of the hinge region. The backbone carbonyl of Val135 also appears to be involved in a hydrogen bond interaction with the NH of the carboxamide group of compound <b>5</b>, while the piperidine nitrogen is oriented toward the guanidine group of Arg141. This configuration orients the terminal phenylacetamide moiety toward the external solvent accessible part of the binding pocket. The apparent lack of tight interactions between protein and ligand in this broad section of the binding site could be useful for modulating physicochemical properties of the molecules without significantly influencing the inhibitory potency. Interestingly, the indazole 5-methyl group is directed toward the inner cavity of the ATP binding pocket suggesting opportunities for additional polar interactions with Lys85 and Asp200 or lipophilic interaction with other proximal residues (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>B).</div><div class="NLM_p last">The encouraging initial <i>in vitro</i> results together with the knowledge of the protein structure information, obtained from the X-ray analysis of cocrystallized <b>5</b> with GSK-3β, supported an extensive hit to a lead medicinal chemistry program around the hit series core scaffold. The analysis of the crystal structure together with already available SAR information for a bioisosteric class of GSK-3β inhibitors<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> suggested focus on two areas of interest: the indazole 5-substituent and piperidine N-substitution. Both, as previously indicated, provide opportunities to probe positive interaction with the protein and to modulate physicochemical properties.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Chemistry</h3><div class="NLM_p">The compounds described in this article were prepared according to the general routes outlined in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>–<a class="ref internalNav" href="#sch4" aria-label="4">4</a>. The 5-methoxyindazol-3-carboxamide derivatives <b>9a</b>, <b>c</b>, <b>f</b>, <b>g</b>, <b>o</b>–<b>q</b>, <b>u</b>, and <b>v</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) were readily prepared by a direct hydroxybenzotriazole (HOBt)–<i>N</i>,<i>N</i>′-dicyclohexylcarbodiimide (DCC) mediated carboxylic acid–amine coupling reaction between 5-methoxy-indazol-3-carboxylic acid <b>10a</b> and the corresponding 1-(piperidin-4-yl)methane amines <b>6</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/medium/jm-2015-01208k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0005.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Indazole-3-carboxamide Derivatives <b>9a</b>, <b>c</b>, <b>f</b>, <b>g</b>, <b>n</b>–<b>q</b>, <b>u</b>, <b>v</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01208&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HOBt, DCC, DMF, r.t., 39–67%; (b) H<sub>2</sub>, 10% Pd/C, 80 °C, 37%.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. GSK-3β Activity of 5-Methoxy-<i>N</i>-(piperidin-4-ylmethyl)-1<i>H</i>-indazole-3-carboxamide Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/medium/jm-2015-01208k_0009.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/medium/jm-2015-01208k_0010.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> values were calculated from data points obtained as averages of duplicate wells. A table with a complete list of IC<sub>50</sub> values and 95% confidence intervals is shown in <a href="/doi/suppl/10.1021/acs.jmedchem.5b01208/suppl_file/jm5b01208_si_002.pdf" class="ext-link">Supporting Information</a> (Table S.I.1).</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Sodium salt.</p></div></div><div></div></div><div class="NLM_p">The remaining derivatives <b>9</b> were synthesized by piperidine <i>N</i>-alkylation of the 5-methoxy-1<i>H</i>-indazole-3-carboxamide key intermediate <b>8a</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). For carboxylic acid derivatives <b>9b</b>, <b>9d</b>, <b>9x</b>, <b>9z</b>, and <b>9ab</b>, alkaline hydrolysis of the corresponding ester produced the final compounds.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/medium/jm-2015-01208k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0006.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Indazole-3-carboxamide Derivatives <b>9b</b>, <b>d</b>, <b>e</b>, <b>m</b>, <b>t</b>, <b>w</b>–<b>z</b>, and <b>aa</b>–<b>ah</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01208&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HOBt, DCC, DMF, 0 °C, 2 h → r. t., o.n., 87–96%; (b) 2 M HCl-EtOH, MeOH, r.t., 3 h, 76–89%; (c) R<sub>1</sub>-X, K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 1 h, 11–59%; (d) acq. NaOH, MeOH, Δ, o.n., 43–87%.</p></p></figure><div class="NLM_p">The acyl amides <b>9h</b>–<b>l</b> were prepared starting from the intermediate <b>8a</b> after N-alkylation with <i>tert</i>-butyl <i>N</i>-(3-bromopropyl)carbamate, subsequent deprotection, and acylation with the appropriate acyl chloride (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/medium/jm-2015-01208k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0007.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Amide Derivatives <b>9h</b>–<b>l</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01208&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BOC-NH(CH<sub>2</sub>)<sub>3</sub>Br, TEA, MEK, 80 °C, 1 h; (b) TFA, DCM, r. t.; o.n., 63%; (c) R-COCl, DMSO, DCM, r. t., 2 h, 17–69%.</p></p></figure><div class="NLM_p">Compounds with different indazole 5-substituents were generally prepared following the route depicted in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. The key intermediate 5-bromo-<i>N</i>-(piperidin-4-ylmethyl)-1<i>H</i>-indazole-3-carboxamide <b>8b</b> was piperidine N-alkylated with the appropriate alkyl halide to give the 5-bromoindazole-3-carboxamide intermediates <b>13c</b>, <b>14c</b>, <b>15d</b>, <b>16d</b>, and <b>17d</b>, which were then coupled with a range of boronic acids or esters, to afford the target compounds <b>13</b>–<b>17</b> (see <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a> for structures).</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/medium/jm-2015-01208k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0008.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. <sup>a</sup> Synthesis of Derivatives <b>13</b>–<b>17</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01208&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sub>1</sub>-X, K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 1 h, 16–62%; (b) R<sub>2</sub>B(OH)<sub>2</sub> or R<sub>2</sub>B(OR)<sub>2</sub>, Pd(dppf)Cl<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O (3:1), μ-wave (45’@ T = 160 °C, max power 300 W), 15–45%.</p></p></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Substituent Combinations Used to Study the GSK-3β Inhibitory Activity of an Indazole 5-Substituent R<sub>2</sub></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/medium/jm-2015-01208k_0011.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/medium/jm-2015-01208k_0012.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> values were calculated from data points obtained as averages of duplicate wells. A table with a complete list of IC<sub>50</sub> values and 95% confidence intervals is shown in <a href="/doi/suppl/10.1021/acs.jmedchem.5b01208/suppl_file/jm5b01208_si_002.pdf" class="ext-link">Supporting Information</a> (Table S.I.1).</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Methyl ester.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Ethyl ester.</p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">Sodium salt. Blank cells indicate compounds not prepared.</p></div></div><div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Structure–Enzymatic Activity Relationship Analysis</h3><div class="NLM_p">All of the molecules prepared were tested in the GSK-3β ATP-ase enzymatic assay where the human recombinant enzyme GSK-3β was incubated in the presence of compounds or vehicle in a reaction buffer containing ATP plus the unphosphorylated specific substrate peptide. Substrate phosphorylation was measured and percent inhibition calculated relative to a positive control. The half maximal inhibitory concentration values (IC<sub>50</sub>) were determined by nonlinear regression analysis of the inhibition curves.</div><div class="NLM_p">Focusing initially on the piperidine substitution of the 5-methoxy-<i>N</i>-(piperidin-4-ylmethyl)-1<i>H</i>-indazole-3-carboxamide derivatives (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>), straight chain <i>N</i>-alkylcarboxylic acids showed some improvement in activity with an increase in potency of 2-fold for the acetyl and propionyl derivatives (<b>9b</b> and <b>9c</b>) and 5-fold for the longer butyryl derivative <b>9d</b>. Substituents bearing a terminal neutral polar group (e.g., methoxyethyl <b>9e</b> and methansulfonyl ethyl amine <b>9f</b>) did not significantly affect kinase inhibitory activity relative to the parent methyl analogue (<b>9a</b>). Some, particularly more lipophilic, alkyl amides such as derivatives <b>9k</b> and <b>9l</b> did give submicromolar activity.</div><div class="NLM_p">Alkylaryl or alkylpyridyl analogues did show some improvements in the inhibitory potency. For example, benzyl derivatives (<b>9m</b>–<b>q</b>), phenyl-ethyl derivatives (<b>9t</b>–<b>u</b>), and, encouragingly, the more polar pyridine-methyl derivatives (<b>9r</b>–<b>s</b>) and the pyridine-ethyl derivative (<b>9v</b>) all have IC<sub>50</sub> values between 0.64 μM and 0.25 μM, despite the different natures of the inserted substituents. Esters and carboxylic acid substituted methylene 5-ring heteroaryl analogues showed significantly improved target affinity, with IC<sub>50</sub>s of 70 and 50 nM, respectively, with the 2-methylen-1,3-oxazole-4-carboxylic acid <b>9z</b> and its 1,3-thiazole counterpart <b>9ab</b>. All of these results are in agreement with our structural hypothesis of a section of the binding pocket without stringent electronic and steric requirements that can tolerate a broad series of terminal groups, while also identifying specific polar interactions with Arg141 or Arg144 as proposed for compound <b>9z</b> depicted in <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>.</div><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/medium/jm-2015-01208k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0002.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Docking study of compound <b>9z</b> in the GSK-3β ATP site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01208&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Interesting is the loss of potency observed for the 4-substituted 1,3-thiazole-2-carboxylic ethyl ester <b>9ad</b>, in comparison to its methyl ester isomer <b>9ac</b>, indicating a preference for the position of the hydrogen-bond acceptor heteroatoms. Alkylmorpholine substitution, such as in <b>9ag</b>, was poorly tolerated.</div><div class="NLM_p">Following the investigation of the effect of the substituents extending from the piperidine ring, we turned our attention to the 5-position of the indazole, replacing the initial methoxy group with bromine, alkyl, aryl, or heteroaryl groups, with the aim of identifying additional H-bond or van der Waals interactions. The effect of these changes on the GSK-3β activity was studied using a range of piperidine N-substituents to cover potential mismatches in the structure–activity relationship (SAR) between the two positions (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>).</div><div class="NLM_p">On the basis of the results obtained with the previous 5-methoxy-indazole-3-carboxamide derivatives, five different piperidine-nitrogen substituent’s (selected on the basis of potency and physicochemical properties) were selected for this SAR analysis: phenethyl group (<b>13</b>), methoxyethyl chain (<b>14</b>), 5-methylen-furan-2-carboxylic acid (<b>15</b>), 2-methylen-1,3-oxazole-4-carboxylic acid (<b>16</b>), and acetic acid (<b>17</b>).</div><div class="NLM_p">A marked increase in inhibitory potency was obtained with indazole 5-aryl or 5-heteroaryl substituents compared with that of 5-methoxy or 5-bromo substituted analogues. For instance, the 5-phenyl derivative <b>14f</b> in comparison with its 5-methoxy counterpart <b>9e</b> showed a 4-fold increase in activity (IC<sub>50</sub> of 200 nM and 870 nM, respectively). A further 3-fold increase in potency was noted when switching to the 2-fluorophenyl derivative <b>14g</b> (IC<sub>50</sub> = 72 nM) with further improvements in activity with the 2,3-difluorophenyl derivative <b>14i</b> (IC<sub>50</sub> = 18 nM).</div><div class="NLM_p">Replacing the two fluorine atoms of <b>17i</b> with two chlorine atoms (<b>17j</b>) gave comparable potency (IC<sub>50</sub> of 27 and 40 nM respectively) but no advantage to compensate for the increased lipophilicity. In contrast, 2-methyl derivative <b>14h</b> or 4-methoxy phenyl derivatives <b>14k</b> and <b>15k</b> showed a marked loss in potency being comparable to that of the corresponding 5-methoxy indazole derivatives.</div><div class="NLM_p">The introduction of a (pyridine-3-yl) indazole 5-substituent gave potent GSK-3β inhibitors <b>13l</b> and <b>14l</b>, with activity comparable to that of the 2,3-difluorophenyl analogues <b>13i</b> and <b>14i</b>. The incorporation of a methoxy group at the 4-, 5-, or 6-position of the pyridine ring generally was well tolerated providing two of the most potent kinase inhibitors (<b>15m</b> and <b>17n</b>). Interestingly, the methoxypyridine <b>14o</b> is 10-fold more potent than the corresponding 4-methoxyphenyl analogue <b>14k</b>, suggesting a direct effect of the pyridine nitrogen.</div><div class="NLM_p">The significant increase in potency produced by 5-(hetero)aryl indazole derivatives could be rationalized through docking studies. Compound <b>14n</b>, for example, (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A and B), with its 5-methoxy-3-pyridine moiety, is able to form a new H-bond interaction with Lys85 (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A) and hydrophobic interactions with the residues lining the deep part of the binding pocket (e.g., Cys199, Val70, and Phe67) (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B). The trends in activity seen with the indazole 5-substituent were independent of the indazole 3-substituent, consistent with conserved indazole-hinge region interactions regardless of the piperidine substituent proximal to the solvent accessible area of the binding site.</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/medium/jm-2015-01208k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0003.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Docking study of compound <b>14n</b> in the GSK-3β ATP site: (A) view of the hinge region interactions; (B) view from the inner cavity toward the hinge region and solvent accessible area.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01208&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Finally, 2-methoxy substitution (<b>14p</b> and <b>15p</b>) had at least a 10-fold drop in potency compared with that of the other methoxypyridyl regioisomers (also <b>14m</b>) suggesting a steric clash between the methoxy group and the nearby amino acid residues. No significant difference in potency was found replacing the 6-methoxy group of <b>14o</b> with a methyl group (<b>14q</b>).</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Mode of Action</h3><div class="NLM_p last">Two compounds (<b>14i</b> and <b>9c</b>) were selected to characterize in more detail their enzymatic mode of action using microfluidic technology. Their mechanism of inhibition was determined by performing phosphorylation assays while varying inhibitor and substrate concentrations around their IC<sub>50</sub> and Michaelis constant (<i>K</i><sub>M</sub>), respectively. Results were fitted to 3 equations for competitive, noncompetitive, and uncompetitive mechanisms. The inhibition for both compounds was found to be reversible, linear, and ATP competitive (<b>14i</b><i>K</i><sub>i</sub> = 15 nM; <b>9c</b><i>K</i><sub>i</sub> = 600 nM), consistent with the ATP site binding mode used for <i>in silico</i> screening and confirmed with crystallographic studies with compound <b>5</b>.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Functional Tau Phosphorylation Assay</h3><div class="NLM_p">A series of the most potent GSK-3β inhibitors was also evaluated, in duplicate, for their activity in a whole cell Tau phosphorylation assay using recombinant CHO pTau expressing cells. The cells were incubated with the selected compounds for 2 h at 37 °C, 5% CO<sub>2</sub> lysed, and processed for the detection of phosphorylated tau protein (Luminex). The comparison between IC<sub>50</sub>s obtained in the enzyme inhibition and cell-based assays is shown in <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Cellular Tau Phosphorylation Inhibition Results</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/medium/jm-2015-01208k_0013.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> values were calculated from data points obtained as averages of duplicate wells. A table with a complete list of IC<sub>50</sub> values and 95% confidence intervals is shown in <a href="/doi/suppl/10.1021/acs.jmedchem.5b01208/suppl_file/jm5b01208_si_002.pdf" class="ext-link">Supporting Information</a> (Table S. I. 3).</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">cLogP calculated by ACD/Percepta.</p></div></div><div></div></div><div class="NLM_p last">Selected compounds showed potent inhibitory effect in the Tau protein phosphorylation cellular assay with IC<sub>50</sub> in the low micromolar range reflecting a loss in potency of 10–40-fold between the isolated enzyme and whole cell pTau assays. Compounds <b>15o</b> and <b>16i</b> showed a major loss of activity probably due to their zwitterionic nature (both cLogP < 0.5; cLogD7.4, respectively, of −0.08 and −0.01) that limits their membrane permeability.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Pharmacokinetic Characterization</h3><div class="NLM_p">Compounds <b>9ac</b>, <b>9af</b>, <b>14i</b>, and <b>14n</b> were assessed for mouse plasma stability at a concentration of 5 μM. We measured the time related percentage of remaining compound and noticed that ester <b>9ac</b> was rapidly hydrolyzed to the corresponding carboxylic acid, with elimination half-life less than 10 min. Other compounds including the vinylogous carbonate <b>9af</b> were stable, with the percent of remaining compounds ≥80% after 2h.</div><div class="NLM_p">On the basis of their plasma stability, compounds <b>9af</b>, <b>14i</b>, and <b>14n</b> were progressed to <i>in vivo</i> PK studies. Plasma and brain levels were evaluated after intraperitoneal (i.p.) administration of 10 mg/kg of compounds. The PK parameters obtained for the selected compounds are shown in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. <i>In Vivo</i> PK Parameters in Mice (10 mg/kg, ip)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center">plasma</th><th class="rowsep1 colsep0" align="center">brain</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" align="center">AUC<sub>0,inf</sub> (μg·min/ml)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (μg/mL)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>max</sub> (min)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub><b>1/2</b></sub> (min)</th><th class="colsep0 rowsep0" align="center"><i>Vd</i> (L/kg)</th><th class="colsep0 rowsep0" align="center">Cl (L/min/kg)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (ng/mg prot.)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9af</b></td><td class="colsep0 rowsep0" align="left">21 ± 4</td><td class="colsep0 rowsep0" align="left">0.7 ± 0.1</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">68 ± 13</td><td class="colsep0 rowsep0" align="left">47 ± 9</td><td class="colsep0 rowsep0" align="left">0.5 ± 0.1</td><td class="colsep0 rowsep0" align="left">1.5 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14i</b></td><td class="colsep0 rowsep0" align="left">370 ± 96</td><td class="colsep0 rowsep0" align="left">2.1 ± 0.7</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">203 ± 53</td><td class="colsep0 rowsep0" align="left">6 ± 2</td><td class="colsep0 rowsep0" align="left">0.02 ± 0.01</td><td class="colsep0 rowsep0" align="left">5.5 ± 0.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14n</b></td><td class="colsep0 rowsep0" align="left">34 ± 11</td><td class="colsep0 rowsep0" align="left">1.3 ± 0.2</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">48 ± 15</td><td class="colsep0 rowsep0" align="left">20 ± 6</td><td class="colsep0 rowsep0" align="left">0.3 ± 0.1</td><td class="colsep0 rowsep0" align="left">0.7 ± 0.5</td></tr></tbody></table></div></div><div class="NLM_p last">Among the tested compounds, <b>14i</b> displayed the highest exposures, both in plasma and in brain tissue, reaching the maximum concentration in plasma in 15 min with a favorable elimination half-life (<i>t</i><sub>1/2</sub>) of 203 min and moderate clearance (Cl) of 22 mL/min/kg. Consistent with its good PK parameters, <b>14i</b> was selected for evaluation in an <i>in vivo</i> efficacy model of mood disorders.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Amphetamine Model</h3><div class="NLM_p">This model is believed to mimic the hyperactivity component of bipolar disorder. Both reference GSK-3β inhibitors tested, i.e., LiCl and TDZD-8 given intraperitonelly, were very effective in blocking amphetamine hyperactivity with LiCl being slightly more active than TDZD-8 (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A and B). At the highest dose tested, both compounds also showed a trend to inhibit spontaneous locomotor activity, suggesting the appearance of some sedative effects. Compound <b>14i</b> was tested in the range of doses between 1 and 30 mg/kg, and a dose-dependent inhibition of amphetamine induced hypermotility was observed (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>C). The first significant dose was 1 mg/kg, and the effect was maximal at 3 and 10 mg/kg. The efficacy of <b>14i</b> at 10 mg/kg was similar to that of lithium at the highest nonsedative dose and was higher than that of TDZD-8 (compare <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A, B, and C). Also <b>14i</b>, when dosed at 30 mg/kg, showed some sedative activity on spontaneous locomotor activity.</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/medium/jm-2015-01208k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0004.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of lithium chloride (A), TDZD-8 (B), and <b>14i</b> (C) on spontaneous motility (saline) and on amphetamine hyperactivity (amphetamine). Each bar is the average ± SEM (<i>n</i> = 8 each group). °°°<i>p</i> < 0.001 vs saline; *<i>p</i> < 0.05, **<i>p</i> < 0.01, and ***<i>p</i> < 0.001 vs amphetamine. Two way ANOVA, Bonferroni post-test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01208&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Kinases Selectivity Assays</h3><div class="NLM_p">The kinase profile of <b>14i</b> was first assessed in a 216 kinase assay platform performed by CEREP, at 10 μM in duplicate. Briefly, human recombinant kinases were incubated in the presence of specific peptide substrates plus ATP for different times at 22 °C. The results are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (see <a href="/doi/suppl/10.1021/acs.jmedchem.5b01208/suppl_file/jm5b01208_si_002.pdf" class="ext-link">Supporting Information</a> Table S.I.3 for the complete list of results). Only for 34 kinases did <b>14i</b> show more than 50% inhibition at the screening concentration. For these selected kinases, the IC<sub>50</sub> determination was performed (see <a href="/doi/suppl/10.1021/acs.jmedchem.5b01208/suppl_file/jm5b01208_si_002.pdf" class="ext-link">Supporting Information</a> Table S.I.4, for the complete list of results).</div><div class="NLM_p">These experiments showed that compound <b>14i</b> has an IC<sub>50</sub> selectivity ratio versus GSK-3β, below 30-fold, only for seven additional human recombinant kinases: DYRK1a and DYRK2, CLK1, LynB kinase, ERK5, GRK2 (ADRBK1), and GSK-3α (the isoform of GSK-3β) (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. GSK-3β Kinase Selectivity of Compound <b>14i</b> over Many Other Kinases</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">assay</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">selectivity ratio (vs GSK-3β)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>h-</i>GSK-3β</td><td class="colsep0 rowsep0" align="left">0.018</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>h-</i>DYRK1a</td><td class="colsep0 rowsep0" align="left">0.040</td><td class="colsep0 rowsep0" align="left">2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>h-</i>GSK-3α</td><td class="colsep0 rowsep0" align="left">0.040</td><td class="colsep0 rowsep0" align="left">2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>h-</i>CLK1</td><td class="colsep0 rowsep0" align="left">0.071</td><td class="colsep0 rowsep0" align="left">3.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>h-</i>LynB kinase</td><td class="colsep0 rowsep0" align="left">0.170</td><td class="colsep0 rowsep0" align="left">9.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>h-</i>ERK5</td><td class="colsep0 rowsep0" align="left">0.220</td><td class="colsep0 rowsep0" align="left">12.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>h-DYRK2</i> kinase</td><td class="colsep0 rowsep0" align="left">0.530</td><td class="colsep0 rowsep0" align="left">29.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">h-GRK2 (ADRBK1)</td><td class="colsep0 rowsep0" align="left">0.530</td><td class="colsep0 rowsep0" align="left">29.4</td></tr></tbody></table></div></div><div class="NLM_p last">On the basis of available literature, none of the above seven kinases have been specifically linked to mood disorders, and they are not expected to affect <b>14i</b>’s efficacy in major depression or bipolar disorder. In fact, DYRK1A and DYRK2 have been linked to cell proliferation and neurocognitive deficits associated with Down syndrome,<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a> while ERK5 has been also linked to cell proliferation, differentiation, and death.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> CLK1 has been involved in neurodegeneration and Parkinsonism.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25, 26)</a> Lyn kinase participates to the regulation of myeloid lineage proliferation,<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27, 28)</a> and finally, GRK2, a member of the G protein-coupled receptor kinases (GRKs) family, participates, together with arrestins, in the regulation of G protein-coupled receptors (GPCR).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24682" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24682" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The hit to lead program described in this work for the novel class of 5-substituted-<i>N</i>-(piperidin-4-ylmethyl)-1<i>H</i>-indazole-3-carboxamides identified a series of novel and potent GSK-3β inhibitors. Key interventions leading to an increase in GSK-3β inhibition potency were the identification of additional interactions with the target from both the indazole 3-position (e.g., Arg141) and from the indazole 5-position (probing to Lys85) while improving hydrophobic interactions. Activity against the isolated enzyme translated well to cells, which is indicative of good permeability. Using two compounds (<b>9c</b> and <b>14i</b>), we demonstrated that their mechanism of action was ATP-competitive and reversible, consistent with the binding hypothesis studied <i>in silico</i> and results of X-ray cocrystallization studies. Some indazole-3-carboxamide derivatives showed the necessary cellular potency and plasma stability to be progressed to an <i>in vivo</i> assessment. Compound <b>14i</b>, showing good preliminary pharmacokinetic profiles after i.p. administration, was tested in an <i>in vivo</i> efficacy animal model: the low dose amphetamine test, believed to mimic mania, a key symptom of mood disorders. In this model, the selected compound showed excellent efficacy and maximal effect (i.e., complete reversal of amphetamine hypermotility). Some sedative effects, at the highest doses tested, were noticed with the positive controls (TDZD-8 and LiCl) and with <b>14i</b>. As known, selectivity versus other kinases is a critical factor for the potential clinical uses of kinase inhibitors. To address this point, compound <b>14i</b> was tested on a panel of 216 kinases, and we found a potency ratio below 30-fold only on 6 assays (in addition to the expected isoform GSK-3α) indicating an excellent degree of kinase selectivity.</div><div class="NLM_p last">In summary, this article describes the synthesis and the initial pharmacological characterization of a novel class of GSK-3β inhibitors. The encouraging results of our work suggest that the present class of selective GSK-3β inhibitors may lead to molecules providing a significant improvement over existing mood disorder therapy.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Materials and Methods</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53602" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53602" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Chemistry</h3><div class="NLM_p last">Reagents were purchased from Sigma-Aldrich and were used as received. Reaction progress was monitored by TLC or UPLC-qtof chromatography. For TLC, we used Merck silica gel 60 F254 (0.04–0.063 mm) with detection by UV (214 or 254 nm). Merck silica gel 60 or aluminum oxide 90 (active neutral) was used for column chromatography. Melting points (uncorrected) were determined in open Pyrex capillary tubes using a Buchi 510 melting point apparatus. Final compound purity, always >95%, was determined both by high pressure liquid chromatography (HPLC) and ultraperformance liquid chromatography (UPLC), using the area percentage of all peaks detected. HPLC analysis was carried out with a pump/autosampler (Waters 2695, Alliance model), a UV photo diode array detector (Waters 2996 model), and a Waters system data management (Empower 2). The column used was generally Suplex pkb-100 (250 × 4.6 mm, 5 μm). UPLC/QToF chromatography data (exact mass data) were obtained by means of a SYNAPT MS-ACQUITY UPLC system (Waters). The system was operated in positive ion mode in the “V-Optics” configuration. Leucine-enkephalin (200 pg/μL) was employed as the lock mass in order to provide authenticated exact mass measurement in MS and MS/MS modes within 5 ppm RMS mass accuracy. The column was an Acquity BEH C18 (2.1 × 50 mm, 1.7 μm). Nuclear Magnetic Resonance Spectroscopy (<sup>1</sup>H NMR) were obtained using a Bruker Avance system, operating at 300 MHz. All resonance bands were referenced to tetramethylsilane (internal standard). For <sup>1</sup>H NMR spectroscopy: (s) = singlet; (d) = doublet; (t) = triplet; (br) = broad; (dd) = double doublet; (dt) = double triplet; (ddd) = double double doublet; (dtd) = double triple doublet; (m) = multiplet; <i>J</i> = coupling constant; and δ = chemical shift (in ppm). The preparative HPLC/MS system consisted of a Waters 2767 Sample manager, a Waters 2478 dual λ absorbance detector, and a Waters Micromass ZQ single quadrupole mass spectrometer with an electrospray ionization (ESI) source. The column used was a X-Bridge Prep C18 5 μm with 19 × 10 mm (Waters) precolumn. Fraction collection was available from the system software MassLynx v. 4.1. Detection wavelength was set to 230 nm and temperature to 25 °C. Elemental analysis was conducted by means of a CHNS-O EA1108 elemental analyzer, Carlo Erba Instruments, and the results were within ±0.3% of the theoretical values, unless otherwise noted. Compounds were purified with one of the following techniques: flash chromatography on silica gel (Grace Reveleris flash chromatography system with a 40 μM silica cartridge (generally flow was 60 mL/min); with an appropriate gradient of mixtures of CHCl<sub>3</sub> and CH<sub>3</sub>OH as eluents; preparative HPLC/MS system (sample was dissolved (50 mg/mL) in DMSO/CH<sub>3</sub>CN in 1:1 ratio; using an appropriate gradient of the two phases CH<sub>3</sub>CN + 0.1% formic acid and H<sub>2</sub>O + 0.1% formic acid; flow =40 mL/min. The starting material 1-(1-methylpiperidin-4-yl)methanamine (<b>6a</b>), ethyl 3-[4-(aminomethyl)piperidin-1-yl]propanoate (<b>6c</b>), <i>N</i>-{2-[4-(aminomethyl)piperidin-1-yl]ethyl}methanesulfonamide (<b>6f</b>), 3-[4-(aminomethyl)piperidin-1-yl]-<i>N</i>,<i>N</i>-dimethylpropan-1-amine (<b>6g</b>), 1-{1-[2-(pyridin-4-yl)ethyl]piperidin-4-yl}methanamine (<b>6v</b>), and <i>tert</i>-butyl 4-(aminomethyl)piperidine-1-carboxylate (<b>6z</b>) were purchased from commercial sources.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> General Method for the Preparation of Intermediates <b>7</b>, <b>9a</b>, <b>c</b>, <b>f</b>–<b>g</b>, <b>n</b>–<b>q</b>, and <b>u</b>–<b>v</b></h3><div class="NLM_p">1-Hydroxybenzotriazole (HOBt, 7.40 g, 54.8 mmol) and <i>N</i>,<i>N</i>′-dicyclohexylcarbodiimide (DCC, 11 g, 53.3 mmol) were added to a solution of an appropriately substituted 1<i>H</i>-indazole-3-carboxylic acid <b>10</b> (49.8 mmol) in DMF (200 mL) at 0 °C. After 1 h, a solution of an appropriate 1-substituted [piperidin-4-yl]methanamine (<b>6a</b>, <b>c</b>, <b>f</b>–<b>g</b>, <b>o</b>–<b>q</b>, and <b>u</b>–<b>z</b>) (58.1 mmol) in DMF (100 mL) was added at the same temperature. The mixture was stirred at 0 °C for 2 h, then it was left to reach room temperature overnight. The mixture was diluted with AcOEt, then the solid was removed by filtration. The solution was extracted three times with hydrochloric acid (HCl) 2 N. The pH of the acid phase was increased (about 13) with 5 N NaOH, and the solution was extracted three times with dichloromethane (DCM). The organic phase was dried with anhydrous Na<sub>2</sub>SO<sub>4</sub>. The solution was filtered and evaporated under reduced pressure, and the residue was adequately purified.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 5-Methoxy-<i>N</i>-[(1-methylpiperidin-4-yl)methyl]-1<i>H</i>-indazole-3-carboxamide (<b>9a</b>) Hydrochloride</h4><div class="NLM_p last">Yield 61%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 13.55 (s, 1H), 10.27 (br. s., 1H), 8.47 (t, <i>J</i> = 5.8 Hz, 1H), 7.56 (d, <i>J</i> = 2.4 Hz, 1H), 7.53 (dd, <i>J</i> = 0.5, 9.0 Hz, 1H), 7.06 (dd, <i>J</i> = 2.5, 9.1 Hz, 1H), 3.81 (s, 3H), 3.38 (d, <i>J</i> = 11.0 Hz, 2H), 3.32 (s, 2H), 2.88 (t, <i>J</i> = 11.5 Hz, 2H), 2.69 (s, 3H), 2.18–1.72 (m, 3H), 1.70–1.26 (m, 2H). [M + H<sup>+</sup>] exact mass found, 303.1816, for C<sub>16</sub>H<sub>23</sub>N<sub>4</sub>O<sub>2</sub>.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> [4-({[(5-Methoxy-1<i>H</i>-indazol-3-yl)-carbonyl]amino}methyl)piperidin-1-yl]propionic Acid (<b>9c</b>) Hydrochloride</h4><div class="NLM_p last">Compound <b>9c</b> was obtained by hydrolysis of the crude ethyl [4-({[(5-methoxy-1<i>H</i>-indazol-3-yl)-carbonyl]amino}methyl)piperidin-1-yl]propionate during the reaction alkalyne workup. (42%) <sup>1</sup>H NMR spectra of the HCl salt. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.24 (t, <i>J</i> = 6.0 Hz, 1H), 7.55 (s, 1H), 7.53 (dd, <i>J</i> = 0.5, 7.1 Hz, 1H), 7.03 (dd, <i>J</i> = 2.6, 8.7 Hz, 1H), 3.81 (s, 3H), 3.18 (t, <i>J</i> = 6.3 Hz, 2H), 2.83 (d, <i>J</i> = 11.3 Hz, 2H), 2.49–2.43 (m, 2H), 2.17–2.05 (m, 2H), 1.89 (d, <i>J</i> = 12.6 Hz, 2H), 1.76–1.46 (m, 4H), 1.30–1.10 (m, 3H). [M + H<sup>+</sup>] exact mass found, 361.1870, for C<sub>18</sub>H<sub>25</sub>N<sub>4</sub>O<sub>4</sub>.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 5-Methoxy-<i>N</i>-[(1-{2-[(methylsulfonyl)amino]ethyl}piperidin-4-yl)methyl]-1<i>H</i>-indazole-3-carboxamide (<b>9f</b>)</h4><div class="NLM_p last">Yield 46%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 13.43 (br. s., 1H), 8.27 (t, <i>J</i> = 6.1 Hz, 1H), 7.56 (d, <i>J</i> = 2.0 Hz, 1H), 7.51 (dd, <i>J</i> = 0.5, 9.0 Hz, 1H), 7.06 (dd, <i>J</i> = 2.5, 9.1 Hz, 1H), 6.81 (t, <i>J</i> = 6.2 Hz, 1H), 3.81 (s, 3H), 3.19 (t, <i>J</i> = 6.2 Hz, 2H), 3.04 (q, <i>J</i> = 5.1 Hz, 2H), 2.93 (s, 3H), 2.85 (d, <i>J</i> = 11.3 Hz, 2H), 2.38 (t, <i>J</i> = 6.8 Hz, 2H), 1.91 (t, <i>J</i> = 10.6 Hz, 2H), 1.72–1.45 (m, 3H), 1.34–1.04 (m, 2H). [M + H<sup>+</sup>] exact mass found, 410.1856, for C<sub>18</sub>H<sub>28</sub>N<sub>5</sub>O<sub>4</sub>S.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>N</i>-({1-[3-(Dimethylamino)propyl]piperidin-4-yl}methyl)-5-methoxy-1<i>H</i>-indazole-3-carboxamide (<b>9g</b>) Dihydrochloride</h4><div class="NLM_p last">Yield 67%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.62 (t, <i>J</i> = 5.9 Hz, 1 H), 8.0 (br. s., 5 H), 7.56 (d, <i>J</i> = 2.6 Hz, 1 H), 7.49 (d, <i>J</i> = 8.9 Hz, 1 H), 7.06 (dd, <i>J</i> = 2.4, 9.1 Hz, 1 H), 3.80 (s, 3 H), 3.55–3.34 (m, 4 H), 3.16–3.02 (m, 4 H), 2.75 (s, 6 H), 2.15 (quin, <i>J</i> = 7.5 Hz, 2 H), 2.04–1.81 (m, 3 H), 1.61 (dtd, <i>J</i> = 4.3, 12.2, 12.4 Hz, 2 H). [M + H<sup>+</sup>] exact mass found, 374.2550, for C<sub>20</sub>H<sub>32</sub>N<sub>5</sub>O<sub>2</sub>.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 5-Methoxy-<i>N</i>-({1-[4-(trifluoromethyl)benzyl]piperidin-4-yl}methyl)-1<i>H</i>-indazole-3-carboxamide (<b>9o</b>)</h4><div class="NLM_p last">Yield 53%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 13.40 (s, 1H), 8.27 (t, <i>J</i> = 6.10 Hz, 1H), 7.67 (d, <i>J</i> = 8.01 Hz, 2H), 7.47–7.57 (m, 4H), 7.05 (dd, <i>J</i> = 2.44, 9.06 Hz, 1H), 3.80 (s, 3H), 3.53 (s, 2H), 3.20 (t, <i>J</i> = 6.27 Hz, 2H), 2.78 (d, <i>J</i> = 11.50 Hz, 2H), 1.94 (t, <i>J</i> = 10.80 Hz, 2H), 1.47–1.77 (m, 3H), 1.12–1.36 (m, 2H). HRMS, Q-TOF found for C<sub>23</sub>H<sub>26</sub>F<sub>3</sub>N<sub>4</sub>O<sub>2</sub>: 447.2003.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>N</i>-{[1-(2,4-Dichlorobenzyl)piperidin-4-yl]methyl}-5-methoxy-1<i>H</i>-indazole-3-carboxamide (<b>9p</b>)</h4><div class="NLM_p last">Yield 68%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.38 (br. s., 1H), 8.28 (t, <i>J</i> = 6.22 Hz, 1H), 7.56 (t, <i>J</i> = 2.38 Hz, 2H), 7.52 (d, <i>J</i> = 2.56 Hz, 1H), 7.50 (d, <i>J</i> = 1.83 Hz, 1H), 7.41 (dd, <i>J</i> = 2.20, 8.20 Hz, 1H), 7.06 (dd, <i>J</i> = 2.56 and 9.15 Hz, 1H), 3.81 (s, 3H), 3.51 (s, 2H), 3.21 (t, <i>J</i> = 6.22 Hz, 2H), 2.80 (d, <i>J</i> = 11.34 Hz, 2H), 2.01 (t, <i>J</i> = 10.79 Hz, 2H), 1.48–1.78 (m, 3H), 1.07–1.35 ppm (m, 2H). HRMS, Q-TOF found for C<sub>22</sub>H<sub>25</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>2</sub>: 447.1357.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> <i>N</i>-({1-[4-(Benzyloxy)benzyl]piperidin-4-yl}methyl)-5-methoxy-1<i>H</i>-indazole-3-carboxamide (<b>9q</b>)</h4><div class="NLM_p last">Yield 77%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.44 (br. s., 1H), 8.25 (t, <i>J</i> = 6.22 Hz, 1H), 7.55 (d, <i>J</i> = 1.83 Hz, 1H), 7.50 (d, <i>J</i> = 9.15 Hz, 1H), 7.28–7.46 (m, 5H), 7.14–7.21 (m, 2H), 7.04 (dd, <i>J</i> = 2.38 and 8.96 Hz, 1H), 6.88–6.98 (m, 2H), 5.07 (s, 2H), 3.79 (s, 3H), 3.35 (s, 2H), 3.18 (t, <i>J</i> = 6.22 Hz, 2H), 2.77 (d, <i>J</i> = 11.34 Hz, 2H), 1.85 (t, <i>J</i> = 10.79 Hz, 2H), 1.45–1.71 (m, 3H), 1.00–1.32 ppm (m, 2H). HRMS, Q-TOF found for C<sub>29</sub>H<sub>33</sub>N<sub>4</sub>O<sub>3</sub>: 485.2548.</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> <i>N</i>-{[1-(4-Hydroxybenzyl)piperidin-4-yl]methyl}-5-methoxy-1<i>H</i>-indazole-3-carboxamide (<b>9n</b>)</h4><div class="NLM_p last">Compound <b>9q</b> (0.6 mmol) was dissolved in THF and hydrogenated in a microreactor continuous flow system (H-Cube) using CartCart Pd/C 10% as the cartridge. Key parameters of H-Cube were set as follows: temperature 80 °C; pressure 1 bar; and flow 1 mL/min. The solvent was removed by evaporating under reduced pressure, and the compound <b>9n</b> was purified by preparative HPLC-MS. Yield 47%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.50 (s, 1H), 9.70 (br. s., 1H), 8.35 (d, <i>J</i> = 17.17 Hz, 1H), 7.55 (d, <i>J</i> = 2.31 Hz, 1H), 7.51 (d, <i>J</i> = 8.92 Hz, 1H), 7.27 (br. s., 2H), 7.05 (dd, <i>J</i> = 2.31 and 8.92 Hz, 1H), 6.78 (d, <i>J</i> = 7.60 Hz, 2H), 3.80 (s, 3H), 2.60–3.59 (m, 8H), 0.99–2.15 ppm (m, 5H). HRMS, Q-TOF found for C<sub>22</sub>H<sub>27</sub>N<sub>4</sub>O<sub>3</sub>: 395.2083.</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 5-Methoxy-<i>N</i>-({1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl}methyl)-1<i>H</i>-indazole-3-carboxamide (<b>9u</b>)</h4><div class="NLM_p last">Yield 55%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.62 (br. s., 1H), 8.24 (t, <i>J</i> = 6.06 Hz, 1H), 7.55 (d, <i>J</i> = 2.42 Hz, 1H), 7.52 (dd, <i>J</i> = 0.61 and 8.88 Hz, 1H), 7.07–7.16 (m, 2H), 7.03 (dd, <i>J</i> = 2.42 and 8.88 Hz, 1H), 6.75–6.87 (m, 2H), 3.80 (s, 3H), 3.71 (s, 3H), 3.19 (t, <i>J</i> = 6.26 Hz, 2H), 2.90 (d, <i>J</i> = 11.10 Hz, 2H), 2.57–2.74 (m, 2H), 2.34–2.47 (m, 2H), 1.80–1.98 (m, 2H), 1.46–1.76 (m, 3H), 1.08–1.30 ppm (m, 2H). HRMS, Q-TOF found for C<sub>24</sub>H<sub>31</sub>N<sub>4</sub>O<sub>3</sub>: 423.2402.</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 5-Methoxy-<i>N</i>-({1-[2-(pyridine-4-yl)ethyl]piperidin-4-yl}methyl)-1<i>H</i>-indazole-3-carboxamide (<b>9v</b>)</h4><div class="NLM_p last">Yield 39%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.43 (br. s., 1H), 8.51–8.36 (m, 2H), 8.26 (t, <i>J</i> = 6.2 Hz, 1H), 7.56 (d, <i>J</i> = 1.8 Hz, 1H), 7.51 (d, <i>J</i> = 9.1 Hz, 1H), 7.29–7.21 (m, 2H), 7.06 (dd, <i>J</i> = 2.6 and 9.1 Hz, 1H), 3.81 (s, 3H), 3.19 (t, <i>J</i> = 6.4 Hz, 2H), 2.90 (d, <i>J</i> = 11.3 Hz, 2H), 2.80–2.67 (m, 2H), 2.6–2.4 (m, 2H), 2.02–1.82 (m, 2H), 1.72–1.48 (m, 3H), 1.32–1.03 ppm (m, 2H). HRMS, Q-TOF found for C<sub>22</sub>H<sub>28</sub>N<sub>5</sub>O<sub>2</sub>: 394.2238.</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> <i>tert</i>-Butyl 4-({[(5-Methoxy-1<i>H</i>-indazol-3-yl)carbonyl]amino}methyl)piperidine-1-carboxylate (<b>7a</b>)</h4><div class="NLM_p last">Yield 96%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.47 (br. s., 1H), 8.40 (t, <i>J</i> = 6.1 Hz, 1H), 7.55 (d, <i>J</i> = 2.6 Hz, 1H), 7.52 (d, <i>J</i> = 9.2 Hz, 1H), 7.05 (dd, <i>J</i> = 2.6 and 8.9 Hz, 1H), 3.99–3.87 (m, 2H), 3.80 (s, 3H), 3.17 (t, <i>J</i> = 6.4 Hz, 2H), 2.78–2.60 (m, 2H), 1.81–1.61 (m, 3H), 1.39 (s, 9H), 1.14–0.92 ppm (m, 2H). HRMS, Q-TOF found for C<sub>20</sub>H<sub>29</sub>N<sub>4</sub>O<sub>4</sub>: 389.2183.</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> <i>tert</i>-Butyl 4-({[(5-Bromo-1<i>H</i>-indazol-3-yl)carbonyl]amino}methyl)piperidine-1-carboxylate (<b>7b</b>)</h4><div class="NLM_p last">Yield 87%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.76 (br. s., 1H), 8.49 (t, <i>J</i> = 6.2 Hz, 1H), 8.32 (dd, <i>J</i> = 0.8 and 1.9 Hz, 1H), 7.61 (dd, <i>J</i> = 0.8 and 8.9 Hz, 1H), 7.53 (dd, <i>J</i> = 1.9 and 8.9 Hz, 1H), 3.92 (d, <i>J</i> = 12.7 Hz, 2H), 3.20 (t, <i>J</i> = 6.4 Hz, 2H), 2.79–2.59 (m, 2H), 1.93–1.56 (m, 3H), 1.39 (s, 9H), 1.11–0.95 (m, 2H). HRMS, Q-TOF found for C<sub>19</sub>H<sub>26</sub>BrN<sub>4</sub>O<sub>3</sub>: 437.1182.</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 5-Methoxy-<i>N</i>-(piperidin-4-ylmethyl)-1<i>H</i>-indazole-3-carboxamide Hydrochloride (<b>8a</b>)</h4><div class="NLM_p last">2 M HCl in Et<sub>2</sub>O (1.8 L) was added to a solution of compound <b>7a</b> (92.8 g, 0.24 mol) in MeOH (500 mL). The mixture was stirred for 3 h at room temperature, then the resulting solid was filtered and dried to give 5-methoxy-<i>N</i>-(piperidin-4-ylmethyl)-1<i>H</i>-indazole-3-carboxamide hydrochloride (<b>8a)</b> (61.1 g, 89% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.43 (br. s., 1H), 8.27 (t, <i>J</i> = 6.13 Hz, 1H), 7.56 (d, <i>J</i> = 2.01 Hz, 1H), 7.51 (dd, <i>J</i> = 0.55, 8.96 Hz, 1H), 7.06 (dd, <i>J</i> = 2.47, 9.06 Hz, 1H), 6.81 (br. s., 1H), 3.81 (s, 3H), 3.19 (t, <i>J</i> = 6.22 Hz, 2H), 2.85 (d, <i>J</i> = 11.34 Hz, 2H), 1.91 (t, <i>J</i> = 10.61 Hz, 2H), 1.45–1.72 (m, 3H), 1.04–1.34 ppm (m, 2H). HRMS, Q-TOF found for C<sub>15</sub>H<sub>21</sub>N<sub>4</sub>O<sub>2</sub>: 289.1648.</div></div><div id="sec4_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 5-Bromo-<i>N</i>-(piperidin-4-ylmethyl)-1<i>H</i>-indazole-3-carboxamide Hydrochloride (<b>8b</b>)</h4><div class="NLM_p last">Yield 76%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 14.00 (br. s., 1H), 9.12 (br. s., 1H), 8.99–8.69 (m, 1H), 8.60 (t, <i>J</i> = 6.2 Hz, 1H), 8.32 (d, <i>J</i> = 2.2 Hz, 1H), 7.63 (d, <i>J</i> = 8.7 Hz, 1H), 7.53 (dd, <i>J</i> = 2.2 and 8.8 Hz, 1H), 3.23 (t, <i>J</i> = 6.4 Hz, 4H), 2.93–2.69 (m, 2H), 1.98–1.73 (m, 3H), 1.56–1.32 ppm (m, 2H). HRMS, Q-TOF found for C<sub>15</sub>H<sub>18</sub>BrN<sub>4</sub>O<sub>3</sub>: 381.0557.</div></div><div id="sec4_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> General Method for the Preparation of Compounds <b>9</b> and <b>20</b></h4><div class="NLM_p last">A mixture of compound <b>8a</b> or <b>8b</b> (5.4 mmol) and potassium carbonate (16.6 mmol) in DMF (45 mL) was stirred for 1 h at 80 °C. A solution of the proper alkyl halide (8 mmol) in DMF (5 mL) was added dropwise. After 3 h at 70 °C, the reaction mixture was cooled, diluted with water, and extracted with EtOAc. The collected organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated under vacuum, and then properly purified.</div></div><div id="sec4_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Ethyl [4-({[(5-Methoxy-1<i>H</i>-indazol-3-yl)carbonyl]amino}methyl)piperidin-1-yl]acetate (<b>20b</b>)</h4><div class="NLM_p last">Yield 42%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.47 (br. s., 1 H), 8.36 (t, <i>J</i> = 5.9 Hz, 1H), 7.57–7.49 (m, 2H), 7.07 (dd, <i>J</i> = 2.6 and 8.9 Hz, 1H), 4.07 (q, <i>J</i> = 7.0 Hz, 2H), 3.80 (s, 3H), 3.29–3.12 (m, 4H), 2.88–2.76 (m, 2H), 2.19–2.05 (m, 2H), 1.69–1.48 (m, 3H), 1.34–1.07 ppm (m, 5H). HRMS, Q-TOF found for C<sub>19</sub>H<sub>27</sub>N<sub>4</sub>O<sub>4</sub>: 375.2027.</div></div><div id="sec4_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Ethyl 4-[4-({[(5-Methoxy-1<i>H</i>-indazol-3-yl)carbonyl]amino}methyl)piperidin-1-yl]butanoate Hydrochloride (<b>20d</b>)</h4><div class="NLM_p last">Yield 63%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 8.12 (br. s., 1H), 7.71–7.43 (m, 2H), 7.06 (d, <i>J</i> = 8.6 Hz, 1H), 6.98–5.82 (m, 2H), 4.05 (q, <i>J</i> = 7.3 Hz, 2H), 3.81 (s, 3H), 3.25 (br. s., 2H), 3.04 (d, <i>J</i> = 10.6 Hz, 2H), 2.55 (t, <i>J</i> = 6.9 Hz, 2H), 2.40–2.11 (m, 4H), 2.00–1.53 (m, 5H), 1.48–1.26 (m, 2H), 1.17 ppm (t, <i>J</i> = 7.1 Hz, 3H). HRMS, Q-TOF found for C<sub>21</sub>H<sub>31</sub>N<sub>4</sub>O<sub>4</sub>: 403.233982.</div></div><div id="sec4_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 5-Methoxy-<i>N</i>-{[1-(2-methoxyethyl)-piperidin-4-yl]methyl}-1<i>H</i>-indazole-3-carboxamide (<b>9e</b>)</h4><div class="NLM_p last">Yield 38%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>); δ 13.41 (br. s., 1H), 8.25 (t, <i>J</i> = 6.07 Hz, 1H), 7.56 (d, <i>J</i> = 2.50 Hz, 1H), 7.51 (d, <i>J</i> = 9.06 Hz, 1H), 7.06 (dd, <i>J</i> = 2.50 and 9.05 Hz, 1H), 3.81 (s, 3H), 3.41 (t, <i>J</i> = 5.97 Hz, 2H), 3.23 (s, 3H), 3.19 (t, <i>J</i> = 6.26 Hz, 2H), 2.85 (d, <i>J</i> = 11.56 Hz, 2H), 2.43 (t, <i>J</i> = 5.97 Hz, 2H), 1.79–2.06 (m, 2H), 1.48–1.73 (m, 3H), 0.99–1.39 ppm (m, 2H). HRMS, Q-TOF found for C<sub>18</sub>H<sub>27</sub>N<sub>4</sub>O<sub>3</sub>: 347.2080.</div></div><div id="sec4_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>N</i>-[(1-Benzylpiperidin-4-yl)methyl]-5-methoxy-1<i>H</i>-indazole-3-carboxamide (<b>9m</b>)</h4><div class="NLM_p last">Yield 43%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.39 (br. s., 1H), 8.25 (t, <i>J</i> = 6.0 Hz, 1H), 7.56 (d, <i>J</i> = 2.0 Hz, 1H), 7.50 (dd, <i>J</i> = 0.5 and 9.0 Hz, 1H), 7.36–7.17 (m, 5H), 7.05 (dd, <i>J</i> = 2.5 and 9.1 Hz, 1H), 3.80 (s, 3H), 3.43 (s, 2H), 3.20 (t, <i>J</i> = 6.1 Hz, 2H), 2.79 (d, <i>J</i> = 11.2 Hz, 2H), 1.89 (t, <i>J</i> = 10.6 Hz, 2H), 1.74–1.46 (m, 3H), 1.34–1.07 ppm (m, 2H). HRMS, Q-TOF found for C<sub>22</sub>H<sub>27</sub>N<sub>4</sub>O<sub>2</sub>: 379.2124.</div></div><div id="sec4_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>N</i>-({1-[2-(4-Hydroxyphenyl)ethyl]-piperidin-4-yl}methyl)-5-methoxy-1<i>H</i>-indazole-3-carboxamide (<b>9t</b>)</h4><div class="NLM_p last">Yield 41%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>); δ 13.40 (br. s., 1H), 9.07 (s, 1H), 8.26 (t, <i>J</i> = 6.16 Hz, 1H), 7.55 (d, <i>J</i> = 2.42 Hz, 1H), 7.50 (dd, <i>J</i> = 0.61 and 9.08 Hz, 1H), 7.05 (dd, <i>J</i> = 2.50 and 9.10 Hz, 1H), 6.94–7.02 (m, 2H), 6.60–6.68 (m, 2H), 3.80 (s, 3H), 3.19 (t, <i>J</i> = 6.36 Hz, 2H), 2.89 (d, <i>J</i> = 11.30 Hz, 2H), 2.53–2.65 (m, 2H), 2.30–2.46 (m, 2H), 1.79–2.00 (m, 2H), 1.47–1.74 (m, 3H), 1.06–1.31 ppm (m, 2H). HRMS, Q-TOF found for C<sub>23</sub>H<sub>29</sub>N<sub>4</sub>O<sub>3</sub>: 409.2226.</div></div><div id="sec4_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 5-Methoxy-<i>N</i>-({1-[2-(3-methylcyclohexyl)ethyl]piperidin-4-yl}methyl)-1<i>H</i>-indazole-3-carboxamide (<b>9w</b>)</h4><div class="NLM_p last">A solution of compound <b>8a</b> (1.46 mmol) in DMF (45 mL) and triethylamine (0.61 mL, 4.4 mmol) was stirred at 80 °C for 1 h and then was treated with 1-(2-bromoethyl)-3-methylcyclohexane (300 mg, 1.46 mmol). The mixture was stirred overnight at the same temperature. The reaction was then cooled to room temperature, and the solvent was removed by evaporation at reduced pressure. The residue was poured in water and extracted with AcOEt. The organic phases were dried with Na<sub>2</sub>SO<sub>4</sub>, then evaporated under reduced pressure. 5-Methoxy-<i>N</i>-({1-[2-(3-methylcyclohexyl)ethyl]piperidin-4-yl}methyl)-1<i>H</i>-indazole-3-carboxamide was purified by flash chromatography using a mixture of CHCl<sub>3</sub>/MeOH (9:1) as eluent. (Yield = 45 mg, 18.0%.) <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.41 (s, 1H), 8.30–8.20 (t, <i>J</i> = 6.11 Hz, 1H), 7.58–7.53 (d, <i>J</i> = 2.31 Hz, 1H), 7.53–7.47 (d, <i>J</i> = 8.59 Hz, 1H), 7.08–7.02 (dd, <i>J</i> = 8.92 and 2.32 Hz, 1H), 3.80 (s, 3H), 3.23–3.13 (t, <i>J</i> = 6.28 Hz, 2H), 2.90–2.78 (d, <i>J</i> = 10.57 Hz, 2H), 2.35–2.20 (m, 2H), 1.97–1.05 (m, 17H), 0.90–0.45 ppm (m, 5H). HRMS, Q-TOF found for C<sub>24</sub>H<sub>37</sub>N<sub>4</sub>O<sub>2</sub>: 413.2910.</div></div><div id="sec4_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> Ethyl 5-{[4-({[(5-Methoxy-1<i>H</i>-indazol-3-yl)carbonyl]amino}methyl)piperidin-1-yl]-methyl}furan-2-carboxylate (<b>9y</b>)</h4><div class="NLM_p last">Yield 71%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.37 (br. s., 1H), 8.25 (t, <i>J</i> = 6.04 Hz, 1H), 7.42–7.60 (m, 2H), 7.21 (d, <i>J</i> = 3.29 Hz, 1H), 6.97–7.12 (m, 1H), 6.48 (d, <i>J</i> = 3.29 Hz, 1H), 4.26 (q, <i>J</i> = 7.32 Hz, 2H), 3.80 (s, 3H), 3.53 (s, 2H), 3.18 (t, <i>J</i> = 6.22 Hz, 2H), 2.81 (d, <i>J</i> = 11.34 Hz, 2H), 1.87–2.05 (m, 2H), 1.46–1.73 (m, 3H), 1.28 (t, <i>J</i> = 6.95 Hz, 3H), 1.01–1.41 ppm (m, 2H). HRMS, Q-TOF found for C<sub>23</sub>H<sub>29</sub>N<sub>4</sub>O<sub>5</sub>: 441.2134.</div></div><div id="sec4_2_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> Methyl 2-{[4-({[(5-Methoxy-1<i>H</i>-indazol-3-yl)carbonyl]amino}methyl)piperidin-1-yl] methyl}-1,3-oxazole-4-carboxylate (<b>9aa</b>)</h4><div class="NLM_p last">Yield 45%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.40 (br. s., 1H), 8.80 (s, 1H), 8.26 (t, J = 6.2 Hz, 1H), 7.55 (d, <i>J</i> = 2.6 Hz, 1H), 7.51 (d, <i>J</i> = 9.1 Hz, 1H), 7.05 (dd, <i>J</i> = 2.4 and 9.0 Hz, 1H), 3.80 (s, 6H), 3.67 (s, 2H), 3.18 (t, <i>J</i> = 6.2 Hz, 2H), 2.82 (d, <i>J</i> = 11.3 Hz, 2H), 2.14–1.93 (m, 2H), 1.74–1.45 (m, 3H), 1.29–1.10 ppm (m, 2H). HRMS, Q-TOF found for C<sub>21</sub>H<sub>26</sub>N<sub>5</sub>O<sub>5</sub>: 428.1926.</div></div><div id="sec4_2_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Methyl 2-{[4-({[(5-Methoxy-1<i>H</i>-indazol-3-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}-1,3-thiazole-4-carboxylate (<b>9ac</b>)</h4><div class="NLM_p last">Yield 32%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.41 (s, 1H), 8.46 (s, 1H), 8.29 (t, <i>J</i> = 6.0 Hz, 1H), 7.55 (d, <i>J</i> = 2.2 Hz, 1H), 7.50 (d, <i>J</i> = 9.1 Hz, 1H), 7.05 (dd, <i>J</i> = 2.4 and 9.0 Hz, 1H), 3.81 (s, 3H), 3.80 (s, 5H), 3.21 (t, <i>J</i> = 6.2 Hz, 2H), 2.89 (d, <i>J</i> = 11.3 Hz, 2H), 2.13 (t, <i>J</i> = 10.8 Hz, 2H), 1.78–1.54 (m, 3H), 1.37–1.14 ppm (m, 2H). HRMS, Q-TOF found for C<sub>21</sub>H<sub>26</sub>N<sub>5</sub>O<sub>4</sub>S: 444.1700.</div></div><div id="sec4_2_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> Ethyl 4-{[4-({[(5-Methoxy-1<i>H</i>-indazol-3-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}-1,3-thiazole-2-carboxylate (<b>9ad</b>)</h4><div class="NLM_p last">Yield 11%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.39 (s, 1H), 8.26 (t, <i>J</i> = 6.0 Hz, 1H), 7.86 (s, 1H), 7.55 (d, <i>J</i> = 2.2 Hz, 1H), 7.50 (d, <i>J</i> = 8.8 Hz, 1H), 7.04 (dd, <i>J</i> = 2.2, 8.8 Hz, 1H), 4.37 (q, J = 7.0 Hz, 2H), 3.80 (s, 3H), 3.64 (s, 2H), 3.19 (t, J = 6.2 Hz, 2H), 2.85 (d, <i>J</i> = 11.3 Hz, 2H), 1.98 (t, <i>J</i> = 10.6 Hz, 2H), 1.79–1.45 (m, 3H), 1.33 (t, <i>J</i> = 7.1 Hz, 3H), 1.29–0.96 ppm (m, 2H). HRMS, Q-TOF found for C<sub>22</sub>H<sub>28</sub>N<sub>5</sub>O<sub>4</sub>S: 458.1855.</div></div><div id="sec4_2_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> <i>N</i>-({1-[(5-Carbamoyl-1,2,4-oxadiazol-3-yl)methyl]piperidin-4-yl}methyl)-5-methoxy-1<i>H</i>-indazole-3-carboxamide (<b>9ae</b>)</h4><div class="NLM_p last">Yield 14%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.18 (br. s., 1H), 8.70 (br. s., 1H), 8.32 (br. s., 1H), 8.26 (t, <i>J</i> = 6.2 Hz, 1H), 7.55 (d, <i>J</i> = 1.8 Hz, 1H), 7.50 (dd, <i>J</i> = 0.7 and 9.1 Hz, 1H), 7.05 (dd, <i>J</i> = 1.8, 9.1 Hz, 1H), 3.80 (s, 3H), 3.69 (s, 2H), 3.19 (t, <i>J</i> = 6.2 Hz, 2H), 2.86 (d, <i>J</i> = 11.0 Hz, 2H), 2.19–1.93 (m, 2H), 1.82–1.39 (m, 3H), 1.33–1.07 ppm (m, 2H). HRMS, Q-TOF found for C<sub>19</sub>H<sub>24</sub>N<sub>7</sub>O<sub>4</sub>: 414.1881.</div></div><div id="sec4_2_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Methyl 2-{[4-({[(5-Methoxy-1<i>H</i>-indazol-3-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}furan-3-carboxylate (<b>9af</b>)</h4><div class="NLM_p last">Yield 13%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.39 (s, 1H), 8.23 (t, <i>J</i> = 6.0 Hz, 1H), 7.70 (d, <i>J</i> = 2.2 Hz, 1H), 7.54 (d, <i>J</i> = 2.6 Hz, 1H), 7.50 (d, <i>J</i> = 8.4 Hz, 1H), 7.04 (dd, <i>J</i> = 2.4 and 9.0 Hz, 1H), 6.70 (d, <i>J</i> = 2.2 Hz, 1H), 3.83 (s, 2H), 3.80 (s, 3H), 3.76 (s, 3H), 3.17 (t, <i>J</i> = 6.4 Hz, 2H), 2.80 (d, <i>J</i> = 11.3 Hz, 2H), 2.10–1.88 (m, 2H), 1.70–1.42 (m, 3H), 1.31–1.02 ppm (m, 2H). HRMS, Q-TOF found for C<sub>22</sub>H<sub>27</sub>N<sub>4</sub>O<sub>5</sub>: 427.1977.</div></div><div id="sec4_2_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> <i>N</i>-[(1-{2-[(2<i>R</i>,6<i>S</i>)-2,6-Dimethylmorpholin-4-yl]ethyl}piperidin-4-yl)methyl]-5-methoxy-1<i>H</i>-indazole-3-carboxamide (<b>9ag</b>)</h4><div class="NLM_p last">Yield 48%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.40 (s, 1H), 8.30–8.14 (t, <i>J</i> = 6.11 Hz, 1H), 7.58–7.53 (d, <i>J</i> = 1.98 Hz, 1H), 7.53–7.46 (dd, <i>J</i> = 8.92, 0.66 Hz, 1H), 7.11–6.96 (dd, <i>J</i> = 8.92, 2.31 Hz, 1H), 3.80 (s, 3H), 3.57–3.43 (m, 2H), 3.21–3.11 (t, <i>J</i> = 6.28 Hz, 2H), 2.92–2.77 (d, <i>J</i> = 11.23 Hz, 2H), 2.76–2.63 (d, <i>J</i> = 10.24 Hz, 2H), 2.44–2.26 (m, 4H), 1.97–1.77 (t, <i>J</i> = 10,90 Hz, 2H), 1.71–1.46 (t, <i>J</i> = 10.73 Hz, 4H), 1.27–1.07 (m, 3H), 1.06–0.94 ppm (d, <i>J</i> = 6.28 Hz, 6H). HRMS, Q-TOF found for C<sub>23</sub>H<sub>36</sub>N<sub>5</sub>O<sub>3</sub>: 430.2816.</div></div><div id="sec4_2_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> <i>N</i>-[(1-{3-[(2<i>R</i>,6<i>S</i>)-2,6-Dimethylmorpholin-4-yl]propyl}piperidin-4-yl)methyl]-5-methoxy-1<i>H</i>-indazole-3-carboxamide (<b>9ah</b>)</h4><div class="NLM_p last">Yield 59%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 12.12 (s, 1H), 7.80–7.62 (d, <i>J</i> = 2.20 Hz, 1H), 7.40–7.32 (d, <i>J</i> = 9.15, 1H), 7.27–7.18 (t, <i>J</i> = 6.04 Hz, 1H), 7.07–6.99 (dd, <i>J</i> = 9.15 and 2.20 Hz, 1H), 3.89–3.78 (s, 3H), 3.76–3.53 (m, 2H), 3.47–3.30 (t, <i>J</i> = 6.22 Hz, 2H), 3.07–2.93 (m, 2H), 2.75–2.68 (d, <i>J</i> = 10.98 Hz, 2H), 2.45–2.24 (m, 4H), 2.07–1.88 (t, <i>J</i> = 10.79 Hz, 2H), 1.83–1.59 (m, 7H), 1.53–1.35 (m, 2H), 1.18–1.05 ppm (d, <i>J</i> = 6.22 Hz, 6H). HRMS, Q-TOF found for C<sub>24</sub>H<sub>38</sub>N<sub>5</sub>O<sub>3</sub>: 444.2971.</div></div><div id="sec4_2_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> General Method for the Alkaline Hydrolysis of Ester Derivatives <b>20b</b>,<b>d</b> and <b>9y</b>,<b>aa</b>,<b>ac</b></h4><div class="NLM_p last">To a solution of an ester derivative (<b>9y</b>, <b>9aa</b>, <b>9ac</b>, <b>20b</b>, or <b>20d</b>, 1.85 mmol) in MeOH (10 mL), aqueous NaOH (1 M, 3.7 mL) was added. The solution was heated to reflux overnight, then the organic solvent was removed under vacuum, the residue was diluted with H<sub>2</sub>O, and the pH was adjusted to 5–6 by adding 1 M HCl. The mixture was kept at 4 °C overnight, then the resulting solid was filtered, washed with water, dried under vacuum, and then properly purified.</div></div><div id="sec4_2_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> [4-({[(5-Methoxy-1<i>H</i>-indazol-3-yl)-carbonyl]amino}methyl)piperidin-1-yl]acetic Acid (<b>9b</b>)</h4><div class="NLM_p last">Yield 87%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.95 (br. s., 2H), 8.24 (t, <i>J</i> = 6.06 Hz, 1H), 7.38–7.62 (m, 2H), 6.86–7.13 (m, 1H), 3.81 (s, 3H), 3.18 (t, <i>J</i> = 6.16 Hz, 2H), 2.94 (d, <i>J</i> = 11.10 Hz, 2H), 2.74 (s, 2H), 1.99 (t, <i>J</i> = 10.90 Hz, 2H), 1.45–1.66 (m, 3H), 1.11–1.35 ppm (m, 2H). HRMS, Q-TOF found for C<sub>17</sub>H<sub>23</sub>N<sub>4</sub>O<sub>4</sub>: 347.1677.</div></div><div id="sec4_2_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 4-[4-({[(5-Methoxy-1<i>H</i>-indazol-3-yl)carbonyl]amino}methyl)piperidin-1-yl]butanoic Acid (<b>9d</b>)</h4><div class="NLM_p last">Yield 75%. <sup>1</sup>H NMR (DMSO-d6) δ 13.54 (br. s., 1H), 11.25 (br. s., 1H), 8.46 (t, <i>J</i> = 6.1 Hz, 1H), 7.55 (d, <i>J</i> = 2.3 Hz, 1H), 7.52 (d, <i>J</i> = 8.9 Hz, 1H), 7.05 (dd, <i>J</i> = 2.3, 8.9 Hz, 1H), 3.80 (s, 3H), 3.37 (d, <i>J</i> = 12.2 Hz, 2H), 3.23 (t, <i>J</i> = 6.1 Hz, 2H), 3.00–2.89 (m, 2H), 2.81 (t, <i>J</i> = 11.4 Hz, 2H), 2.32 (t, <i>J</i> = 7.1 Hz, 2H), 2.01–1.70 (m, 5H), 1.64–1.41 ppm (m, 2H). HRMS, Q-TOF found for C<sub>19</sub>H<sub>27</sub>N<sub>4</sub>O<sub>4</sub>: 375.2029.</div></div><div id="sec4_2_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Sodium 5-{[4-({[(5-Methoxy-1<i>H</i>-indazol-3-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}pyridine-2-carboxylate (<b>9r</b>)</h4><div class="NLM_p last">Compound <b>9r</b> was obtained after the alkaline workup of the crude methyl 5-{[4-({[(5-methoxy-1<i>H</i>-indazol-3-yl)carbonyl]amino}methyl)-piperidin-1-yl]methyl}pyridine-2-carboxylate. Yield 91%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.86 (br. s., 1H), 8.37 (d, <i>J</i> = 1.2 Hz, 1H), 8.24 (t, <i>J</i> = 6.1 Hz, 1H), 7.91 (d, <i>J</i> = 8.1 Hz, 1H), 7.65 (dd, <i>J</i> = 2.0, 8.1 Hz, 1H), 7.61–7.48 (m, 2H), 7.01 (dd, <i>J</i> = 2.5 and 8.8 Hz, 1H), 3.79 (s, 3H), 3.47 (s, 2H), 3.19 (t, <i>J</i> = 6.1 Hz, 2H), 2.77 (d, <i>J</i> = 10.9 Hz, 2H), 1.91 (t, <i>J</i> = 10.9 Hz, 2H), 1.65 (s, 3H), 1.35–1.07 ppm (m, 2H). HRMS, Q-TOF found for C<sub>22</sub>H<sub>26</sub>N<sub>5</sub>O<sub>4</sub>: 424.1977.</div></div><div id="sec4_2_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 4-{[4-({[(5-Methoxy-1<i>H</i>-indazol-3-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}pyridine-2-carboxylic Acid (<b>9s</b>)</h4><div class="NLM_p last">Compound <b>9s</b> was obtained after the alkaline workup of the crude methyl 4-{[4-({[(5-methoxy-1<i>H</i>-indazol-3-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}pyridine-2-carboxylate (yield 16%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.25 (br. s, 2H), 8.54 (d, <i>J</i> = 4.8 Hz, 1H), 8.27 (t, <i>J</i> = 6.0 Hz, 1H), 7.93 (s, 1H), 7.56 (d, <i>J</i> = 2.2 Hz, 1H), 7.51 (d, <i>J</i> = 9.5 Hz, 1H), 7.43 (d, <i>J</i> = 4.0 Hz, 1H), 7.04 (dd, <i>J</i> = 2.2, 9.5 Hz, 1H), 3.80 (s, 3H), 3.53 (s, 2H), 3.20 (t, <i>J</i> = 6.0 Hz, 2H), 2.78 (d, <i>J</i> = 11.0 Hz, 2H), 1.96 (t, <i>J</i> = 10.6 Hz, 2H), 1.75–1.45 (m, 3H), 1.35–1.16 ppm (m, 2H). HRMS, Q-TOF found for C<sub>22</sub>H<sub>26</sub>N<sub>5</sub>O<sub>4</sub>: 424.1981.</div></div><div id="sec4_2_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 5-{[4-({[(5-Methoxy-1<i>H</i>-indazol-3-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}furan-2-carboxylic Acid (<b>9x</b>)</h4><div class="NLM_p last">Yield 84%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 12.78–14.43 (m, 1H), 8.26 (t, <i>J</i> = 6.04 Hz, 1H), 7.55 (d, <i>J</i> = 2.56 Hz, 1H), 7.52 (d, <i>J</i> = 9.15 Hz, 1H), 7.04 (dd, <i>J</i> = 2.60 and 9.10 Hz, 1H), 6.91 (d, <i>J</i> = 3.29 Hz, 1H), 6.35 (d, <i>J</i> = 3.29 Hz, 1H), 4.04 (br. s., 1H), 3.80 (s, 3H), 3.50 (s, 2H), 3.18 (t, <i>J</i> = 6.22 Hz, 2H), 2.83 (d, <i>J</i> = 11.34 Hz, 2H), 1.97 (t, <i>J</i> = 10.79 Hz, 2H), 1.47–1.73 (m, 3H), 1.04–1.33 ppm (m, 2H). HRMS, Q-TOF found for C<sub>21</sub>H<sub>25</sub>N<sub>4</sub>O<sub>5</sub>: 413.181946.</div></div><div id="sec4_2_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 2-{[4-({[(5-Methoxy-1<i>H</i>-indazol-3-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}-1,3-oxazole-4-carboxylic Acid (<b>9z</b>)</h4><div class="NLM_p last">Yield 82%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.40 (s, 1H), 12.99 (br. s., 1H), 8.67 (s, 1H), 8.26 (t, <i>J</i> = 6.0 Hz, 1H), 7.55 (d, <i>J</i> = 2.2 Hz, 1H), 7.50 (d, <i>J</i> = 9.5 Hz, 1H), 7.04 (dd, <i>J</i> = 2.6 and 9.1 Hz, 1H), 3.80 (s, 3H), 3.66 (s, 2H), 3.18 (t, <i>J</i> = 6.4 Hz, 2H), 2.82 (d, <i>J</i> = 11.0 Hz, 2H), 2.05 (t, <i>J</i> = 10.4 Hz, 2H), 1.76–1.44 (m, 3H), 1.33–1.05 (m, 2H). HRMS, Q-TOF found for C<sub>20</sub>H<sub>24</sub>N<sub>5</sub>O<sub>5</sub>: 414.177195.</div></div><div id="sec4_2_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 2-{[4-({[(5-Methoxy-1<i>H</i>-indazol-3-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}-1,3-thiazole-4-carboxylic Acid (<b>9ab</b>)</h4><div class="NLM_p last">Yield 43%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.42 (br. s., 1H), 12.91 (br. s., 1H), 8.34 (s, 1H), 8.29 (t, <i>J</i> = 6.0 Hz, 1H), 7.56 (d, <i>J</i> = 2.2 Hz, 1H), 7.51 (d, <i>J</i> = 9.1 Hz, 1H), 7.05 (dd, <i>J</i> = 2.6 and 9.1 Hz, 1H), 3.87–3.69 (m, 5H), 3.22 (t, <i>J</i> = 6.2 Hz, 2H), 2.89 (d, <i>J</i> = 11.3 Hz, 2H), 2.12 (t, <i>J</i> = 10.6 Hz, 2H), 1.81–1.50 (m, 3H), 1.37–1.11 ppm (m, 2H). HRMS, Q-TOF found for C<sub>20</sub>H<sub>24</sub>N<sub>5</sub>O<sub>4</sub>S: 430.1545.</div></div><div id="sec4_2_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> <i>tert</i>-Butyl {3-[4-({[(5-Methoxy-1<i>H</i>-indazol-3-yl)carbonyl]amino}methyl)piperidin-1-yl]propyl}carbamate (<b>20l</b>)</h4><div class="NLM_p last">A solution of compound <b>8a</b> (1.37g, 4.36 mmol) in DMF (45 mL) and triethylamine (1.3 mL, 9.5 mmol) was stirred at 80 °C for 1 h and treated with <i>tert</i>-butyl (3-bromopropyl)carbamate (1.7 g, 7.1 mmol). The mixture was stirred overnight at the same temperature. The reaction was cooled to room temperature, and the solvent was removed by evaporation at reduced pressure. The crude <i>tert</i>-butyl {3-[4-({[(5-methoxy-1<i>H</i>-indazol-3-yl)carbonyl]amino}methyl)piperidin-1-yl]propyl}carbamate <b>20l</b> was used for the following reaction without further purification. HRMS, Q-TOF found for C<sub>23</sub>H<sub>36</sub>N<sub>5</sub>O<sub>4</sub>: 446.2763.</div></div><div id="sec4_2_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> <i>N</i>-{[1-(3-Aminopropyl)piperidin-4-yl]methyl}-5-methoxy-1<i>H</i>-indazole-3-carboxamide (<b>21l</b>)</h4><div class="NLM_p last">A solution of crude <i>tert</i>-butyl {3-[4-({[(5-methoxy-1<i>H</i>-indazol-3-yl)carbonyl]amino}methyl)piperidin-1-yl]propyl}carbamate <b>20l</b> (approximately 1.8 g) in CH<sub>2</sub>Cl<sub>2</sub> (15 mL) was treated with trifluoroacetic acid (7 mL) at room temperature overnight. The solution was poured into water (50 mL) and washed with CH<sub>2</sub>Cl<sub>2</sub>. The acid phase was basified and concentrated at reduced pressure. The solid residue was extracted with a mixture of CH<sub>3</sub>Cl/CH<sub>3</sub>OH in 8/2 ratio and the solvent evaporated at reduced pressure. The crude <i>N</i>-{[1-(3-aminopropyl)piperidin-4-yl]methyl}-5-methoxy-1<i>H</i>-indazole-3-carboxamide <b>21l</b> was used for the next step without further purification.</div></div><div id="sec4_2_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> General Procedure for the Synthesis of Compounds <b>9h</b>–<b>l</b></h4><div class="NLM_p last">To a solution of crude <i>N</i>-{[1-(3-aminopropyl)piperidin-4-yl]methyl}-5-methoxy-1<i>H</i>-indazole-3-carboxamide <b>21l</b> (approximately 350 mg, 1 mmol) in DMSO (1.5 mL) and CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added the appropriate acyl chloride (0.61 mmol). The solution was then stirred at room temperature for 2 h. The mixture was added to water and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic phases were concentrated at reduced pressure, and the crude product was purify by preparative HPLC-MS.</div></div><div id="sec4_2_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 5-Methoxy-<i>N</i>-({1-[3-(propanoylamino)propyl]piperidin-4-yl}methyl)-1<i>H</i>-indazole-3-carboxamide (<b>9h</b>)</h4><div class="NLM_p last">Yield 69%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.28 (s, 1H), 8.17–8.00 (m, 1H), 7.65–7.55 (m, 1H), 7.58–7.54 (d, <i>J</i> = 2.20 Hz, 1H), 7.52–7.45 (d, <i>J</i> = 9.20 Hz, 1H), 7.10–7.00 (dd, <i>J</i> = 9.15 and 2.60 Hz, 1H), 3.81 (s, 3H), 3.30–2.85 (m, 8H), 2.11–2.00 (q, <i>J</i> = 7.70 Hz, 2H), 1.80–1.52 (m, 6H), 1.40–1.15 (m, 3H), 1.03–0.95 ppm (t, <i>J</i> = 7.70 Hz, 3H). HRMS, Q-TOF found for C<sub>21</sub>H<sub>32</sub>N<sub>5</sub>O<sub>3</sub>: 402.2499.</div></div><div id="sec4_2_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> <i>N</i>-({1-[3-(Butanoylamino)propyl]piperidin-4-yl}methyl)-5-methoxy-1<i>H</i>-indazole-3-carboxamide (<b>9i</b>)</h4><div class="NLM_p last">Yield 36%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.44 (s,1H), 8.41–8.26 (t, <i>J</i> = 6.11 Hz, 1H), 7.89–7.69 (t, <i>J</i> = 5.12 Hz, 1H), 7.58–7.54 (d, <i>J</i> = 2.31, 1H), 7.53–7.47 (dd, <i>J</i> = 8.92 and 0.66 Hz, 1H), 7.11–6.96 (dd, <i>J</i> = 9.08, 2.48 Hz, 1H), 3.80 (s, 3H), 3.52–2.77 (m, 10H), 2.10–1.92 (t, <i>J</i> = 7.27 Hz, 2H), 1.81–1.12 (m, 9H), 0.91–0.77 ppm (t, <i>J</i> = 7.27, 3H). HRMS, Q-TOF found for C<sub>22</sub>H<sub>34</sub>N<sub>5</sub>O<sub>3</sub>: 416.265616.</div></div><div id="sec4_2_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> <i>N</i>-[(1-{3-[(2<i>E</i>)-But-2-enoylamino]propyl}piperidin-4-yl)methyl]-5-methoxy-1<i>H</i>-indazole-3-carboxamide (<b>9j</b>)</h4><div class="NLM_p last">Yield 51%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.44 (s, 1H), 8.45–8.25 (m, 1H), 8.00–7.75 (m, 1H), 7.60–7.53 (d, <i>J</i> = 2.40 Hz, 1H), 7.53–7.47 (d, <i>J</i> = 8.90 Hz, 1H), 7.09–7.01 (dd, <i>J</i> = 2.70 and 2.30 Hz, 1H), 6.67–6.50 (m, 1H), 5.75–6.00 (m, 1H), 3.80 (s, 3H), 3.50–1.00 ppm (m, 20H). HRMS, Q-TOF found for C<sub>22</sub>H<sub>32</sub>N<sub>5</sub>O<sub>3</sub>: 414.2501.</div></div><div id="sec4_2_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> <i>N</i>-({1-[3-(But-2-ynoylamino)propyl]piperidin-4-yl}methyl)-5-methoxy-1<i>H</i>-indazole-3-carboxamide (<b>9k</b>)</h4><div class="NLM_p last">Yield 17%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.34 (s, 1H), 8.52–8.42 (t, <i>J</i> = 5.31 Hz, 1H), 8.27–8.18 (t, <i>J</i> = 6.04 Hz, 1H), 7.56–7.52 (d, <i>J</i> = 2.20 Hz, 1H), 7.52–7.47 (d, <i>J</i> = 8.78 Hz, 1H), 7.05–6.99 (dd, <i>J</i> = 8.96, 2.38 Hz, 1H), 3.80 (s, 3H), 3.21–3.13 (t, <i>J</i> = 6.40 Hz, 2H), 3.11–3.01 (q, <i>J</i> = 6.59 Hz, 2H), 2.87–2.75 (d, <i>J</i> = 11.34 Hz, 2H), 2.30–2.18 (t, <i>J</i> = 6.95 Hz, 2H), 1.94 (s, 3H), 1.88–1.73 (t, <i>J</i> = 10.61 Hz, 2H), 1.70–1.45 (m, 5H), 1.30–1.10 ppm (m, 2H). HRMS, Q-TOF found for C<sub>22</sub>H<sub>30</sub>N<sub>5</sub>O<sub>3</sub>: 412.2346.</div></div><div id="sec4_2_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 5-Methoxy-<i>N</i>-[(1-{3-[(phenylcarbonyl)amino]propyl}piperidin-4-yl)methyl]-1<i>H</i>-indazole-3-carboxamide (<b>9l</b>)</h4><div class="NLM_p last">Yield 23%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.43 (s,1H), 8.59–8.47 (t, <i>J</i> = 5.31 Hz, 1H), 8.38–8.24 (t, <i>J</i> = 6.04 Hz, 1H), 7.90–7.74 (m, 2H), 7.61–7.35 (m, 5H), 7.10–6.99 (dd, <i>J</i> = 9.15 and 2.56 Hz, 1H), 3.89–3.69 (s, 3H), 3.39–3.12 (m, 6H), 3.11–2.94 (m, 2H), 2.25–1.89 (m, 2H), 1.83–1.53 (m, 5H), 1.36–1.12 ppm (d, <i>J</i> = 11.34 Hz, 2H). HRMS, Q-TOF found for C<sub>25</sub>H<sub>32</sub>N<sub>5</sub>O<sub>3</sub>: 450.2498.</div></div><div id="sec4_2_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> Synthesis of 5-Bromoindazole Intermediates <b>13c</b>, <b>14c</b>, <b>15d</b>, <b>16d</b>, and <b>17d</b></h4><div class="NLM_p last">Compounds <b>13c</b>, <b>14c</b>, <b>15d</b>, <b>16d</b>, and <b>17d</b> were prepared using the same procedure as that described for compound <b>9a</b>, starting from the 5-bromoindazole intermediate <b>8b</b>.</div></div><div id="sec4_2_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 5-Bromo-<i>N</i>-{[1-(2-phenylethyl)piperidin-4-yl]methyl}-1<i>H</i>-indazole-3-carboxamide (<b>13c</b>)</h4><div class="NLM_p last">Yield 53%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ = 13.73 (br. s., 1H), 8.42 (t, <i>J</i> = 6.0 Hz, 1H), 8.32 (dd, <i>J</i> = 0.7, 1.8 Hz, 1H), 7.61 (dd, <i>J</i> = 0.7 and 8.8 Hz, 1H), 7.53 (dd, <i>J</i> = 1.8 and 8.8 Hz, 1H), 7.32–7.10 (m, 5H), 3.20 (t, <i>J</i> = 6.3 Hz, 2H), 2.93 (d, <i>J</i> = 10.2 Hz, 2H), 2.79–2.64 (m, <i>J</i> = 8.4 Hz, 2H), 2.50–2.41 (m, 2H), 1.93 (t, <i>J</i> = 9.9 Hz, 2H), 1.64 (br. s., 3H), 1.39–1.04 ppm (m, 2H). HRMS, Q-TOF found for C<sub>22</sub>H<sub>26</sub>BrN<sub>4</sub>O: 441.1284.</div></div><div id="sec4_2_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 5-Bromo-<i>N</i>-{[1-(2-methoxyethyl)piperidine-4-yl]methyl}-1<i>H</i>-indazole-3-carboxamide (<b>14c</b>)</h4><div class="NLM_p last">Yield 42%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.4 (br. s., 1H), 8.42 (t, <i>J</i> = 6.07 Hz, 1H), 8.31 (dd, <i>J</i> = 1.83 and 0.67 Hz, 1H), 7.61 (dd, <i>J</i> = 8.70 and 0.70 Hz, 1H), 7.53 (dd, <i>J</i> = 8.70 and 1.70 Hz, 1H), 3.41 (t, <i>J</i> = 5.97 Hz, 2H), 3.22 (s, 3H), 3.13–3.21 (m, 2H), 2.78–2.94 (m, 2H), 2.30–2.47 (m, 2H), 1.82–2.09 (m, 2H), 1.39–1.77 (m, 3H), 1.08–1.30 ppm (m, 2H). HRMS, Q-TOF found for C<sub>17</sub>H<sub>24</sub>BrN<sub>4</sub>O<sub>2</sub>: 395.1077.</div></div><div id="sec4_2_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> Ethyl 5-{[4-({[(5-Bromo-1<i>H</i>-indazol-3-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}furan-2-carboxylate (<b>15d</b>)</h4><div class="NLM_p last">Yield 62%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.73 (br. s., 1H), 8.41 (t, <i>J</i> = 6.04 Hz, 1H), 8.32 (dd, <i>J</i> = 0.73 and 1.83 Hz, 1H), 7.57–7.65 (m, 1H), 7.45–7.56 (m, 1H), 7.21 (d, <i>J</i> = 3.66 Hz, 1H), 6.48 (d, <i>J</i> = 3.66 Hz, 1H), 4.27 (q, <i>J</i> = 7.32 Hz, 2H), 3.53 (s, 2H), 3.19 (t, <i>J</i> = 6.40 Hz, 2H), 2.81 (d, <i>J</i> = 11.34 Hz, 2H), 1.82–2.09 (m, 2H), 1.64 (d, <i>J</i> = 12.44 Hz, 3H), 1.02–1.36 ppm (m, 5H). HRMS, Q-TOF found for C<sub>22</sub>H<sub>26</sub>BrN<sub>4</sub>O<sub>4</sub>: 489.1132.</div></div><div id="sec4_2_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> Methyl 2-{[4-({[(5-Bromo-1<i>H</i>-indazol-3-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}-1,3-oxazole-4-carboxylate (<b>16d</b>)</h4><div class="NLM_p last">Yield 16%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.73 (br. s., 1H), 8.80 (s, 1H), 8.42 (t, <i>J</i> = 6.0 Hz, 1H), 8.31 (dd, <i>J</i> = 0.8, 1.8 Hz, 1H), 7.60 (dd, <i>J</i> = 0.8, 8.8 Hz, 1H), 7.52 (dd, <i>J</i> = 1.8, 8.8 Hz, 1H), 3.80 (s, 3H), 3.67 (s, 2H), 3.18 (t, <i>J</i> = 6.4 Hz, 2H), 2.81 (d, J = 11.3 Hz, 2H), 2.13–1.95 (m, 2H), 1.74–1.44 (m, 3H), 1.32–1.06 ppm (m, 2H). HRMS, Q-TOF found for C<sub>20</sub>H<sub>23</sub>BrN<sub>5</sub>O<sub>4</sub>: 476.0928.</div></div><div id="sec4_2_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Ethyl [4-({[(5-Bromo-1<i>H</i>-indazol-3-yl)carbonyl]amino}methyl)piperidin-1-yl]acetate (<b>17d</b>)</h4><div class="NLM_p last">Yield 31%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.74 (s, 1H), 8.43 (t, <i>J</i> = 6.0 Hz, 1H), 8.32 (dd, <i>J</i> = 0.6 and 1.9 Hz, 1H), 7.61 (dd, <i>J</i> = 0.6 and 8.9 Hz, 1H), 7.53 (dd, <i>J</i> = 1.9 and 8.9 Hz, 1H), 4.07 (q, <i>J</i> = 7.1 Hz, 2H), 3.20 (t, <i>J</i> = 6.4 Hz, 2H), 3.17 (s, 2H), 2.81 (d, <i>J</i> = 11.2 Hz, 2H), 2.22–2.03 (m, 2H), 1.72–1.46 (m, 3H), 1.31–1.08 ppm (m, 5H). HRMS, Q-TOF found for C<sub>18</sub>H<sub>24</sub>BrN<sub>4</sub>O<sub>3</sub>: 423.1026.</div></div><div id="sec4_2_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> Sodium 5-{[4-({[(5-Bromo-1<i>H</i>-indazol-3-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}furan-2-carboxylate (<b>15c</b>)</h4><div class="NLM_p last">Compound <b>15c</b> was prepared with the same procedure described for compound <b>9b</b>, starting from the 5-bromoindazole intermediate <b>15d</b>. Yield 98%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.78 (br. s., 1H), 8.43 (t, <i>J</i> = 5.85 Hz, 1H), 8.32 (d, <i>J</i> = 1.21 Hz, 1H), 7.61 (d, <i>J</i> = 8.80 Hz, 1H), 7.53 (dd, <i>J</i> = 2.00 and 8.80 Hz, 1H), 7.11 (d, <i>J</i> = 3.63 Hz, 1H), 6.45 (d, <i>J</i> = 3.23 Hz, 1H), 3.57 (s, 2H), 3.19 (t, <i>J</i> = 6.26 Hz, 2H), 2.85 (d, <i>J</i> = 11.30 Hz, 2H), 2.02 (t, <i>J</i> = 10.90 Hz, 2H), 1.45–1.77 (m, 3H), 1.08–1.37 ppm (m, 2H). HRMS, Q-TOF found for C<sub>20</sub>H<sub>22</sub>BrN<sub>4</sub>O<sub>4</sub>: 461.081887.</div></div><div id="sec4_2_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> General Method for the Preparation of Compounds <b>13</b>–<b>17</b></h4><div class="NLM_p last">A mixture of the starting 5-bromoindazole derivative (<b>13c</b>, <b>14c</b>, <b>15d</b>, <b>16d</b>, or <b>17d</b>) (0.44 mmol), the appropriately substituted arylboronic acid (1.77 mmol), [1,1′-bis(diphenylphosphino)ferrocene]-dichloro-palladium(II) [Pd(dppf)Cl<sub>2</sub>] (81 mg, 0.11 mmol), and cesium carbonate (575 mg, 1.76 mmol) in 1,4-dioxane and water (ratio 3/1; 8 mL) was subjected to microwave irradiation in a Milestone oven: (45′ @ T = 160 °C, max power 300W). After microwave irradiation, solvents were removed by evaporating under reduced pressure, and the reaction mixture was diluted with a mixture of chloroform and methanol in a 2:1 ratio and filtered. Final compounds were purified by the preparative HPLC-MS method.</div></div><div id="sec4_2_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 5-(2-Fluorophenyl)-<i>N</i>-{[1-(2-phenylethyl)piperidin-4-yl]methyl}-1<i>H</i>-indazole-3-carboxamide (<b>13g</b>)</h4><div class="NLM_p last">Yield 45%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 15.02–11.90 (m, 1H), 8.38 (t, <i>J</i> = 6.0 Hz, 1H), 8.33 (d, <i>J</i> = 0.7 Hz, 1H), 7.72 (dd, <i>J</i> = 0.7 and 8.6 Hz, 1H), 7.64–7.52 (m, 2H), 7.49–7.06 (m, 8H), 3.22 (t, <i>J</i> = 6.3 Hz, 2H), 2.92 (d, <i>J</i> = 11.2 Hz, 2H), 2.78–2.65 (m, 2H), 2.50–2.41 (m, 2H), 1.93 (t, <i>J</i> = 10.6 Hz, 2H), 1.78–1.47 (m, 3H), 1.33–1.07 ppm (m, 2H). HRMS, Q-TOF found for C<sub>28</sub>H<sub>30</sub>FN<sub>4</sub>O: 457.2398.</div></div><div id="sec4_2_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 5-(2,3-Difluorophenyl)-<i>N</i>-{[1-(2-phenylethyl)piperidin-4-yl]methyl}-1<i>H</i>-indazole-3-carboxamide (<b>13i</b>)</h4><div class="NLM_p last">Yield 28%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.71 (s, 1H), 8.48–8.20 (m, 2H), 7.74 (d, <i>J</i> = 8.8 Hz, 1H), 7.56 (d, <i>J</i> = 8.8 Hz, 1H), 7.51–7.03 (m, 8H), 3.22 (t, <i>J</i> = 6.2 Hz, 2H), 2.92 (d, <i>J</i> = 11.3 Hz, 2H), 2.81–2.61 (m, 2H), 2.49–2.41 (m, 2H), 1.93 (t, <i>J</i> = 10.7 Hz, 2H), 1.77–1.49 (m, 3H), 1.34–1.08 ppm (m, 2H). HRMS, Q-TOF found for C<sub>28</sub>H<sub>29</sub>F<sub>2</sub>N<sub>4</sub>O: 475.2305.</div></div><div id="sec4_2_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> <i>N</i>-{[1-(2-Phenylethyl)piperidin-4-yl]methyl}-5-(pyridin-3-yl)-1<i>H</i>-indazole-3-carboxamide (<b>13l</b>)</h4><div class="NLM_p last">Yield 19%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.70 (br. s., 1H), 8.91 (dd, <i>J</i> = 0.6 and 2.5 Hz, 1H), 8.59 (dd, <i>J</i> = 1.6 and 4.8 Hz, 1H), 8.49–8.31 (m, 2H), 8.10 (ddd, <i>J</i> = 1.6, 2.3, and 7.9 Hz, 1H), 7.76 (d, <i>J</i> = 1.5 Hz, 2H), 7.51 (ddd, <i>J</i> = 0.8, 4.8, and 7.9 Hz, 1H), 7.33–7.09 (m, 5H), 3.23 (t, <i>J</i> = 6.3 Hz, 2H), 2.92 (d, <i>J</i> = 11.3 Hz, 2H), 2.79–2.64 (m, 2H), 2.52–2.41 (m, 2H), 1.93 (t, <i>J</i> = 10.6 Hz, 2H), 1.75–1.51 (m, 3H), 1.32–1.09 ppm (m, 2H). HRMS, Q-TOF found for C<sub>27</sub>H<sub>30</sub>N<sub>5</sub>O: 440.2446.</div></div><div id="sec4_2_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 5-(4-Methoxypyridin-3-yl)-<i>N</i>-{[1-(2-phenylethyl)piperidin-4-yl]methyl}-1<i>H</i>-indazole-3-carboxamide (<b>13m</b>)</h4><div class="NLM_p last">Yield 17%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.32 (s, 1H), 8.47 (d, <i>J</i> = 5.7 Hz, 1H), 8.39 (s, 1H), 8.34 (t, <i>J</i> = 6.0 Hz, 1H), 8.24 (dd, <i>J</i> = 0.9 and 1.6 Hz, 1H), 7.67 (dd, <i>J</i> = 0.8 and 8.7 Hz, 1H), 7.50 (dd, <i>J</i> = 1.6 and 8.6 Hz, 1H), 7.32–7.10 (m, 6H), 3.87 (s, 3H), 3.21 (t, <i>J</i> = 6.4 Hz, 2H), 2.92 (d, <i>J</i> = 11.9 Hz, 2H), 2.77–2.67 (m, 2H), 2.50–2.42 (m, 2H), 2.02–1.83 (m, 2H), 1.74–1.50 (m, 3H), 1.33–1.08 (m, 2H). HRMS, Q-TOF found for C<sub>28</sub>H<sub>32</sub>N<sub>5</sub>O<sub>2</sub>: 470.2552.</div></div><div id="sec4_2_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 5-(6-Methylpyridin-3-yl)-<i>N</i>-{[1-(2-phenylethyl)piperidin-4-yl]methyl}-1<i>H</i>-indazole-3-carboxamide (<b>13q</b>)</h4><div class="NLM_p last">Yield 23%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.68 (br. s., 1H), 8.77 (d, <i>J</i> = 2.6 Hz, 1H), 8.46–8.34 (m, 2H), 7.99 (dd, <i>J</i> = 2.6 and 8.1 Hz, 1H), 7.74 (d, <i>J</i> = 0.9 Hz, 2H), 7.37 (d, <i>J</i> = 8.1 Hz, 1H), 7.31–7.11 (m, 5H), 3.23 (t, <i>J</i> = 6.2 Hz, 2H), 2.92 (d, <i>J</i> = 11.3 Hz, 2H), 2.72 (dd, <i>J</i> = 6.2 and 9.1 Hz, 2H), 2.53 (s, 3H), 2.50–2.43 (m, 2H), 1.93 (t, <i>J</i> = 10.6 Hz, 2H), 1.76–1.49 (m, 3H), 1.34–1.10 ppm (m, 2H). HRMS, Q-TOF found for C<sub>28</sub>H<sub>32</sub>N<sub>5</sub>O: 454.2600.</div></div><div id="sec4_2_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> <i>N</i>-{[1-(2-Methoxyethyl)piperidin-4-yl]methyl}-5-phenyl-1<i>H</i>-indazole-3-carboxamide (<b>14f</b>)</h4><div class="NLM_p last">Yield 15%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.65 (br. s., 1H), 8.40 (t, <i>J</i> = 1.28 Hz, 1H), 8.36 (t, <i>J</i> = 6.13 Hz, 1H), 7.65–7.75 (m, 4H), 7.44–7.53 (m, 2H), 7.32–7.41 (m, 1H), 3.40 (t, <i>J</i> = 6.04 Hz, 2H), 3.12–3.27 (m, <i>J</i> = 6.00 and 6.00 Hz, 5H), 2.84 (d, <i>J</i> = 11.34 Hz, 2H), 2.42 (t, <i>J</i> = 6.04 Hz, 2H), 1.83–1.97 (m, 2H), 1.49–1.71 (m, 3H), 1.09–1.31 ppm (m, 2H). HRMS, Q-TOF found for C<sub>23</sub>H<sub>29</sub>N<sub>4</sub>O<sub>2</sub>: 393.2290.</div></div><div id="sec4_2_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> 5-(2-Fluorophenyl)-<i>N</i>-{[1-(2-methoxyethyl)piperidin-4-yl]methyl}-1<i>H</i>-indazole-3-carboxamide (<b>14g</b>)</h4><div class="NLM_p last">Yield 39%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.55 (s, 1H), 8.25–8.40 (m, 2H), 7.70 (dd, <i>J</i> = 0.73 and 8.78 Hz, 1H), 7.50–7.63 (m, 2H), 7.38–7.49 (m, 1H), 7.28–7.38 (m, 2H), 3.40 (t, <i>J</i> = 5.95 Hz, 2H), 3.12–3.25 (m, 5H), 2.84 (d, <i>J</i> = 11.34 Hz, 2H), 2.42 (t, <i>J</i> = 6.04 Hz, 2H), 1.82–1.99 (m, 2H), 1.46–1.72 (m, 3H), 1.06–1.28 ppm (m, 2H). HRMS, Q-TOF found for C<sub>23</sub>H<sub>28</sub>FN<sub>4</sub>O<sub>2</sub>: 411.2196.</div></div><div id="sec4_2_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> <i>N</i>-{[1-(2-Methoxyethyl)piperidin-4-yl]methyl}-5-(2-methylphenyl)-1<i>H</i>-indazole-3-carboxamide (<b>14h</b>)</h4><div class="NLM_p last">Yield 35%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.59 (s, 1H), 8.34 (t, <i>J</i> = 6.13 Hz, 1H), 8.06 (dd, <i>J</i> = 1.56 and 0.82 Hz, 1H), 7.65 (dd, <i>J</i> = 0.73 and 8.60 Hz, 1H), 7.39 (dd, <i>J</i> = 1.65 and 8.60 Hz, 1H), 7.35–7.20 (m, 4H), 3.40 (t, <i>J</i> = 5.95 Hz, 2H), 3.27–3.13 (m, 5H), 2.84 (d, <i>J</i> = 11.53 Hz, 2H), 2.42 (t <i>J</i> = 6.04 Hz, 2H), 2.23 (s, 3H), 1.90 (t, <i>J</i> = 10.61 Hz, 2H), 1.50–1.70 (m, 3H), 1.10–1.30 ppm (m, 2H). HRMS, Q-TOF found for C<sub>24</sub>H<sub>31</sub>N<sub>4</sub>O<sub>2</sub>: 407.2453.</div></div><div id="sec4_2_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> 5-(2,3-Difluorophenyl)-<i>N</i>-{[1-(2-methoxyethyl)piperidin-4-yl]methyl}-1<i>H</i>-indazole-3-carboxamide (<b>14i</b>)</h4><div class="NLM_p last">Yield 19%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.09 (s, 1H), 8.23–8.42 (m, 2H), 7.72 (dd, <i>J</i> = 0.82 and 8.69 Hz, 1H), 7.55 (td, <i>J</i> = 1.76 and 8.74 Hz, 1H), 7.24–7.49 (m, 3H), 3.40 (t, <i>J</i> = 6.04 Hz, 2H), 3.22 (s, 3H), 3.18 (d, <i>J</i> = 6.40 Hz, 2H), 2.84 (d, <i>J</i> = 11.53 Hz, 2H), 2.42 (t, <i>J</i> = 5.95 Hz, 2H), 1.82–2.02 (m, 2H), 1.41–1.71 (m, 3H), 1.06–1.31 (m, 2H). HRMS, Q-TOF found for C<sub>23</sub>H<sub>27</sub>F<sub>2</sub>N<sub>4</sub>O<sub>2</sub>: 429.2105.</div></div><div id="sec4_2_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> <i>N</i>-{[1-(2-Methoxyethyl)piperidin-4-yl]methyl}-5-(4-methoxyphenyl)-1<i>H</i>-indazole-3-carboxamide (<b>14k</b>)</h4><div class="NLM_p last">Yield 17%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.20 (s, 1H), 8.18–8.40 (m, 2H), 7.49–7.73 (m, 4H), 6.88–7.10 (m, 2H), 3.81 (s, 3H), 3.40 (t, <i>J</i> = 5.95 Hz, 2H), 3.22 (s, 5H), 2.84 (d, <i>J</i> = 11.34 Hz, 2H), 2.42 (t, <i>J</i> = 5.95 Hz, 2H), 1.79–2.01 (m, 2H), 1.43–1.74 (m, 3H), 1.09- 1.29 ppm (m, 2H). HRMS, Q-TOF found for C<sub>24</sub>H<sub>31</sub>N<sub>4</sub>O<sub>3</sub>: 423.2400.</div></div><div id="sec4_2_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> <i>N</i>-{[1-(2-Methoxyethyl)piperidin-4-yl]methyl}-5-(pyridin-3-yl)-1<i>H</i>-indazole-3-carboxamide (<b>14l</b>)</h4><div class="NLM_p last">Yield 31%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.71 (br. s., 1H), 8.90 (dd, <i>J</i> = 0.82 and 2.47 Hz, 1H), 8.58 (dd, <i>J</i> = 1.56 and 4.67 Hz, 1H), 8.42–8.44 (m, 1H), 8.40 (t, <i>J</i> = 6.00 Hz, 1H), 8.09 (ddd, <i>J</i> = 1.65, 2.42, and 8.00 Hz, 1H), 7.70–7.81 (m, 2H), 7.51 (ddd, <i>J</i> = 0.82, 4.76, and 7.96 Hz, 1H), 3.37–3.44 (m, 2H), 3.14–3.24 (m, 5H), 2.84 (d, <i>J</i> = 11.53 Hz, 2H), 2.43 (t, <i>J</i> = 6.04 Hz, 2H), 1.82–1.99 (m, 2H), 1.47–1.74 (m, 3H), 1.09–1.29 ppm (m, 2H). HRMS, Q-TOF found for C<sub>22</sub>H<sub>28</sub>N<sub>5</sub>O<sub>2</sub>: 394.2241.</div></div><div id="sec4_2_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> <i>N</i>-{[1-(2-Methoxyethyl)piperidin-4-yl]methyl}-5-(4-methoxypyridin-3-yl)-1<i>H</i>-indazole-3-carboxamide (<b>14m</b>)</h4><div class="NLM_p last">Yield 38%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.66 (br. s., 1H), 8.47 (d, <i>J</i> = 5.85 Hz, 1H), 8.33–8.42 (m, 2H), 8.24 (dd, <i>J</i> = 0.91, 1.65 Hz, 1H), 7.66 (dd, <i>J</i> = 0.91, 8.60 Hz, 1H), 7.53 (dd, <i>J</i> = 1.65, 8.60 Hz, 1H), 7.19 (d, <i>J</i> = 5.67 Hz, 1H), 3.48 (s, 3H), 3.38–3.45 (m, 2H), 3.15–3.25 (m, 5H), 2.88 (d, <i>J</i> = 11.34 Hz, 2H), 2.48 (t, <i>J</i> = 6.00 Hz, 2H), 1.98 (t, <i>J</i> = 10.89 Hz, 2H), 1.47–1.73 (m, 3H), 1.09–1.31 ppm (m, 2H). HRMS, Q-TOF found for C<sub>23</sub>H<sub>30</sub>N<sub>5</sub>O<sub>3</sub>: 424.2350.</div></div><div id="sec4_2_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> <i>N</i>-{[1-(2-Methoxyethyl)piperidin-4-yl]methyl}-5-(5-methylpyridin-3-yl)-1<i>H</i>-indazole-3-carboxamide (<b>14n</b>)</h4><div class="NLM_p last">Yield 43%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.71 (br. s., 1H), 8.49 (d, <i>J</i> = 1.65 Hz, 1H), 8.43 (dd, <i>J</i> = 0.91 and 1.65 Hz, 1H), 8.40 (t, <i>J</i> = 6.13 Hz, 1H), 8.30 (d, <i>J</i> = 2.74 Hz, 1H), 7.78 (dd, <i>J</i> = 1.60 and 8.70 Hz, 1H), 7.73 (dd, <i>J</i> = 0.90 and 8.70 Hz, 1H), 7.62 (dd, <i>J</i> = 1.83 and 2.74 Hz, 1H), 3.94 (s, 3H), 3.40 (t, <i>J</i> = 6.04 Hz, 2H), 3.10–3.26 (m, 5H), 2.84 (d, <i>J</i> = 11.53 Hz, 2H), 2.43 (t, <i>J</i> = 5.95 Hz, 2H), 1.82–2.00 (m, 2H), 1.44–1.73 (m, 3H), 1.05–1.31 ppm (m, 2H). HRMS, Q-TOF found for C<sub>23</sub>H<sub>30</sub>N<sub>5</sub>O<sub>3</sub>: 424.2350.</div></div><div id="sec4_2_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> <i>N</i>-{[1-(2-Methoxyethyl)piperidin-4-yl]methyl}-5-(6-methoxypyridin-3-yl)-1<i>H</i>-indazole-3-carboxamide (<b>14o</b>)</h4><div class="NLM_p last">Yield 25%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.36 (s, 1H), 8.47 (dd, <i>J</i> = 0.73 and 2.56 Hz, 1H), 8.26–8.37 (m, 2H), 8.01 (dd, <i>J</i> = 2.60 and 8.60 Hz, 1H), 7.70 (dd, <i>J</i> = 1.00 and 8.80 Hz, 1H), 7.65 (dd, <i>J</i> = 1.80 and 8.80 Hz, 1H), 6.93 (dd, <i>J</i> = 0.73 and 8.60 Hz, 1H), 3.91 (s, 3H), 3.40 (t, <i>J</i> = 6.04 Hz, 2H), 3.22 (s, 5H), 2.84 (d, <i>J</i> = 11.34 Hz, 2H), 2.42 (t, <i>J</i> = 6.04 Hz, 2H), 1.80–2.01 (m, 2H), 1.47–1.74 (m, 3H), 1.02–1.35 ppm (m, 2H). HRMS, Q-TOF found for C<sub>23</sub>H<sub>30</sub>N<sub>5</sub>O<sub>3</sub>: 424.2343.</div></div><div id="sec4_2_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> <i>N</i>-{[1-(2-Methoxyethyl)piperidin-4-yl]methyl}-5-(2-methoxypyridin-3-yl)-1<i>H</i>-indazole-3-carboxamide (<b>14p</b>)</h4><div class="NLM_p last">Yield 35%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.6 (br. s, 1H), 8.24–8.38 (m, 2H), 8.18 (dd, <i>J</i> = 1.83 and 4.94 Hz, 1H), 7.76 (dd, <i>J</i> = 1.83 and 7.32 Hz, 1H), 7.62–7.69 (m, 1H), 7.46–7.58 (m, 1H), 7.11 (dd, <i>J</i> = 4.94 and 7.14 Hz, 1H), 3.89 (s, 3H), 3.40 (t, <i>J</i> = 5.95 Hz, 2H), 3.22 (s, 5H), 2.84 (d, <i>J</i> = 11.53 Hz, 2H), 2.42 (t, <i>J</i> = 6.04 Hz, 2H), 1.82–1.97 (m, 2H), 1.47- 1.72 (m, 3H), 1.06–1.29 ppm (m, 2H). HRMS, Q-TOF found for C<sub>23</sub>H<sub>30</sub>N<sub>5</sub>O<sub>3</sub>: 424.2340.</div></div><div id="sec4_2_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> <i>N</i>-{[1-(2-Methoxyethyl)piperidin-4-yl]methyl}-5-(6-methylpyridin-3-yl)-1<i>H</i>-indazole-3-carboxamide (<b>14q</b>)</h4><div class="NLM_p last">Yield 18%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.68 (br. s., 1H), 8.77 (d, <i>J</i> = 1.83 Hz, 1H), 8.32–8.43 (m, 2H), 7.98 (dd, <i>J</i> = 2.47 and 7.96 Hz, 1H), 7.73 (d, <i>J</i> = 1.28 Hz, 2H), 7.37 (d, <i>J</i> = 8.05 Hz, 1H), 3.41 (t, <i>J</i> = 5.95 Hz, 2H), 3.23 (s, 5H), 2.85 (d, <i>J</i> = 11.34 Hz, 2H), 2.53 (s, 3H), 2.43 (t, <i>J</i> = 5.95 Hz, 2H), 1.79–2.01 (m, 2H), 1.44–1.74 (m, 3H), 1.07- 1.33 ppm (m, 2H). HRMS, Q-TOF found for C<sub>23</sub>H<sub>30</sub>N<sub>5</sub>O<sub>2</sub>: 408.2397.</div></div><div id="sec4_2_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> 5-({4-[({[5-(2-Fluorophenyl)-1<i>H</i>-indazol-3-yl]carbonyl}amino)methyl]piperidin-1-yl}methyl)furan-2-carboxylic Acid (<b>15g</b>)</h4><div class="NLM_p last">Yield 27%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.7 (br. s., 2H), 8.39 (t, <i>J</i> = 6.04 Hz, 1H), 8.32 (s, 1H), 7.65–7.76 (m, 1H), 7.50–7.63 (m, 2H), 7.38–7.50 (m, 1H), 7.23–7.38 (m, 2H), 7.08 (d, <i>J</i> = 3.29 Hz, 1H), 6.43 (d, <i>J</i> = 3.29 Hz, 1H), 3.52 (s, 2H), 3.20 (t, <i>J</i> = 6.22 Hz, 2H), 2.82 (d, <i>J</i> = 10.98 Hz, 2H), 1.98 (t, <i>J</i> = 10.79 Hz, 2H), 1.44–1.79 (m, 3H), 1.02–1.38 ppm (m, 2H). HRMS, Q-TOF found for C<sub>26</sub>H<sub>26</sub>FN<sub>4</sub>O<sub>4</sub>: 477.1934.</div></div><div id="sec4_2_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> 5-({4-[({[5-(2,3-Difluorophenyl)-1<i>H</i>-indazol-3-yl]carbonyl}amino)methyl]piperidin-1-yl}methyl)furan-2-carboxylic Acid (<b>15i</b>)</h4><div class="NLM_p last">Yield 21%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.7 (br. s., 2H), 8.42 (t, <i>J</i> = 5.65 Hz, 1H), 8.35 (s, 1H), 7.69–7.80 (m, 1H), 7.55–7.67 (m, 1H), 7.21–7.54 (m, 3H), 7.05 (d, <i>J</i> = 3.23 Hz, 1H), 6.41 (d, <i>J</i> = 3.23 Hz, 1H), 3.52 (s, 2H), 3.20 (t, <i>J</i> = 6.06 Hz, 2H), 2.83 (d, <i>J</i> = 10.50 Hz, 2H), 1.98 (t, <i>J</i> = 10.70 Hz, 2H), 1.42–1.79 (m, 3H), 1.04–1.35 ppm (m, 2H). HRMS, Q-TOF found for C<sub>26</sub>H<sub>25</sub>F<sub>2</sub>N<sub>4</sub>O<sub>4</sub>: 495.1837.</div></div><div id="sec4_2_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> 5-({4-[({[5-(4-Methoxyphenyl)-1<i>H</i>-indazol-3-yl]carbonyl}amino)methyl]piperidin-1-yl}methyl)furan-2-carboxylic Acid (<b>15k</b>)</h4><div class="NLM_p last">Yield 15%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.5 (br. s, 2H), 8.27–8.41 (m, 2H), 7.64–7.72 (m, 2H), 7.61 (d, <i>J</i> = 8.88 Hz, 2H), 7.05 (d, <i>J</i> = 8.88 Hz, 2H), 6.96 (br. s., 1H), 6.37 (d, <i>J</i> = 3.23 Hz, 1H), 3.81 (s, 3H), 3.49 (s, 2H), 3.20 (t, <i>J</i> = 6.26 Hz, 2H), 2.82 (d, <i>J</i> = 10.90 Hz, 2H), 1.86–2.05 (m, 2H), 1.66 (d, <i>J</i> = 12.11 Hz, 3H), 1.09–1.33 ppm (m, 2H). HRMS, Q-TOF found for C<sub>27</sub>H<sub>29</sub>N<sub>4</sub>O<sub>5</sub>: 489.2131.</div></div><div id="sec4_2_73" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> 5-({4-[({[5-(4-Methoxypyridin-3-yl)-1<i>H</i>-indazol-3-yl]carbonyl}amino)methyl]piperidin-1-yl}methyl)furan-2-carboxylic Acid (<b>15m</b>)</h4><div class="NLM_p last">Yield 24%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.6 (br. s., 2H), 8.47 (d, <i>J</i> = 5.85 Hz, 1H), 8.31–8.43 (m, 2H), 8.24 (s, 1H), 7.66 (d, <i>J</i> = 8.78 Hz, 1H), 7.53 (dd, <i>J</i> = 1.46 and 8.42 Hz, 1H), 7.18 (d, <i>J</i> = 5.49 Hz, 1H), 7.09 (d, <i>J</i> = 3.29 Hz, 1H), 6.43 (d, <i>J</i> = 3.29 Hz, 1H), 3.86 (s, 3H), 3.54 (s, 2H), 3.19 (t, <i>J</i> = 6.04 Hz, 2H), 2.83 (d, <i>J</i> = 10.98 Hz, 2H), 1.99 (t, <i>J</i> = 10.79 Hz, 2H), 1.44–1.79 (m, 3H), 0.98–1.36 ppm (m, 2H). HRMS, Q-TOF found for C<sub>26</sub>H<sub>28</sub>N<sub>5</sub>O<sub>5</sub>: 490.2085.</div></div><div id="sec4_2_74" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> 5-({4-[({[5-(6-Methoxypyridin-3-yl)-1<i>H</i>-indazol-3-yl]carbonyl}amino)methyl]piperidin-1-yl}methyl)furan-2-carboxylic Acid (<b>15o</b>)</h4><div class="NLM_p last">Yield 18%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.6 (br. s., 2H), 8.48 (d, <i>J</i> = 2.02 Hz, 1H), 8.39 (t, <i>J</i> = 6.06 Hz, 1H), 8.34 (s, 1H), 7.96–8.07 (m, 1H), 7.70 (d, <i>J</i> = 1.21 Hz, 2H), 7.03 (d, <i>J</i> = 3.23 Hz, 1H), 6.94 (d, <i>J</i> = 8.07 Hz, 1H), 6.40 (d, <i>J</i> = 3.23 Hz, 1H), 3.92 (s, 3H), 3.51 (s, 2H), 3.21 (t, <i>J</i> = 6.26 Hz, 2H), 2.83 (d, <i>J</i> = 10.90 Hz, 2H), 1.98 (t, <i>J</i> = 10.90 Hz, 2H), 1.48–1.78 (m, 3H), 1.07–1.34 ppm (m, 2H). HRMS, Q-TOF found for C<sub>26</sub>H<sub>28</sub>N<sub>5</sub>O<sub>5</sub>: 490.2085.</div></div><div id="sec4_2_75" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> 5-({4-[({[5-(2-Methoxypyridin-3-yl)-1<i>H</i>-indazol-3-yl]carbonyl}amino)methyl]piperidin-1-yl}methyl)furan-2-carboxylic Acid (<b>15p</b>)</h4><div class="NLM_p last">Yield 15%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.62 (br. s., 1H), 8.36 (t, <i>J</i> = 6.04 Hz, 1H), 8.28 (s, 1H), 8.19 (dd, <i>J</i> = 1.83 and 5.12 Hz, 1H), 7.77 (dd, <i>J</i> = 2.20, 7.32 Hz, 1H), 7.65 (dd, <i>J</i> = 0.80 and 8.80 Hz, 1H), 7.58 (dd, <i>J</i> = 1.80 and 8.80 Hz, 1H), 7.11 (dd, <i>J</i> = 5.12 and 7.32 Hz, 1H), 6.84 (br. s., 1H), 6.31 (d, <i>J</i> = 2.93 Hz, 1H), 3.89 (s, 3H), 3.47 (s, 2H), 3.19 (t, <i>J</i> = 6.22 Hz, 2H), 2.99 (s, 1H), 2.82 (d, <i>J</i> = 10.98 Hz, 2H), 1.83–2.04 (m, 2H), 1.41–1.75 (m, 3H), 1.06–1.34 ppm (m, 2H). HRMS, Q-TOF found for C<sub>26</sub>H<sub>28</sub>N<sub>5</sub>O<sub>5</sub>: 490.2082.</div></div><div id="sec4_2_76" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> 2-({4-[({[5-(2,3-Difluorophenyl)-1<i>H</i>-indazol-3-yl]carbonyl}amino)methyl]piperidin-1-yl}methyl)-1,3-oxazole-4-carboxylic Acid (<b>16i</b>)</h4><div class="NLM_p last">Yield 26%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.70 (s, 1H), 12.99 (br. s., 1H), 8.57 (s, 1H), 8.42 (t, <i>J</i> = 6.0 Hz, 1H), 8.34 (d, <i>J</i> = 0.7 Hz, 1H), 7.73 (dd, <i>J</i> = 0.8 and 8.8 Hz, 1H), 7.61 (td, <i>J</i> = 1.8 and 8.7 Hz, 1H), 7.52–7.21 (m, 3H), 3.64 (s, 2H), 3.20 (t, <i>J</i> = 6.2 Hz, 2H), 2.82 (d, <i>J</i> = 11.0 Hz, 2H), 2.04 (t, <i>J</i> = 10.6 Hz, 2H), 1.73–1.45 (m, 3H), 1.33–1.09 ppm (m, 2H). HRMS, Q-TOF found for C<sub>25</sub>H<sub>24</sub>F<sub>2</sub>N<sub>5</sub>O<sub>4</sub>: 496.1793.</div></div><div id="sec4_2_77" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> [4-({[(5-Ethyl-1<i>H</i>-indazol-3-yl)carbonyl]amino}methyl)piperidin-1-yl]acetic Acid (<b>17e</b>)</h4><div class="NLM_p last">A mixture of product <b>17d</b> (170 mg, 0.4 mmol), vinyl-boronic acid pinacol ester (0.53 mmol), [1,1′-bis(diphenylphosphino)ferrocene]-dichloro-palladium(II) (50 mg, 0.06 mmol), and saturated sodium carbonate solution (1.7 mL) in toluene/ethanol (ratio 1:1, 10 mL) was heated in a Milestone microwave oven @ 150 °C, 500W for 2 h. After filtration through Celite, solvents were removed under reduce pressure, and the crude product was eluted through a silica gel cartridge with a mixture of chloroform/methanol at a 1:1 ratio. Solvents were removed under reduced pressure, and the resulting crude intermediate was dissolved in ethanol (20 mg/mL) and hydrogenated over a 10% Pd/C cartridge at 30 °C, 1 mL/min in a Thales Nano H–CUBE hydrogenator to obtain [4-({[(5-ethyl-1<i>H</i>-indazol-3-yl)carbonyl]amino}methyl)piperidin-1-yl]acetic acid <b>17e</b>, purified using preparative HPLC-MS (170 mg, yield 41%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.48 (br. s., 1H), 8.38 (t, <i>J</i> = 6.1 Hz, 1H), 7.97 (s, 1H), 7.52 (d, <i>J</i> = 8.6 Hz, 1H), 7.28 (dd, <i>J</i> = 1.6 and 8.6 Hz, 1H), 4.38 (br. s., 1H), 3.33–3.09 (m, 6H), 2.73 (q, <i>J</i> = 7.5 Hz, 2H), 2.65–2.53 (m, 2H), 1.83–1.60 (m, 3H), 1.54–1.31 (m, 2H), 1.23 ppm (t, <i>J</i> = 7.5 Hz, 3H). HRMS, Q-TOF found for C<sub>18</sub>H<sub>25</sub>N<sub>4</sub>O<sub>3</sub>: 345.1921.</div></div><div id="sec4_2_78" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> {4-[({[5-(2-Fluorophenyl)-1<i>H</i>-indazol-3-yl]carbonyl}amino)methyl]piperidin-1-yl}acetic Acid (<b>17g</b>)</h4><div class="NLM_p last">Yield 36%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.71 (br. s., 1H), 8.45 (t, <i>J</i> = 6.0 Hz, 1H), 8.41 (s, 1H), 7.86–7.66 (m, 2H), 7.63–7.41 (m, 3H), 7.19 (dddd, <i>J</i> = 2.4, 2.6, 6.5, and 9.0 Hz, 1H), 4.75 (br. s., 1H), 3.34–3.07 (m, 6H), 2.64–2.53 (m, 2H), 1.75 (d, <i>J</i> = 11.0 Hz, 3H), 1.42 ppm (q, <i>J</i> = 11.5 Hz, 2H). HRMS, Q-TOF found for C<sub>22</sub>H<sub>24</sub>FN<sub>4</sub>O<sub>3</sub>: 411.1825.</div></div><div id="sec4_2_79" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> {4-[({[5-(2,3-Difluorophenyl)-1<i>H</i>-indazol-3-yl]carbonyl}amino)methyl]piperidin-1-yl}acetic Acid (<b>17i</b>)</h4><div class="NLM_p last">Yield 17%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.68 (br. s., 1H), 8.51 (t, <i>J</i> = 6.1 Hz, 1H), 8.35 (d, <i>J</i> = 0.6 Hz, 1H), 7.74 (dd, <i>J</i> = 0.7 and 8.8 Hz, 1H), 7.61 (td, <i>J</i> = 1.7 and 8.7 Hz, 1H), 7.51–7.25 (m, 3H), 4.0 (br. s., 1H), 3.33–3.10 (m, 6H), 2.64–2.53 (m, 2H), 1.74 (d, <i>J</i> = 10.5 Hz, 3H), 1.54–1.29 ppm (m, 2H). HRMS, Q-TOF found for C<sub>22</sub>H<sub>23</sub>F<sub>2</sub>N<sub>4</sub>O<sub>3</sub>: 429.1733.</div></div><div id="sec4_2_80" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> {4-[({[5-(2,3-Dichlorophenyl)-1<i>H</i>-indazol-3-yl]carbonyl}amino)methyl]piperidin-1-yl}acetic Acid (<b>17j</b>)</h4><div class="NLM_p last">Yield 15%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.81 (br. s., 1H), 8.50 (t, <i>J</i> = 6.0 Hz, 1H), 8.17 (dd, <i>J</i> = 0.9 and 1.6 Hz, 1H), 7.78–7.60 (m, 2H), 7.54–7.34 (m, 3H), 4.1 (br. s., 1H), 3.38–2.96 (m, 6H), 2.58 (t, <i>J</i> = 11.0 Hz, 2H), 1.74 (d, <i>J</i> = 11.0 Hz, 3H), 1.42 ppm (q, <i>J</i> = 11.6 Hz, 2H). HRMS, Q-TOF found for C<sub>22</sub>H<sub>23</sub>Cl<sub>2</sub>N<sub>4</sub>O<sub>3</sub>: 461.1142.</div></div><div id="sec4_2_81" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> {4-[({[5-(5-Methoxypyridin-3-yl)-1<i>H</i>-indazol-3-yl]carbonyl}amino)methyl]piperidin-1-yl}acetic Acid (<b>17n</b>)</h4><div class="NLM_p last">Yield 28%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 13.7 (br. s., 2H), 8.54–8.49 (m, 1H), 8.48 (d, <i>J</i> = 1.6 Hz, 1H), 8.44–8.39 (m, 1H), 8.30 (d, <i>J</i> = 2.7 Hz, 1H), 7.81–7.76 (m, 1H), 7.76–7.69 (m, <i>J</i> = 0.7 Hz, 1H), 7.61 (dd, <i>J</i> = 1.8 and 2.7 Hz, 1H), 3.93 (s, 3H), 3.29–3.12 (m, 6H), 2.69–2.55 (m, 2H), 1.75 (d, <i>J</i> = 11.0 Hz, 3H), 1.58–1.27 ppm (m, 2H). HRMS, Q-TOF found for C<sub>22</sub>H<sub>26</sub>N<sub>5</sub>O<sub>4</sub>: 424.1979.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i106" class="anchor-spacer"></div><h3 class="article-section__title" id="_i106"> Enzymatic GSK-3β Assay</h3><div class="NLM_p last">Using the described methods,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> compounds were assayed on human GSK-3β at several concentrations ranging from 1 nM to 100 μM with 10-fold dilutions in duplicate. Human recombinant enzyme GSK-3β was incubated for 90 min at 22 °C in the presence of compounds or vehicle in a reaction buffer containing ATP plus 100 nM unphosphorylated specific substrate peptide (Ulight-CFFKNIVTPRTPPPSQGK-amide). Substrate phosphorylation was measured by LANCE technology (PerkinElmer, CT, USA). IC<sub>50</sub> curves were generated using GraphPad 5 and a standard 4-parameter nonlinear regression algorithm (log (inhibitor) versus response–variable slope). Data points are the averages of duplicate wells. See <a href="/doi/suppl/10.1021/acs.jmedchem.5b01208/suppl_file/jm5b01208_si_002.pdf" class="ext-link">Supporting Information</a> file for the full list of results expressed as IC<sub>50</sub> plus 95% confidence intervals.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i107" class="anchor-spacer"></div><h3 class="article-section__title" id="_i107"> Cellular GSK-3β Assay</h3><div class="NLM_p last">Recombinant Chinese Hamster Ovary (CHO) pTau overexpressing cells were suspended in medium at the appropriate concentration and then plated in a 96-well plate at 15,000 cells per well. The cells were incubated with the selected compounds (each compound was tested at 7 concentrations; 1:5 dilutions starting from 30 μM in duplicate) for 2 h at 37 °C, 5% CO<sub>2</sub> and then lysed and processed for the detection of phosphorylated tau protein (Luminex). <i>N</i>-[(4-Methoxyphenyl)methyl]-<i>N</i>′-(5-nitro-2-thiazolyl) urea (AR-A014418), a selective GSK-3 inhibitor, was used as reference compound. The percent values of activity with respect to control (untreated cells) were calculated. IC<sub>50</sub> curves were generated using GraphPad 5 and a standard 4-parameter nonlinear regression algorithm (log (inhibitor) versus response–variable slope). Data points are the averages of duplicate wells. See <a href="/doi/suppl/10.1021/acs.jmedchem.5b01208/suppl_file/jm5b01208_si_002.pdf" class="ext-link">Supporting Information</a> for the full list of results expressed as IC<sub>50</sub> plus 95% confidence intervals.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i108" class="anchor-spacer"></div><h3 class="article-section__title" id="_i108"> Mode of Action Method</h3><div class="NLM_p last">The mode of action of compounds <b>14i</b> and <b>9c</b> was investigated using a microfluidic technology where the phosphorylated product and substrate are separated by electrophoresis and detected via laser-induced fluorescence. The standard screening reaction is carried out in 100 mM HEPES (pH 7.5), 10 mM MgCl<sub>2</sub>, 1 mM DTT, 0.015% Brij-35, 1.5 μM Na<sub>2</sub>VO<sub>4</sub>, 1.5 μM peptide substrate, and 14 μM ATP. The reaction is started by the addition of ATP and incubated for 60 min at RT. The reaction is terminated by the addition of stop buffer containing 100 mM HEPES (pH 7.5), 30 mM EDTA, 0.015% Brij-35, and 5% DMSO. Phosphorylated and unphosphorylated substrates are separated by charge using electrophoretic mobility shift. The product formed is compared to control wells to determine inhibition or enhancement of enzyme activity. Results were analyzed with GraphPad Prism v5.0, fitting to nonlinear regression with variable slope, constraints of 0 and 100 for bottom and top, respectively.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i109" class="anchor-spacer"></div><h3 class="article-section__title" id="_i109"> <i>In Vitro</i> Plasma Stability Assessment</h3><div class="NLM_p last">Compound was added to blank mouse plasma preincubated at 37 °C. Final molecule concentration was 5 μM. Final DMSO concentration was 2.5%. The mixture was shaken at 37 °C for 3 h. Aliquots (50 μL) were taken at various time points and crashed with 150 μL of acetonitrile spiked with 500 nM internal standard. After mixing and centrifugation, 3 μL of supernatant was analyzed by LC-MS/MS by multiple reaction monitoring (MRM).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i110" class="anchor-spacer"></div><h3 class="article-section__title" id="_i110"> Amphetamine Model</h3><div id="sec4_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i111" class="anchor-spacer"></div><h4 class="article-section__title" id="_i111"> Animal Preparation</h4><div class="NLM_p last">Male C57BL/6J mice, 8 weeks old (Charles River, Calco, Italy), were used for <i>in vivo</i> studies. Animals were group-housed in ventilated cages and had free access to food and water. They were maintained under a 12-h light/dark cycle (lights on at 8:00 am) at a controlled temperature of 21 ± 1 °C and relative humidity of 55 ± 10%. All experiments were carried out in accordance with the guidelines established by the European Communities Council Directive (Directive 2010/63/EU of 22 September 2010) and approved by the National Council on Animal Care of the Italian Ministry of Health. All efforts were made to minimize animal suffering and to use the minimal number of animals required to produce reliable results.</div></div><div id="sec4_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i112" class="anchor-spacer"></div><h4 class="article-section__title" id="_i112"> Behavioral Assay</h4><div class="NLM_p last">Eight week old male C57BL/6J mice were used. Drugs were administered intraperitoneally by dissolving in PEG400/Tween 80/saline solution at 10/10/80% (v/v). Experiments were started by placing the mouse in an open field apparatus. At this stage, motility was not recorded, and the mouse could freely explore the box for 20 min (habituation). The mouse was then treated with the test molecule and placed back in the box, and motility was recorded for the subsequent 15 min (effect on spontaneous motility). Finally, amphetamine was administered (2 mg/kg i.p.), and motility was recorded for the subsequent 90 min to measure the inhibition of amphetamine hyperactivity. Two way ANOVA was used to evaluate statistical significance, followed by Bonferroni’s posthoc test. GraphPad Prism 5 was used for all statistical analysis (GraphPad Software Inc. San Diego, CA, USA). <i>P</i> values less than 0.05 were considered significant.</div></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i113" class="anchor-spacer"></div><h3 class="article-section__title" id="_i113"> Kinase Selectivity Assays</h3><div class="NLM_p last">The kinase profile of <b>14i</b> was first assessed in a 216 kinase assay platform performed by CEREP, at 10 μM in duplicate. Briefly, human recombinant kinases were incubated in the presence of specific peptide substrates plus ATP for different times at 22 °C. Phosphorylated substrate was detected by LANCE or HTRF technology. In each experiment, a relevant reference compound was tested concurrently with the test compound. The results are expressed as a percent of inhibition of control specific activity obtained in the presence of the test compounds (mean of two values ± standard deviation). For 34 selected kinases, the IC<sub>50</sub> determination was performed. Compound <b>14i</b> was tested in duplicate at five concentrations in the range from 10 nM to 100 μM. IC<sub>50</sub> curves were generated using GraphPad 5 and a standard 4-parameter nonlinear regression algorithm (log (inhibitor) versus response–variable slope). See <a href="/doi/suppl/10.1021/acs.jmedchem.5b01208/suppl_file/jm5b01208_si_002.pdf" class="ext-link">Supporting Information</a> for the full list of results expressed as IC<sub>50</sub> plus 95% confidence intervals.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i114"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01208">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51075" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51075" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b01208" class="ext-link">10.1021/acs.jmedchem.5b01208</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">SMILES data (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01208/suppl_file/jm5b01208_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Experimental description of the synthetic preparation of (piperidin-4-yl)methan-amines <b>6o</b>–<b>q</b> and <b>u</b>, with their analytical characterizations, <i>in vivo</i> pharmacokinetic assessment procedures, full lists of enzymatic and cellular GSK-3β assay results, full list of the kinase selectivity results for <b>14i</b>, and crystallization conditions and X-ray data collection (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01208/suppl_file/jm5b01208_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01208/suppl_file/jm5b01208_si_001.csv">jm5b01208_si_001.csv (3.75 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01208/suppl_file/jm5b01208_si_002.pdf">jm5b01208_si_002.pdf (665.29 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.5b01208" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57222" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57222" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guido Furlotti</span> - <span class="hlFld-Affiliation affiliation">Angelini
S.p.A., Angelini Research Center, P.le della Stazione s.n.c., Santa
Palomba-Pomezia, 00071 Rome, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#abcc85cdded9c7c4dfdfc2ebcac5cccec7c2c5c285c2df85"><span class="__cf_email__" data-cfemail="1770397162657b7863637e57767970727b7e797e397e6339">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angelo Reggiani</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Department, Istituto
Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f3b29d94969f9cdda19694949a929d9ab39a9a87dd9a87"><span class="__cf_email__" data-cfemail="7938171e1c1516572b1c1e1e101817103910100d57100d">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Alessandra Alisi</span> - <span class="hlFld-Affiliation affiliation">Angelini
S.p.A., Angelini Research Center, P.le della Stazione s.n.c., Santa
Palomba-Pomezia, 00071 Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicola Cazzolla</span> - <span class="hlFld-Affiliation affiliation">Angelini
S.p.A., Angelini Research Center, P.le della Stazione s.n.c., Santa
Palomba-Pomezia, 00071 Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrizia Dragone</span> - <span class="hlFld-Affiliation affiliation">Angelini
S.p.A., Angelini Research Center, P.le della Stazione s.n.c., Santa
Palomba-Pomezia, 00071 Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lucia Durando</span> - <span class="hlFld-Affiliation affiliation">Angelini
S.p.A., Angelini Research Center, P.le della Stazione s.n.c., Santa
Palomba-Pomezia, 00071 Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gabriele Magarò</span> - <span class="hlFld-Affiliation affiliation">Angelini
S.p.A., Angelini Research Center, P.le della Stazione s.n.c., Santa
Palomba-Pomezia, 00071 Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francesca Mancini</span> - <span class="hlFld-Affiliation affiliation">Angelini
S.p.A., Angelini Research Center, P.le della Stazione s.n.c., Santa
Palomba-Pomezia, 00071 Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giorgina Mangano</span> - <span class="hlFld-Affiliation affiliation">Angelini
S.p.A., Angelini Research Center, P.le della Stazione s.n.c., Santa
Palomba-Pomezia, 00071 Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rosella Ombrato</span> - <span class="hlFld-Affiliation affiliation">Angelini
S.p.A., Angelini Research Center, P.le della Stazione s.n.c., Santa
Palomba-Pomezia, 00071 Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marco Vitiello</span> - <span class="hlFld-Affiliation affiliation">Angelini
S.p.A., Angelini Research Center, P.le della Stazione s.n.c., Santa
Palomba-Pomezia, 00071 Rome, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrea Armirotti</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Department, Istituto
Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Valeria Capurro</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Department, Istituto
Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Massimiliano Lanfranco</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Department, Istituto
Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giuliana Ottonello</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Department, Istituto
Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Summa</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Department, Istituto
Italiano di Tecnologia, Via Morego 30, 16163 Genova, Italy</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d14028e6425-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i115">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33370" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33370" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Professor Giovanni Zappia and Dr. Rod Porter for the excellent support provided during the preparation of the manuscript. G.F. also thanks Angelini’s Physical Chemistry Laboratory for the analytical support provided for the characterization of the compounds.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i116" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i116"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i117" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i117"> Abbreviations Used</h2><tr><td class="NLM_term">GSK-3</td><td class="NLM_def"><p class="first last">glycogen synthase kinases 3</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">DCC</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>′-dicyclohexylcarbodiimide</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half maximal inhibitory concentration</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term"><i>K</i><sub>M</sub></td><td class="NLM_def"><p class="first last">Michaelis constant</p></td></tr><tr><td class="NLM_term"><i>K</i><sub>i</sub></td><td class="NLM_def"><p class="first last">dissociation constant</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">elimination half-life</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">i.p.</td><td class="NLM_def"><p class="first last">intraperitoneal</p></td></tr><tr><td class="NLM_term">AUC<sub>0,inf</sub></td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">peak plasma or brain concentration</p></td></tr><tr><td class="NLM_term"><i>T</i><sub>max</sub></td><td class="NLM_def"><p class="first last">time to reach <i>C</i><sub>max</sub></p></td></tr><tr><td class="NLM_term"><i>Vd</i></td><td class="NLM_def"><p class="first last">volume of distribution</p></td></tr><tr><td class="NLM_term">Cl</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">mpk</td><td class="NLM_def"><p class="first last">mg/kg</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i118">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72751" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72751" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 30 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Merikangas, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampson, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viana, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karam, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladea, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina-Mora, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Posada-Villa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarkov, Z.</span><span> </span><span class="NLM_article-title">Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">251</span><span class="refDoi"> DOI: 10.1001/archgenpsychiatry.2011.12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1001%2Farchgenpsychiatry.2011.12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=21383262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A280%3ADC%252BC3M3kvVWjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2011&pages=241-251&issue=3&author=K.+R.+Merikangasauthor=R.+Jinauthor=J.+P.+Heauthor=R.+C.+Kesslerauthor=S.+Leeauthor=N.+A.+Sampsonauthor=M.+C.+Vianaauthor=L.+H.+Andradeauthor=C.+Huauthor=E.+G.+Karamauthor=M.+Ladeaauthor=M.+E.+Medina-Moraauthor=Y.+Onoauthor=J.+Posada-Villaauthor=R.+Sagarauthor=J.+E.+Wellsauthor=Z.+Zarkov&title=Prevalence+and+correlates+of+bipolar+spectrum+disorder+in+the+world+mental+health+survey+initiative&doi=10.1001%2Farchgenpsychiatry.2011.12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative</span></div><div class="casAuthors">Merikangas Kathleen R; Jin Robert; He Jian-Ping; Kessler Ronald C; Lee Sing; Sampson Nancy A; Viana Maria Carmen; Andrade Laura Helena; Hu Chiyi; Karam Elie G; Ladea Maria; Medina-Mora Maria Elena; Ono Yutaka; Posada-Villa Jose; Sagar Rajesh; Wells J Elisabeth; Zarkov Zahari</div><div class="citationInfo"><span class="NLM_cas:title">Archives of general psychiatry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">241-51</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">CONTEXT:  There is limited information on the prevalence and correlates of bipolar spectrum disorder in international population-based studies using common methods.  OBJECTIVES:  To describe the prevalence, impact, patterns of comorbidity, and patterns of service utilization for bipolar spectrum disorder (BPS) in the World Health Organization World Mental Health Survey Initiative.  DESIGN, SETTING, AND PARTICIPANTS:  Cross-sectional, face-to-face, household surveys of 61,392 community adults in 11 countries in the Americas, Europe, and Asia assessed with the World Mental Health version of the World Health Organization Composite International Diagnostic Interview, version 3.0, a fully structured, lay-administered psychiatric diagnostic interview.  MAIN OUTCOME MEASURES:  Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) disorders, severity, and treatment.  RESULTS:  The aggregate lifetime prevalences were 0.6% for bipolar type I disorder (BP-I), 0.4% for BP-II, 1.4% for subthreshold BP, and 2.4% for BPS.  Twelve-month prevalences were 0.4% for BP-I, 0.3% for BP-II, 0.8% for subthreshold BP, and 1.5% for BPS.  Severity of both manic and depressive symptoms as well as suicidal behavior increased monotonically from subthreshold BP to BP-I.  By contrast, role impairment was similar across BP subtypes.  Symptom severity was greater for depressive episodes than manic episodes, with approximately 74.0% of respondents with depression and 50.9% of respondents with mania reporting severe role impairment.  Three-quarters of those with BPS met criteria for at least 1 other disorder, with anxiety disorders (particularly panic attacks) being the most common comorbid condition.  Less than half of those with lifetime BPS received mental health treatment, particularly in low-income countries, where only 25.2% reported contact with the mental health system.  CONCLUSIONS:  Despite cross-site variation in the prevalence rates of BPS, the severity, impact, and patterns of comorbidity were remarkably similar internationally.  The uniform increases in clinical correlates, suicidal behavior, and comorbidity across each diagnostic category provide evidence for the validity of the concept of BPS.  Treatment needs for BPS are often unmet, particularly in low-income countries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTMABAeAsogHHELvajU9pjPfW6udTcc2ebEwPvNJ0CEorntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3kvVWjtA%253D%253D&md5=37d524cfd194d45407095c3b2b3b9af3</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1001%2Farchgenpsychiatry.2011.12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchgenpsychiatry.2011.12%26sid%3Dliteratum%253Aachs%26aulast%3DMerikangas%26aufirst%3DK.%2BR.%26aulast%3DJin%26aufirst%3DR.%26aulast%3DHe%26aufirst%3DJ.%2BP.%26aulast%3DKessler%26aufirst%3DR.%2BC.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DSampson%26aufirst%3DN.%2BA.%26aulast%3DViana%26aufirst%3DM.%2BC.%26aulast%3DAndrade%26aufirst%3DL.%2BH.%26aulast%3DHu%26aufirst%3DC.%26aulast%3DKaram%26aufirst%3DE.%2BG.%26aulast%3DLadea%26aufirst%3DM.%26aulast%3DMedina-Mora%26aufirst%3DM.%2BE.%26aulast%3DOno%26aufirst%3DY.%26aulast%3DPosada-Villa%26aufirst%3DJ.%26aulast%3DSagar%26aufirst%3DR.%26aulast%3DWells%26aufirst%3DJ.%2BE.%26aulast%3DZarkov%26aufirst%3DZ.%26atitle%3DPrevalence%2520and%2520correlates%2520of%2520bipolar%2520spectrum%2520disorder%2520in%2520the%2520world%2520mental%2520health%2520survey%2520initiative%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D2011%26volume%3D68%26issue%3D3%26spage%3D241%26epage%3D251%26doi%3D10.1001%2Farchgenpsychiatry.2011.12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Mao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koehler, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doud, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tassa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biechele, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petryshen, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moon, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haggarty, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, L. H.</span><span> </span><span class="NLM_article-title">Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1031</span><span class="refDoi"> DOI: 10.1016/j.cell.2008.12.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1016%2Fj.cell.2008.12.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=19303846" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltFSntrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2009&pages=1017-1031&issue=6&author=Y.+Maoauthor=X.+Geauthor=C.+L.+Frankauthor=J.+M.+Madisonauthor=A.+N.+Koehlerauthor=M.+K.+Doudauthor=C.+Tassaauthor=E.+M.+Berryauthor=T.+Sodaauthor=K.+K.+Singhauthor=T.+Biecheleauthor=T.+L.+Petryshenauthor=R.+T.+Moonauthor=S.+J.+Haggartyauthor=L.+H.+Tsai&title=Disrupted+in+schizophrenia+1+regulates+neuronal+progenitor+proliferation+via+modulation+of+GSK3beta%2Fbeta-catenin+signaling&doi=10.1016%2Fj.cell.2008.12.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3β/β-catenin signaling</span></div><div class="casAuthors">Mao, Yingwei; Ge, Xuecai; Frank, Christopher L.; Madison, Jon M.; Koehler, Angela N.; Doud, Mary Kathryn; Tassa, Carlos; Berry, Erin M.; Soda, Takahiro; Singh, Karun K.; Biechele, Travis; Petryshen, Tracey L.; Moon, Randall T.; Haggarty, Stephen J.; Tsai, Li-Huei</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1017-1031</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The Disrupted in Schizophrenia 1 (DISC1) gene is disrupted by a balanced chromosomal translocation (1; 11) (q42; q14.3) in a Scottish family with a high incidence of major depression, schizophrenia, and bipolar disorder.  Subsequent studies provided indications that DISC1 plays a role in brain development.  Here, we demonstrate that suppression of DISC1 expression reduces neural progenitor proliferation, leading to premature cell cycle exit and differentiation.  Several lines of evidence suggest that DISC1 mediates this function by regulating GSK3β.  First, DISC1 inhibits GSK3β activity through direct phys. interaction, which reduces β-catenin phosphorylation and stabilizes β-catenin.  Importantly, expression of stabilized β-catenin overrides the impairment of progenitor proliferation caused by DISC1 loss of function.  Furthermore, GSK3 inhibitors normalize progenitor proliferation and behavioral defects caused by DISC1 loss of function.  Together, these results implicate DISC1 in GSK3β/β-catenin signaling pathways and provide a framework for understanding how alterations in this pathway may contribute to the etiol. of psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpy05n-L5CETbVg90H21EOLACvtfcHk0liamBFiSu2XLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltFSntrs%253D&md5=c049804aefd16bf1ebb760af8d82c469</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2008.12.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2008.12.044%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DY.%26aulast%3DGe%26aufirst%3DX.%26aulast%3DFrank%26aufirst%3DC.%2BL.%26aulast%3DMadison%26aufirst%3DJ.%2BM.%26aulast%3DKoehler%26aufirst%3DA.%2BN.%26aulast%3DDoud%26aufirst%3DM.%2BK.%26aulast%3DTassa%26aufirst%3DC.%26aulast%3DBerry%26aufirst%3DE.%2BM.%26aulast%3DSoda%26aufirst%3DT.%26aulast%3DSingh%26aufirst%3DK.%2BK.%26aulast%3DBiechele%26aufirst%3DT.%26aulast%3DPetryshen%26aufirst%3DT.%2BL.%26aulast%3DMoon%26aufirst%3DR.%2BT.%26aulast%3DHaggarty%26aufirst%3DS.%2BJ.%26aulast%3DTsai%26aufirst%3DL.%2BH.%26atitle%3DDisrupted%2520in%2520schizophrenia%25201%2520regulates%2520neuronal%2520progenitor%2520proliferation%2520via%2520modulation%2520of%2520GSK3beta%252Fbeta-catenin%2520signaling%26jtitle%3DCell%26date%3D2009%26volume%3D136%26issue%3D6%26spage%3D1017%26epage%3D1031%26doi%3D10.1016%2Fj.cell.2008.12.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">De Sarno, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jope, R. S.</span><span> </span><span class="NLM_article-title">Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1158</span><span class="NLM_x">–</span> <span class="NLM_lpage">1164</span><span class="refDoi"> DOI: 10.1016/S0028-3908(02)00215-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1016%2FS0028-3908%2802%2900215-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=1158-1164&issue=7&author=P.+De+Sarnoauthor=X.+Liauthor=R.+S.+Jope&title=Regulation+of+Akt+and+glycogen+synthase+kinase-3+beta+phosphorylation+by+sodium+valproate+and+lithium&doi=10.1016%2FS0028-3908%2802%2900215-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2802%2900215-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252802%252900215-0%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BSarno%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DJope%26aufirst%3DR.%2BS.%26atitle%3DRegulation%2520of%2520Akt%2520and%2520glycogen%2520synthase%2520kinase-3%2520beta%2520phosphorylation%2520by%2520sodium%2520valproate%2520and%2520lithium%26jtitle%3DNeuropharmacology%26date%3D2002%26volume%3D43%26issue%3D7%26spage%3D1158%26epage%3D1164%26doi%3D10.1016%2FS0028-3908%2802%2900215-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manji, H. K.</span><span> </span><span class="NLM_article-title">The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1327</span><span class="NLM_x">–</span> <span class="NLM_lpage">1330</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.2000.0721327.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1046%2Fj.1471-4159.2000.0721327.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10037507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A528%3ADyaK1MXhsFWgtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1999&pages=1327-1330&issue=3&author=G.+Chenauthor=L.+D.+Huangauthor=Y.+M.+Jiangauthor=H.+K.+Manji&title=The+mood-stabilizing+agent+valproate+inhibits+the+activity+of+glycogen+synthase+kinase-3&doi=10.1046%2Fj.1471-4159.2000.0721327.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3</span></div><div class="casAuthors">Chen, Guang; Huang, Li-Dong; Jiang, Yi-Ming; Manji, Husseini K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1327-1330</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Valproic acid (VPA) is a potent broad-spectrum anti-epileptic with demonstrated efficacy in the treatment of bipolar affective disorder.  It has previously been demonstrated that both VPA and lithium increase activator protein-1 (AP-1) DNA binding activity, but the mechanisms underlying these effects have not been elucidated.  However, it is known that phosphorylation of c-jun by glycogen synthase kinase (GSK)-3β inhibits AP-1 DNA binding activity, and lithium has recently been demonstrated to inhibit GSK-3β.  These results suggest that lithium may increase AP-1 DNA binding activity by inhibiting GSK-3β.  In the present study, we sought to det. if VPA, like lithium, regulates GSK-3.  We have found that VPA concn.-dependently inhibits both GSK-3α and -3β, with significant effects obsd. at concns. of VPA similar to those attained clin.  Incubation of intact human neuroblastoma SH-SY5Y cells with VPA results in an increase in the subsequent in vitro recombinant GSK-3β-mediated 32P incorporation into two putative GSK-3 substrates (∼85 and 200 kDa), compatible with inhibition of endogenous GSK-3β by VPA.  Consistent with GSK-3β inhibition, incubation of SH-SY5Y cells with VPA results in a significant time-dependent increase in both cytosolic and nuclear β-catenin levels.  GSK-3β plays a crit. role in the CNS by regulating various cytoskeletal processes as well as long-term nuclear events and is a common target for both lithium and VPA; inhibition of GSK-3β in the CNS may thus underlie some of the long-term therapeutic effects of mood-stabilizing agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoivImxXJEehrVg90H21EOLACvtfcHk0liamBFiSu2XLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhsFWgtrs%253D&md5=c33e39007f1180b9282080a62fa18ae3</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2000.0721327.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2000.0721327.x%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DL.%2BD.%26aulast%3DJiang%26aufirst%3DY.%2BM.%26aulast%3DManji%26aufirst%3DH.%2BK.%26atitle%3DThe%2520mood-stabilizing%2520agent%2520valproate%2520inhibits%2520the%2520activity%2520of%2520glycogen%2520synthase%2520kinase-3%26jtitle%3DJ.%2520Neurochem.%26date%3D1999%26volume%3D72%26issue%3D3%26spage%3D1327%26epage%3D1330%26doi%3D10.1046%2Fj.1471-4159.2000.0721327.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Klein, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melton, D. A.</span><span> </span><span class="NLM_article-title">A molecular mechanism for the effect of lithium on development</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">8455</span><span class="NLM_x">–</span> <span class="NLM_lpage">8459</span><span class="refDoi"> DOI: 10.1073/pnas.93.16.8455</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1073%2Fpnas.93.16.8455" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=8455-8459&issue=16&author=P.+S.+Kleinauthor=D.+A.+Melton&title=A+molecular+mechanism+for+the+effect+of+lithium+on+development&doi=10.1073%2Fpnas.93.16.8455"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.16.8455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.16.8455%26sid%3Dliteratum%253Aachs%26aulast%3DKlein%26aufirst%3DP.%2BS.%26aulast%3DMelton%26aufirst%3DD.%2BA.%26atitle%3DA%2520molecular%2520mechanism%2520for%2520the%2520effect%2520of%2520lithium%2520on%2520development%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1996%26volume%3D93%26issue%3D16%26spage%3D8455%26epage%3D8459%26doi%3D10.1073%2Fpnas.93.16.8455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Silva, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesquita, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bessa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sousa, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotiropoulos, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almeida, O. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sousa, N.</span><span> </span><span class="NLM_article-title">Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthase-kinase-3beta</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">656</span><span class="NLM_x">–</span> <span class="NLM_lpage">669</span><span class="refDoi"> DOI: 10.1016/j.neuroscience.2007.12.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1016%2Fj.neuroscience.2007.12.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2008&pages=656-669&issue=3&author=R.+Silvaauthor=A.+R.+Mesquitaauthor=J.+Bessaauthor=J.+C.+Sousaauthor=I.+Sotiropoulosauthor=P.+Leaoauthor=O.+F.+Almeidaauthor=N.+Sousa&title=Lithium+blocks+stress-induced+changes+in+depressive-like+behavior+and+hippocampal+cell+fate%3A+the+role+of+glycogen-synthase-kinase-3beta&doi=10.1016%2Fj.neuroscience.2007.12.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2007.12.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2007.12.026%26sid%3Dliteratum%253Aachs%26aulast%3DSilva%26aufirst%3DR.%26aulast%3DMesquita%26aufirst%3DA.%2BR.%26aulast%3DBessa%26aufirst%3DJ.%26aulast%3DSousa%26aufirst%3DJ.%2BC.%26aulast%3DSotiropoulos%26aufirst%3DI.%26aulast%3DLeao%26aufirst%3DP.%26aulast%3DAlmeida%26aufirst%3DO.%2BF.%26aulast%3DSousa%26aufirst%3DN.%26atitle%3DLithium%2520blocks%2520stress-induced%2520changes%2520in%2520depressive-like%2520behavior%2520and%2520hippocampal%2520cell%2520fate%253A%2520the%2520role%2520of%2520glycogen-synthase-kinase-3beta%26jtitle%3DNeuroscience%26date%3D2008%26volume%3D152%26issue%3D3%26spage%3D656%26epage%3D669%26doi%3D10.1016%2Fj.neuroscience.2007.12.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bijur, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jope, R. S.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection</span> <span class="citation_source-journal">Bipolar Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span><span class="refDoi"> DOI: 10.1034/j.1399-5618.2002.40201.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1034%2Fj.1399-5618.2002.40201.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=12071511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsFKhtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=137-144&issue=2&author=X.+Liauthor=G.+N.+Bijurauthor=R.+S.+Jope&title=Glycogen+synthase+kinase-3beta%2C+mood+stabilizers%2C+and+neuroprotection&doi=10.1034%2Fj.1399-5618.2002.40201.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Glycogen synthase kinase-3β, mood stabilizers, and neuroprotection</span></div><div class="casAuthors">Li, Xiaohua; Bijur, Gautam N.; Jope, Richard S.</div><div class="citationInfo"><span class="NLM_cas:title">Bipolar Disorders</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">137-144</span>CODEN:
                <span class="NLM_cas:coden">BDIIAU</span>;
        ISSN:<span class="NLM_cas:issn">1398-5647</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Glycogen synthase kinase-3β (GSK-3β) is a central component in many crit. intracellular signaling mechanisms.  These include the phosphatidylinositol 3-kinase/Akt cell survival pathway, which inhibits GSK-3β activity.  GSK-3β itself inhibits the activation of several transcription factors, which are important cell survival factors, such as heat shock factor 1.  These factors likely contribute to the recent revelation that GSK-3β is a pro-apoptotic enzyme.  Recently, Li was identified as a selective and direct inhibitor of GSK-3β.  Based on these findings, the authors have proposed that part of the neuroprotectant properties of Li is due to its ability to inhibit GSK-3β, and thus block the facilitation of apoptosis produced by GSK-3β.  Since several anticonvulsants recently were shown to be effective mood stabilizers, the authors examd. if these agents are capable of protecting cells from GSK-3β-facilitated apoptosis.  In addn. to Li, both valproic acid and lamotrigine, but not carbamazepine, provided protection from GSK-3β-facilitated apoptosis in human neuroblastoma SH-SY5Y cells.  These results demonstrate that several drugs therapeutic for bipolar disorder can provide neuroprotection by inhibiting the pro-apoptotic effects of GSK-3β, providing new evidence that dysregulation of GSK-3β may contribute to the pathophysiol. of bipolar disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ2qmOneZ5o7Vg90H21EOLACvtfcHk0ljfp3B45YwIkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsFKhtLs%253D&md5=5102f8775d227684c490d1e63835bd7b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1034%2Fj.1399-5618.2002.40201.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1034%252Fj.1399-5618.2002.40201.x%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DBijur%26aufirst%3DG.%2BN.%26aulast%3DJope%26aufirst%3DR.%2BS.%26atitle%3DGlycogen%2520synthase%2520kinase-3beta%252C%2520mood%2520stabilizers%252C%2520and%2520neuroprotection%26jtitle%3DBipolar%2520Disord.%26date%3D2002%26volume%3D4%26issue%3D2%26spage%3D137%26epage%3D144%26doi%3D10.1034%2Fj.1399-5618.2002.40201.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">The hormonal control of glycogen metabolism in mammalian muscle by multivalent phosphorylation</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">480</span><span class="refDoi"> DOI: 10.1042/bst0070459</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1042%2Fbst0070459" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=221283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A528%3ADyaL3cXjsFWm" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1979&pages=459-480&issue=3&author=P.+Cohen&title=The+hormonal+control+of+glycogen+metabolism+in+mammalian+muscle+by+multivalent+phosphorylation&doi=10.1042%2Fbst0070459"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The hormonal control of glycogen metabolism in mammalian muscle by multivalent phosphorylation</span></div><div class="casAuthors">Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">459-80</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    </div><div class="casAbstract">A review with 56 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWmnH8oWNdq7Vg90H21EOLACvtfcHk0ljfp3B45YwIkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXjsFWm&md5=438f34e4fe2ba252bcf4a4008fce300a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1042%2Fbst0070459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbst0070459%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520hormonal%2520control%2520of%2520glycogen%2520metabolism%2520in%2520mammalian%2520muscle%2520by%2520multivalent%2520phosphorylation%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D1979%26volume%3D7%26issue%3D3%26spage%3D459%26epage%3D480%26doi%3D10.1042%2Fbst0070459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Benedetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serretti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorenzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tubazio, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smeraldi, E.</span><span> </span><span class="NLM_article-title">A glycogen synthase kinase 3-beta promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span><span class="refDoi"> DOI: 10.1016/j.neulet.2004.06.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1016%2Fj.neulet.2004.06.050" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2004&pages=123-126&issue=2&author=F.+Benedettiauthor=A.+Serrettiauthor=C.+Colomboauthor=C.+Lorenziauthor=V.+Tubazioauthor=E.+Smeraldi&title=A+glycogen+synthase+kinase+3-beta+promoter+gene+single+nucleotide+polymorphism+is+associated+with+age+at+onset+and+response+to+total+sleep+deprivation+in+bipolar+depression&doi=10.1016%2Fj.neulet.2004.06.050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.neulet.2004.06.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neulet.2004.06.050%26sid%3Dliteratum%253Aachs%26aulast%3DBenedetti%26aufirst%3DF.%26aulast%3DSerretti%26aufirst%3DA.%26aulast%3DColombo%26aufirst%3DC.%26aulast%3DLorenzi%26aufirst%3DC.%26aulast%3DTubazio%26aufirst%3DV.%26aulast%3DSmeraldi%26aufirst%3DE.%26atitle%3DA%2520glycogen%2520synthase%2520kinase%25203-beta%2520promoter%2520gene%2520single%2520nucleotide%2520polymorphism%2520is%2520associated%2520with%2520age%2520at%2520onset%2520and%2520response%2520to%2520total%2520sleep%2520deprivation%2520in%2520bipolar%2520depression%26jtitle%3DNeurosci.%2520Lett.%26date%3D2004%26volume%3D368%26issue%3D2%26spage%3D123%26epage%3D126%26doi%3D10.1016%2Fj.neulet.2004.06.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hanger, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodgett, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brion, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderton, B. H.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase-3 induces Alzheimer’s disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">58</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span><span class="refDoi"> DOI: 10.1016/0304-3940(92)90774-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1016%2F0304-3940%2892%2990774-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=1992&pages=58-62&issue=1&author=D.+P.+Hangerauthor=K.+Hughesauthor=J.+R.+Woodgettauthor=J.+P.+Brionauthor=B.+H.+Anderton&title=Glycogen+synthase+kinase-3+induces+Alzheimer%E2%80%99s+disease-like+phosphorylation+of+tau%3A+generation+of+paired+helical+filament+epitopes+and+neuronal+localisation+of+the+kinase&doi=10.1016%2F0304-3940%2892%2990774-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1016%2F0304-3940%2892%2990774-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3940%252892%252990774-2%26sid%3Dliteratum%253Aachs%26aulast%3DHanger%26aufirst%3DD.%2BP.%26aulast%3DHughes%26aufirst%3DK.%26aulast%3DWoodgett%26aufirst%3DJ.%2BR.%26aulast%3DBrion%26aufirst%3DJ.%2BP.%26aulast%3DAnderton%26aufirst%3DB.%2BH.%26atitle%3DGlycogen%2520synthase%2520kinase-3%2520induces%2520Alzheimer%25E2%2580%2599s%2520disease-like%2520phosphorylation%2520of%2520tau%253A%2520generation%2520of%2520paired%2520helical%2520filament%2520epitopes%2520and%2520neuronal%2520localisation%2520of%2520the%2520kinase%26jtitle%3DNeurosci.%2520Lett.%26date%3D1992%26volume%3D147%26issue%3D1%26spage%3D58%26epage%3D62%26doi%3D10.1016%2F0304-3940%2892%2990774-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mazanetz, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, P. M.</span><span> </span><span class="NLM_article-title">Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">464</span><span class="NLM_x">–</span> <span class="NLM_lpage">479</span><span class="refDoi"> DOI: 10.1038/nrd2111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1038%2Fnrd2111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=17541419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtVSmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=464-479&issue=6&author=M.+P.+Mazanetzauthor=P.+M.+Fischer&title=Untangling+tau+hyperphosphorylation+in+drug+design+for+neurodegenerative+diseases&doi=10.1038%2Fnrd2111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases</span></div><div class="casAuthors">Mazanetz, Michael P.; Fischer, Peter M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">464-479</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Aggregation of hyperphosphorylated tau is one of the characteristic neuropathol. lesions of Alzheimer's disease and other neurodegenerative disorders.  Pharmacol. modulation of tau hyperphosphorylation might represent a valid and feasible therapeutic strategy for such disorders.  Here, we consider recent evidence supporting the validity of the three most relevant kinases affecting tau hyperphosphorylation - GSK3β, CDK5 and ERK2 - as drug targets and describe progress in the design of inhibitors for these kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvocBJpueNO7Vg90H21EOLACvtfcHk0ljfp3B45YwIkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtVSmtbg%253D&md5=7b8dc32d05340020a38be985c5838c0a</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1038%2Fnrd2111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2111%26sid%3Dliteratum%253Aachs%26aulast%3DMazanetz%26aufirst%3DM.%2BP.%26aulast%3DFischer%26aufirst%3DP.%2BM.%26atitle%3DUntangling%2520tau%2520hyperphosphorylation%2520in%2520drug%2520design%2520for%2520neurodegenerative%2520diseases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26issue%3D6%26spage%3D464%26epage%3D479%26doi%3D10.1038%2Fnrd2111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span> </span><span class="NLM_article-title">Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x"> (</span><span class="NLM_issue">40</span><span class="NLM_x">) </span> <span class="NLM_fpage">25326</span><span class="NLM_x">–</span> <span class="NLM_lpage">15332</span><span class="refDoi"> DOI: 10.1074/jbc.272.40.25326</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1074%2Fjbc.272.40.25326" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=25326-15332&issue=40&author=M.+Hongauthor=D.+C.+Chenauthor=P.+S.+Kleinauthor=V.+M.+Lee&title=Lithium+reduces+tau+phosphorylation+by+inhibition+of+glycogen+synthase+kinase-3&doi=10.1074%2Fjbc.272.40.25326"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.40.25326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.40.25326%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DD.%2BC.%26aulast%3DKlein%26aufirst%3DP.%2BS.%26aulast%3DLee%26aufirst%3DV.%2BM.%26atitle%3DLithium%2520reduces%2520tau%2520phosphorylation%2520by%2520inhibition%2520of%2520glycogen%2520synthase%2520kinase-3%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26issue%3D40%26spage%3D25326%26epage%3D15332%26doi%3D10.1074%2Fjbc.272.40.25326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Cedazo-Minguez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popescu, B. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanco-Millan, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akterin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winblad, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowburn, R. F.</span><span> </span><span class="NLM_article-title">Apolipoprotein E and beta-amyloid (1–42) regulation of glycogen synthase kinase-3beta</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1152</span><span class="NLM_x">–</span> <span class="NLM_lpage">1164</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.2003.02088.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1046%2Fj.1471-4159.2003.02088.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=14622095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps1Ohs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2003&pages=1152-1164&issue=5&author=A.+Cedazo-Minguezauthor=B.+O.+Popescuauthor=J.+M.+Blanco-Millanauthor=S.+Akterinauthor=J.+J.+Peiauthor=B.+Winbladauthor=R.+F.+Cowburn&title=Apolipoprotein+E+and+beta-amyloid+%281%E2%80%9342%29+regulation+of+glycogen+synthase+kinase-3beta&doi=10.1046%2Fj.1471-4159.2003.02088.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8dR"><div class="casContent"><span class="casTitleNuber">8d</span><div class="casTitle"><span class="NLM_cas:atitle">Apolipoprotein E and β-amyloid (1-42) regulation of glycogen synthase kinase-3β</span></div><div class="casAuthors">Cedazo-minguez, A.; Popescu, B. O.; Blanco-millan, J. M.; Akterin, S.; Pei, J. -J.; Winblad, B.; Cowburn, R. F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1152-1164</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Glycogen synthase kinase-3β (GSK-3β) is implicated in regulating apoptosis and tau protein hyperphosphorylation in Alzheimer's disease (AD).  We investigated the effects of two key AD mols., namely apoE (E3 and E4 isoforms) and β-amyloid (Aβ) 1-42 on GSK-3β and its major upstream regulators, intracellular calcium and protein kinases C and B (PKC and PKB) in human SH-SY5Y neuroblastoma cells.  ApoE3 induced a mild, transient, Ca2+-independent and early activation of GSK-3β.  ApoE4 effects were biphasic, with an early strong GSK-3β activation that was partially dependent on extracellular Ca2+, followed by a GSK-3β inactivation.  ApoE4 also activated PKC-α and PKB possibly giving the subsequent GSK-3β inhibition.  Aβ(1-42) effects were also biphasic with a strong activation dependent partially on extracellular Ca2+ followed by an inactivation.  Aβ(1-42) induced an early and potent activation of PKC-α and a late decrease of PKB activity.  ApoE4 and Aβ(1-42) were more toxic than apoE3 as shown by MTT redn. assays and generation of activated caspase-3.  ApoE4 and Aβ(1-42)-induced early activation of GSK-3β could lead to apoptosis and tau hyperphosphorylation.  A late inhibition of GSK-3β through activation of upstream kinases likely compensates the effects of apoE4 and Aβ(1-42) on GSK-3β, the unbalanced regulation of which may contribute to AD pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVieJURTy-3bVg90H21EOLACvtfcHk0lhpgkKD74Dv-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps1Ohs7g%253D&md5=8258b17760e825285e4c3c73738bcf0b</span></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2003.02088.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2003.02088.x%26sid%3Dliteratum%253Aachs%26aulast%3DCedazo-Minguez%26aufirst%3DA.%26aulast%3DPopescu%26aufirst%3DB.%2BO.%26aulast%3DBlanco-Millan%26aufirst%3DJ.%2BM.%26aulast%3DAkterin%26aufirst%3DS.%26aulast%3DPei%26aufirst%3DJ.%2BJ.%26aulast%3DWinblad%26aufirst%3DB.%26aulast%3DCowburn%26aufirst%3DR.%2BF.%26atitle%3DApolipoprotein%2520E%2520and%2520beta-amyloid%2520%25281%25E2%2580%259342%2529%2520regulation%2520of%2520glycogen%2520synthase%2520kinase-3beta%26jtitle%3DJ.%2520Neurochem.%26date%3D2003%26volume%3D87%26issue%3D5%26spage%3D1152%26epage%3D1164%26doi%3D10.1046%2Fj.1471-4159.2003.02088.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Anderson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hampton, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pryce, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowther, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giovannoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compston, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spillantini, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandran, S.</span><span> </span><span class="NLM_article-title">Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x"> (</span><span class="NLM_issue">Pt 7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1736</span><span class="NLM_x">–</span> <span class="NLM_lpage">1748</span><span class="refDoi"> DOI: 10.1093/brain/awn119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1093%2Fbrain%2Fawn119" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2008&pages=1736-1748&issue=Pt+7&author=J.+M.+Andersonauthor=D.+W.+Hamptonauthor=R.+Pataniauthor=G.+Pryceauthor=R.+A.+Crowtherauthor=R.+Reynoldsauthor=R.+J.+Franklinauthor=G.+Giovannoniauthor=D.+A.+Compstonauthor=D.+Bakerauthor=M.+G.+Spillantiniauthor=S.+Chandran&title=Abnormally+phosphorylated+tau+is+associated+with+neuronal+and+axonal+loss+in+experimental+autoimmune+encephalomyelitis+and+multiple+sclerosis&doi=10.1093%2Fbrain%2Fawn119"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8e&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawn119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawn119%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DJ.%2BM.%26aulast%3DHampton%26aufirst%3DD.%2BW.%26aulast%3DPatani%26aufirst%3DR.%26aulast%3DPryce%26aufirst%3DG.%26aulast%3DCrowther%26aufirst%3DR.%2BA.%26aulast%3DReynolds%26aufirst%3DR.%26aulast%3DFranklin%26aufirst%3DR.%2BJ.%26aulast%3DGiovannoni%26aufirst%3DG.%26aulast%3DCompston%26aufirst%3DD.%2BA.%26aulast%3DBaker%26aufirst%3DD.%26aulast%3DSpillantini%26aufirst%3DM.%2BG.%26aulast%3DChandran%26aufirst%3DS.%26atitle%3DAbnormally%2520phosphorylated%2520tau%2520is%2520associated%2520with%2520neuronal%2520and%2520axonal%2520loss%2520in%2520experimental%2520autoimmune%2520encephalomyelitis%2520and%2520multiple%2520sclerosis%26jtitle%3DBrain%26date%3D2008%26volume%3D131%26issue%3DPt%25207%26spage%3D1736%26epage%3D1748%26doi%3D10.1093%2Fbrain%2Fawn119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Anderson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spillantini, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandran, S.</span><span> </span><span class="NLM_article-title">Abnormal tau phosphorylation in primary progressive multiple sclerosis</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">591</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span><span class="refDoi"> DOI: 10.1007/s00401-010-0671-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1007%2Fs00401-010-0671-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=20306268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1WqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2010&pages=591-600&issue=5&author=J.+M.+Andersonauthor=R.+Pataniauthor=R.+Reynoldsauthor=R.+Nicholasauthor=A.+Compstonauthor=M.+G.+Spillantiniauthor=S.+Chandran&title=Abnormal+tau+phosphorylation+in+primary+progressive+multiple+sclerosis&doi=10.1007%2Fs00401-010-0671-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8fR"><div class="casContent"><span class="casTitleNuber">8f</span><div class="casTitle"><span class="NLM_cas:atitle">Abnormal tau phosphorylation in primary progressive multiple sclerosis</span></div><div class="casAuthors">Anderson, Jane Marian; Patani, Rickie; Reynolds, Richard; Nicholas, Richard; Compston, Alastair; Spillantini, Maria Grazia; Chandran, Siddharthan</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">591-600</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Although neurodegeneration is the pathol. substrate of progression in multiple sclerosis (MS), the underlying mechanisms remain unresolved.  Abnormal phosphorylation of tau, implicated in the aetiopathogenesis of a no. of classic neurodegenerative disorders, has also recently been described in secondary progressive MS (SPMS).  In contrast to SPMS, primary progressive MS (PPMS) represents a significant subset of patients with accumulating neurol. disability from onset.  The neuropathol. relationship between SPMS and PPMS is unknown.  Against this background, we investigated tau phosphorylation status in five cases of PPMS using immunohistochem. and biochem. methods.  We report widespread abnormal tau hyperphosphorylation of the classic tau phospho-epitopes occurring in multiple cell types but with a clear immunohistochem. glial bias.  In addn., biochem. anal. revealed abnormally phosphorylated insol. tau in all cases.  These findings establish a platform for further study of the role of insol. tau formation, including detg. the relevance of glial tau pathol., in the neurodegenerative phase of MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0XOfQkcpz8bVg90H21EOLACvtfcHk0lhpgkKD74Dv-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1WqsrY%253D&md5=18ebc2cf2ca2ae8b4740d164798832df</span></div><a href="/servlet/linkout?suffix=cit8f&amp;dbid=16384&amp;doi=10.1007%2Fs00401-010-0671-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-010-0671-4%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DJ.%2BM.%26aulast%3DPatani%26aufirst%3DR.%26aulast%3DReynolds%26aufirst%3DR.%26aulast%3DNicholas%26aufirst%3DR.%26aulast%3DCompston%26aufirst%3DA.%26aulast%3DSpillantini%26aufirst%3DM.%2BG.%26aulast%3DChandran%26aufirst%3DS.%26atitle%3DAbnormal%2520tau%2520phosphorylation%2520in%2520primary%2520progressive%2520multiple%2520sclerosis%26jtitle%3DActa%2520Neuropathol.%26date%3D2010%26volume%3D119%26issue%3D5%26spage%3D591%26epage%3D600%26doi%3D10.1007%2Fs00401-010-0671-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, M.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase 3 (GSK-3) and its inhibitors</span> <span class="citation_source-journal">Wiley Series in Drug Discovery and Development</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="refDoi"> DOI: 10.1002/0470052171.ch14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1002%2F0470052171.ch14" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=257&author=A.+Martinezauthor=A.+Castroauthor=M.+Medina&title=Glycogen+synthase+kinase+3+%28GSK-3%29+and+its+inhibitors&doi=10.1002%2F0470052171.ch14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1002%2F0470052171.ch14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F0470052171.ch14%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DMedina%26aufirst%3DM.%26atitle%3DGlycogen%2520synthase%2520kinase%25203%2520%2528GSK-3%2529%2520and%2520its%2520inhibitors%26jtitle%3DWiley%2520Series%2520in%2520Drug%2520Discovery%2520and%2520Development%26date%3D2006%26spage%3D257%26doi%3D10.1002%2F0470052171.ch14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kramer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo Monte, F.</span><span> </span><span class="NLM_article-title">Small-Molecule Inhibitors of GSK-3: Structural insights and their application to Alzheimer’s disease models</span> <span class="citation_source-journal">Int. J. Alzheimer's Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="refDoi"> DOI: 10.1155/2012/381029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1155%2F2012%2F381029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=1&author=T.+Kramerauthor=B.+Schmidtauthor=F.+Lo+Monte&title=Small-Molecule+Inhibitors+of+GSK-3%3A+Structural+insights+and+their+application+to+Alzheimer%E2%80%99s+disease+models&doi=10.1155%2F2012%2F381029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1155%2F2012%2F381029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F381029%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DT.%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DLo%2BMonte%26aufirst%3DF.%26atitle%3DSmall-Molecule%2520Inhibitors%2520of%2520GSK-3%253A%2520Structural%2520insights%2520and%2520their%2520application%2520to%2520Alzheimer%25E2%2580%2599s%2520disease%2520models%26jtitle%3DInt.%2520J.%2520Alzheimer%2527s%2520Dis.%26date%3D2012%26volume%3D2012%26spage%3D1%26doi%3D10.1155%2F2012%2F381029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Eldar-Finkelman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span> </span><span class="NLM_article-title">GSK-3 Inhibitors: Preclinical and clinical focus on CNS</span> <span class="citation_source-journal">Front. Mol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">32</span><span class="refDoi"> DOI: 10.3389/fnmol.2011.00032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.3389%2Ffnmol.2011.00032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=22065134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A528%3ADC%252BC38XovVyg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=32&author=H.+Eldar-Finkelmanauthor=A.+Martinez&title=GSK-3+Inhibitors%3A+Preclinical+and+clinical+focus+on+CNS&doi=10.3389%2Ffnmol.2011.00032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9cR"><div class="casContent"><span class="casTitleNuber">9c</span><div class="casTitle"><span class="NLM_cas:atitle">GSK-3 inhibitors: preclinical and clinical focus on CNS</span></div><div class="casAuthors">Eldar-Finkelman, Hagit; Martinez, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">Oct.</span>),
    <span class="NLM_cas:pages">32</span>CODEN:
                <span class="NLM_cas:coden">FMNRAJ</span>;
        ISSN:<span class="NLM_cas:issn">1662-5099</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  Inhibiting glycogen synthase kinase-3 (GSK-3) activity via pharmacol. intervention has become an important strategy for treating neurodegenerative and psychiatric disorders.  The known GSK-3 inhibitors are of diverse chemotypes and mechanisms of action and include compds. isolated from natural sources, cations, synthetic small-mol. ATP-competitive inhibitors, non-ATP-competitive inhibitors, and substrate-competitive inhibitors.  Here we describe the variety of GSK-3 inhibitors with a specific emphasis on their biol. activities in neurons and neurol. disorders.  We further highlight our current progress in the development of non-ATP-competitive inhibitors of GSK-3.  The available data raise the hope that one or more of these drug design approaches will prove successful at stabilizing or even reversing the aberrant neuropathol. and cognitive deficits of certain central nervous system disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh6s366QUVnLVg90H21EOLACvtfcHk0ljrq2mZFuZHNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovVyg&md5=d497efe2ec600fc16f10260cd53d7103</span></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=10.3389%2Ffnmol.2011.00032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnmol.2011.00032%26sid%3Dliteratum%253Aachs%26aulast%3DEldar-Finkelman%26aufirst%3DH.%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DGSK-3%2520Inhibitors%253A%2520Preclinical%2520and%2520clinical%2520focus%2520on%2520CNS%26jtitle%3DFront.%2520Mol.%2520Neurosci.%26date%3D2011%26volume%3D4%26spage%3D32%26doi%3D10.3389%2Ffnmol.2011.00032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Lovestone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hull, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rinne, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huppertz, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calero, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez-Carrillo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leon, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Ser, T.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">A phase II trial of tideglusib in Alzheimer’s disease</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span><span class="refDoi"> DOI: 10.3233/JAD-141959</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.3233%2FJAD-141959" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=25537011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjslOltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2015&pages=75-88&issue=1&author=S.+Lovestoneauthor=M.+Boadaauthor=B.+Duboisauthor=M.+Hullauthor=J.+O.+Rinneauthor=H.+J.+Huppertzauthor=M.+Caleroauthor=M.+V.+Andresauthor=B.+Gomez-Carrilloauthor=T.+Leonauthor=T.+del+Ser&title=A+phase+II+trial+of+tideglusib+in+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-141959"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">A Phase II Trial of Tideglusib in Alzheimer's Disease</span></div><div class="casAuthors">Lovestone, Simon; Boada, Merce; Dubois, Bruno; Huell, Michael; Rinne, Juha O.; Huppertz, Hans-Juergen; Calero, Miguel; Andres, Maria V.; Gomez-Carrillo, Belen; Leon, Teresa; del Ser, Teodoro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-88</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Background: The ARGO study was a phase II, double-blind, placebo controlled, four parallel arm trial of tideglusib in Alzheimer's disease (AD).  Objective: To prove the clin. efficacy of an inhibitor of glycogen synthase kinase-3 (GSK-3), in AD.  Methods: Mild to moderate (Mini-Mental State Examn. (MMSE) score, 14-26) AD patients on cholinesterase inhibitor and/or memantine treatment were administered tideglusib or placebo for 26 wk.  The ADAS-cog15 was the primary efficacy measure; function, cognition, behavior, and quality of life were assessed as secondary measures; cerebral atrophy in MRI and the levels of tau, amyloid-β, and BACE1 in cerebrospinal fluid (CSF) were exploratory endpoints.  Results: 306 AD patients were randomized to active (1000 mg QD: n = 86, 1000 mg QOD: n = 90, and 500 mg QD: n = 50) or placebo (n = 85) in 55 sites in four European countries.  There were no statistically significant differences between either active and placebo arms in the efficacy variables.  However, BACE1 in CSF significantly decreased with treatment in a small subgroup of patients.  Participants with mild AD in the 500 mg QD group showed significant responses on ADAS-cog15, MMSE, and word fluency.  Diarrhea (14-18% in active, 11% placebo) and dose-dependent, mild to moderate, and fully reversible transaminase increase (9-16% in active, 3.5% placebo) were the most frequent adverse events.  Conclusions: Short term (26 wk) tideglusib was acceptably safe but produced no clin. benefit in this trial.  However, given the non-linear dose response, esp. in mildly affected patients, further dose finding studies in early disease stages and for longer duration are warranted to examine GSK-3 inhibition in AD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru-ZlfznWkUbVg90H21EOLACvtfcHk0ljrq2mZFuZHNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjslOltb8%253D&md5=7a342ad28ad2cfbbc3dc768849fb73ef</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3233%2FJAD-141959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-141959%26sid%3Dliteratum%253Aachs%26aulast%3DLovestone%26aufirst%3DS.%26aulast%3DBoada%26aufirst%3DM.%26aulast%3DDubois%26aufirst%3DB.%26aulast%3DHull%26aufirst%3DM.%26aulast%3DRinne%26aufirst%3DJ.%2BO.%26aulast%3DHuppertz%26aufirst%3DH.%2BJ.%26aulast%3DCalero%26aufirst%3DM.%26aulast%3DAndres%26aufirst%3DM.%2BV.%26aulast%3DGomez-Carrillo%26aufirst%3DB.%26aulast%3DLeon%26aufirst%3DT.%26aulast%3Ddel%2BSer%26aufirst%3DT.%26atitle%3DA%2520phase%2520II%2520trial%2520of%2520tideglusib%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2015%26volume%3D45%26issue%3D1%26spage%3D75%26epage%3D88%26doi%3D10.3233%2FJAD-141959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Bhat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ormo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radesater, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jerning, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markgren, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgegard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nylof, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gimenez-Cassina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz-Nido, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avila, J.</span><span> </span><span class="NLM_article-title">Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x"> (</span><span class="NLM_issue">46</span><span class="NLM_x">) </span> <span class="NLM_fpage">45937</span><span class="NLM_x">–</span> <span class="NLM_lpage">45945</span><span class="refDoi"> DOI: 10.1074/jbc.M306268200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1074%2Fjbc.M306268200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=45937-45945&issue=46&author=R.+Bhatauthor=Y.+Xueauthor=S.+Bergauthor=S.+Hellbergauthor=M.+Ormoauthor=Y.+Nilssonauthor=A.+C.+Radesaterauthor=E.+Jerningauthor=P.+O.+Markgrenauthor=T.+Borgegardauthor=M.+Nylofauthor=A.+Gimenez-Cassinaauthor=F.+Hernandezauthor=J.+J.+Lucasauthor=J.+Diaz-Nidoauthor=J.+Avila&title=Structural+insights+and+biological+effects+of+glycogen+synthase+kinase+3-specific+inhibitor+AR-A014418&doi=10.1074%2Fjbc.M306268200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M306268200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M306268200%26sid%3Dliteratum%253Aachs%26aulast%3DBhat%26aufirst%3DR.%26aulast%3DXue%26aufirst%3DY.%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DHellberg%26aufirst%3DS.%26aulast%3DOrmo%26aufirst%3DM.%26aulast%3DNilsson%26aufirst%3DY.%26aulast%3DRadesater%26aufirst%3DA.%2BC.%26aulast%3DJerning%26aufirst%3DE.%26aulast%3DMarkgren%26aufirst%3DP.%2BO.%26aulast%3DBorgegard%26aufirst%3DT.%26aulast%3DNylof%26aufirst%3DM.%26aulast%3DGimenez-Cassina%26aufirst%3DA.%26aulast%3DHernandez%26aufirst%3DF.%26aulast%3DLucas%26aufirst%3DJ.%2BJ.%26aulast%3DDiaz-Nido%26aufirst%3DJ.%26aulast%3DAvila%26aufirst%3DJ.%26atitle%3DStructural%2520insights%2520and%2520biological%2520effects%2520of%2520glycogen%2520synthase%2520kinase%25203-specific%2520inhibitor%2520AR-A014418%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26issue%3D46%26spage%3D45937%26epage%3D45945%26doi%3D10.1074%2Fjbc.M306268200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gaisina, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ougolkov, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurome, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holzle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luchini, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blond, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billadeau, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">From a natural product lead to the identification of potent and selective benzofuran-3-yl-(indol-3-yl)maleimides as glycogen synthase kinase 3beta inhibitors that suppress proliferation and survival of pancreatic cancer cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1853</span><span class="NLM_x">–</span> <span class="NLM_lpage">1863</span><span class="refDoi"> DOI: 10.1021/jm801317h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801317h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1853-1863&issue=7&author=I.+N.+Gaisinaauthor=F.+Gallierauthor=A.+V.+Ougolkovauthor=K.+H.+Kimauthor=T.+Kuromeauthor=S.+Guoauthor=D.+Holzleauthor=D.+N.+Luchiniauthor=S.+Y.+Blondauthor=D.+D.+Billadeauauthor=A.+P.+Kozikowski&title=From+a+natural+product+lead+to+the+identification+of+potent+and+selective+benzofuran-3-yl-%28indol-3-yl%29maleimides+as+glycogen+synthase+kinase+3beta+inhibitors+that+suppress+proliferation+and+survival+of+pancreatic+cancer+cells&doi=10.1021%2Fjm801317h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1021%2Fjm801317h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801317h%26sid%3Dliteratum%253Aachs%26aulast%3DGaisina%26aufirst%3DI.%2BN.%26aulast%3DGallier%26aufirst%3DF.%26aulast%3DOugolkov%26aufirst%3DA.%2BV.%26aulast%3DKim%26aufirst%3DK.%2BH.%26aulast%3DKurome%26aufirst%3DT.%26aulast%3DGuo%26aufirst%3DS.%26aulast%3DHolzle%26aufirst%3DD.%26aulast%3DLuchini%26aufirst%3DD.%2BN.%26aulast%3DBlond%26aufirst%3DS.%2BY.%26aulast%3DBilladeau%26aufirst%3DD.%2BD.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DFrom%2520a%2520natural%2520product%2520lead%2520to%2520the%2520identification%2520of%2520potent%2520and%2520selective%2520benzofuran-3-yl-%2528indol-3-yl%2529maleimides%2520as%2520glycogen%2520synthase%2520kinase%25203beta%2520inhibitors%2520that%2520suppress%2520proliferation%2520and%2520survival%2520of%2520pancreatic%2520cancer%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D7%26spage%3D1853%26epage%3D1863%26doi%3D10.1021%2Fjm801317h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kuo, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prouty, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeAngelis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, W. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westover, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Look, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demarest, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emanuel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolliffe, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beavers, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span> </span><span class="NLM_article-title">Synthesis and discovery of macrocyclic polyoxygenated bis-7-azaindolylmaleimides as a novel series of potent and highly selective glycogen synthase kinase-3beta inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">4021</span><span class="NLM_x">–</span> <span class="NLM_lpage">4031</span><span class="refDoi"> DOI: 10.1021/jm030115o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030115o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4021-4031&issue=19&author=G.+H.+Kuoauthor=C.+Proutyauthor=A.+DeAngelisauthor=L.+Shenauthor=D.+J.+O%E2%80%99Neillauthor=C.+Shahauthor=P.+J.+Connollyauthor=W.+V.+Murrayauthor=B.+R.+Conwayauthor=P.+Cheungauthor=L.+Westoverauthor=J.+Z.+Xuauthor=R.+A.+Lookauthor=K.+T.+Demarestauthor=S.+Emanuelauthor=S.+A.+Middletonauthor=L.+Jolliffeauthor=M.+P.+Beaversauthor=X.+Chen&title=Synthesis+and+discovery+of+macrocyclic+polyoxygenated+bis-7-azaindolylmaleimides+as+a+novel+series+of+potent+and+highly+selective+glycogen+synthase+kinase-3beta+inhibitors&doi=10.1021%2Fjm030115o"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1021%2Fjm030115o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030115o%26sid%3Dliteratum%253Aachs%26aulast%3DKuo%26aufirst%3DG.%2BH.%26aulast%3DProuty%26aufirst%3DC.%26aulast%3DDeAngelis%26aufirst%3DA.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DD.%2BJ.%26aulast%3DShah%26aufirst%3DC.%26aulast%3DConnolly%26aufirst%3DP.%2BJ.%26aulast%3DMurray%26aufirst%3DW.%2BV.%26aulast%3DConway%26aufirst%3DB.%2BR.%26aulast%3DCheung%26aufirst%3DP.%26aulast%3DWestover%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DJ.%2BZ.%26aulast%3DLook%26aufirst%3DR.%2BA.%26aulast%3DDemarest%26aufirst%3DK.%2BT.%26aulast%3DEmanuel%26aufirst%3DS.%26aulast%3DMiddleton%26aufirst%3DS.%2BA.%26aulast%3DJolliffe%26aufirst%3DL.%26aulast%3DBeavers%26aufirst%3DM.%2BP.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DSynthesis%2520and%2520discovery%2520of%2520macrocyclic%2520polyoxygenated%2520bis-7-azaindolylmaleimides%2520as%2520a%2520novel%2520series%2520of%2520potent%2520and%2520highly%2520selective%2520glycogen%2520synthase%2520kinase-3beta%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26issue%3D19%26spage%3D4021%26epage%3D4031%26doi%3D10.1021%2Fjm030115o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">La Pietra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Regina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coluccia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Famiglini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelliccia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plotkin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eldar-Finkelman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brancale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballatore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunden, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvestri, R.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of 1-phenylpyrazolo[3,4-e]pyrrolo[3,4-g]indolizine-4,6(1H,5H)-diones as new glycogen synthase kinase-3beta inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">10066</span><span class="NLM_x">–</span> <span class="NLM_lpage">10078</span><span class="refDoi"> DOI: 10.1021/jm401466v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401466v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=10066-10078&issue=24&author=V.+La+Pietraauthor=G.+La+Reginaauthor=A.+Colucciaauthor=V.+Famigliniauthor=S.+Pellicciaauthor=B.+Plotkinauthor=H.+Eldar-Finkelmanauthor=A.+Brancaleauthor=C.+Ballatoreauthor=A.+Croweauthor=K.+R.+Brundenauthor=L.+Marinelliauthor=E.+Novellinoauthor=R.+Silvestri&title=Design%2C+synthesis%2C+and+biological+evaluation+of+1-phenylpyrazolo%5B3%2C4-e%5Dpyrrolo%5B3%2C4-g%5Dindolizine-4%2C6%281H%2C5H%29-diones+as+new+glycogen+synthase+kinase-3beta+inhibitors&doi=10.1021%2Fjm401466v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1021%2Fjm401466v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401466v%26sid%3Dliteratum%253Aachs%26aulast%3DLa%2BPietra%26aufirst%3DV.%26aulast%3DLa%2BRegina%26aufirst%3DG.%26aulast%3DColuccia%26aufirst%3DA.%26aulast%3DFamiglini%26aufirst%3DV.%26aulast%3DPelliccia%26aufirst%3DS.%26aulast%3DPlotkin%26aufirst%3DB.%26aulast%3DEldar-Finkelman%26aufirst%3DH.%26aulast%3DBrancale%26aufirst%3DA.%26aulast%3DBallatore%26aufirst%3DC.%26aulast%3DCrowe%26aufirst%3DA.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DSilvestri%26aufirst%3DR.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%25201-phenylpyrazolo%255B3%252C4-e%255Dpyrrolo%255B3%252C4-g%255Dindolizine-4%252C6%25281H%252C5H%2529-diones%2520as%2520new%2520glycogen%2520synthase%2520kinase-3beta%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D24%26spage%3D10066%26epage%3D10078%26doi%3D10.1021%2Fjm401466v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fukunaga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uehara, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aritomo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamakoshi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchiya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamagami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimura, M.</span><span> </span><span class="NLM_article-title">2-(2-Phenylmorpholin-4-yl)pyrimidin-4(3H)-ones; a new class of potent, selective and orally active glycogen synthase kinase-3beta inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">6933</span><span class="NLM_x">–</span> <span class="NLM_lpage">6937</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.09.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1016%2Fj.bmcl.2013.09.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=24176395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1yqt7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6933-6937&issue=24&author=K.+Fukunagaauthor=F.+Ueharaauthor=K.+Aritomoauthor=A.+Shodaauthor=S.+Hikiauthor=M.+Okuyamaauthor=Y.+Usuiauthor=K.+Watanabeauthor=K.+Yamakoshiauthor=T.+Koharaauthor=T.+Hananoauthor=H.+Tanakaauthor=S.+Tsuchiyaauthor=S.+Sunadaauthor=K.+Saitoauthor=J.+Eguchiauthor=S.+Yukiauthor=S.+Asanoauthor=S.+Tanakaauthor=A.+Moriauthor=K.+Yamagamiauthor=H.+Babaauthor=T.+Horikawaauthor=M.+Fujimura&title=2-%282-Phenylmorpholin-4-yl%29pyrimidin-4%283H%29-ones%3B+a+new+class+of+potent%2C+selective+and+orally+active+glycogen+synthase+kinase-3beta+inhibitors&doi=10.1016%2Fj.bmcl.2013.09.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">2-(2-Phenylmorpholin-4-yl)pyrimidin-4(3H)-ones; A new class of potent, selective and orally active glycogen synthase kinase-3β inhibitors</span></div><div class="casAuthors">Fukunaga, Kenji; Uehara, Fumiaki; Aritomo, Keiichi; Shoda, Aya; Hiki, Shinsuke; Okuyama, Masahiro; Usui, Yoshihiro; Watanabe, Kazutoshi; Yamakoshi, Koichi; Kohara, Toshiyuki; Hanano, Tokushi; Tanaka, Hiroshi; Tsuchiya, Susumu; Sunada, Shinji; Saito, Ken-Ichi; Eguchi, Jun-ichi; Yuki, Satoshi; Asano, Shoichi; Tanaka, Shinji; Mori, Akiko; Yamagami, Keiji; Baba, Hiroshi; Horikawa, Takashi; Fujimura, Masatake</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6933-6937</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of 2-(2-phenylmorpholin-4-yl)pyrimidin-4(3H)-ones was synthesized and examd. for their inhibitory activity against glycogen synthase kinase-3β (GSK-3β).  We found compds. I (R = 4-F (II), 2,6-di-OMe, 2-F-6-Cl) to possess potent in vitro GSK-3β inhibitory activity with good in vitro PK profiles.  Compd. II demonstrated significant decrease of tau phosphorylation after oral administration in mice and excellent PK profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9woxQA77rTbVg90H21EOLACvtfcHk0lh2nTUDdlHDLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1yqt7vL&md5=6c8bc95e0ccb21078aff1837d83e649e</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.09.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.09.020%26sid%3Dliteratum%253Aachs%26aulast%3DFukunaga%26aufirst%3DK.%26aulast%3DUehara%26aufirst%3DF.%26aulast%3DAritomo%26aufirst%3DK.%26aulast%3DShoda%26aufirst%3DA.%26aulast%3DHiki%26aufirst%3DS.%26aulast%3DOkuyama%26aufirst%3DM.%26aulast%3DUsui%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DYamakoshi%26aufirst%3DK.%26aulast%3DKohara%26aufirst%3DT.%26aulast%3DHanano%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DTsuchiya%26aufirst%3DS.%26aulast%3DSunada%26aufirst%3DS.%26aulast%3DSaito%26aufirst%3DK.%26aulast%3DEguchi%26aufirst%3DJ.%26aulast%3DYuki%26aufirst%3DS.%26aulast%3DAsano%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DMori%26aufirst%3DA.%26aulast%3DYamagami%26aufirst%3DK.%26aulast%3DBaba%26aufirst%3DH.%26aulast%3DHorikawa%26aufirst%3DT.%26aulast%3DFujimura%26aufirst%3DM.%26atitle%3D2-%25282-Phenylmorpholin-4-yl%2529pyrimidin-4%25283H%2529-ones%253B%2520a%2520new%2520class%2520of%2520potent%252C%2520selective%2520and%2520orally%2520active%2520glycogen%2520synthase%2520kinase-3beta%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26issue%3D24%26spage%3D6933%26epage%3D6937%26doi%3D10.1016%2Fj.bmcl.2013.09.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Uehara, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aritomo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukunaga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinoda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubodera, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoneyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niwa, T.</span><span> </span><span class="NLM_article-title">6-(4-Pyridyl)pyrimidin-4(3H)-ones as CNS penetrant glycogen synthase kinase-3beta inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">6928</span><span class="NLM_x">–</span> <span class="NLM_lpage">6932</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.09.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1016%2Fj.bmcl.2013.09.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6928-6932&issue=24&author=F.+Ueharaauthor=A.+Shodaauthor=K.+Aritomoauthor=K.+Fukunagaauthor=K.+Watanabeauthor=R.+Andoauthor=M.+Shinodaauthor=H.+Uenoauthor=H.+Kuboderaauthor=S.+Sunadaauthor=K.+Saitoauthor=T.+Kajiauthor=S.+Asanoauthor=J.+Eguchiauthor=S.+Yukiauthor=S.+Tanakaauthor=Y.+Yoneyamaauthor=T.+Niwa&title=6-%284-Pyridyl%29pyrimidin-4%283H%29-ones+as+CNS+penetrant+glycogen+synthase+kinase-3beta+inhibitors&doi=10.1016%2Fj.bmcl.2013.09.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.09.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.09.021%26sid%3Dliteratum%253Aachs%26aulast%3DUehara%26aufirst%3DF.%26aulast%3DShoda%26aufirst%3DA.%26aulast%3DAritomo%26aufirst%3DK.%26aulast%3DFukunaga%26aufirst%3DK.%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DAndo%26aufirst%3DR.%26aulast%3DShinoda%26aufirst%3DM.%26aulast%3DUeno%26aufirst%3DH.%26aulast%3DKubodera%26aufirst%3DH.%26aulast%3DSunada%26aufirst%3DS.%26aulast%3DSaito%26aufirst%3DK.%26aulast%3DKaji%26aufirst%3DT.%26aulast%3DAsano%26aufirst%3DS.%26aulast%3DEguchi%26aufirst%3DJ.%26aulast%3DYuki%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DYoneyama%26aufirst%3DY.%26aulast%3DNiwa%26aufirst%3DT.%26atitle%3D6-%25284-Pyridyl%2529pyrimidin-4%25283H%2529-ones%2520as%2520CNS%2520penetrant%2520glycogen%2520synthase%2520kinase-3beta%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26issue%3D24%26spage%3D6928%26epage%3D6932%26doi%3D10.1016%2Fj.bmcl.2013.09.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Fukunaga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabeno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inazawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horikawa, T.</span><span> </span><span class="NLM_article-title">Discovery of novel 2-(alkylmorpholin-4-yl)-6-(3-fluoropyridin-4-yl)-pyrimidin-4(3H)-ones as orally-active GSK-3beta inhibitors for Alzheimer’s disease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1086</span><span class="NLM_x">–</span> <span class="NLM_lpage">1091</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.01.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1016%2Fj.bmcl.2015.01.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=1086-1091&issue=5&author=K.+Fukunagaauthor=D.+Sakaiauthor=K.+Watanabeauthor=K.+Nakayamaauthor=T.+Koharaauthor=H.+Tanakaauthor=S.+Sunadaauthor=M.+Nabenoauthor=M.+Okamotoauthor=K.+Saitoauthor=J.+Eguchiauthor=A.+Moriauthor=S.+Tanakaauthor=K.+Inazawaauthor=T.+Horikawa&title=Discovery+of+novel+2-%28alkylmorpholin-4-yl%29-6-%283-fluoropyridin-4-yl%29-pyrimidin-4%283H%29-ones+as+orally-active+GSK-3beta+inhibitors+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmcl.2015.01.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DFukunaga%26aufirst%3DK.%26aulast%3DSakai%26aufirst%3DD.%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DKohara%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DSunada%26aufirst%3DS.%26aulast%3DNabeno%26aufirst%3DM.%26aulast%3DOkamoto%26aufirst%3DM.%26aulast%3DSaito%26aufirst%3DK.%26aulast%3DEguchi%26aufirst%3DJ.%26aulast%3DMori%26aufirst%3DA.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DInazawa%26aufirst%3DK.%26aulast%3DHorikawa%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520novel%25202-%2528alkylmorpholin-4-yl%2529-6-%25283-fluoropyridin-4-yl%2529-pyrimidin-4%25283H%2529-ones%2520as%2520orally-active%2520GSK-3beta%2520inhibitors%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26issue%3D5%26spage%3D1086%26epage%3D1091%26doi%3D10.1016%2Fj.bmcl.2015.01.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Coffman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanyon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schachter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng-Lovering, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wessel, M.</span><span> </span><span class="NLM_article-title">6-Amino-4-(pyrimidin-4-yl)pyridones: novel glycogen synthase kinase-3beta inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1429</span><span class="NLM_x">–</span> <span class="NLM_lpage">1433</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.01.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1016%2Fj.bmcl.2011.01.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1429-1433&issue=5&author=K.+Coffmanauthor=M.+Brodneyauthor=J.+Cookauthor=L.+Lanyonauthor=J.+Panditauthor=S.+Sakyaauthor=J.+Schachterauthor=E.+Tseng-Loveringauthor=M.+Wessel&title=6-Amino-4-%28pyrimidin-4-yl%29pyridones%3A+novel+glycogen+synthase+kinase-3beta+inhibitors&doi=10.1016%2Fj.bmcl.2011.01.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13d&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.01.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.01.017%26sid%3Dliteratum%253Aachs%26aulast%3DCoffman%26aufirst%3DK.%26aulast%3DBrodney%26aufirst%3DM.%26aulast%3DCook%26aufirst%3DJ.%26aulast%3DLanyon%26aufirst%3DL.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DSakya%26aufirst%3DS.%26aulast%3DSchachter%26aufirst%3DJ.%26aulast%3DTseng-Lovering%26aufirst%3DE.%26aulast%3DWessel%26aufirst%3DM.%26atitle%3D6-Amino-4-%2528pyrimidin-4-yl%2529pyridones%253A%2520novel%2520glycogen%2520synthase%2520kinase-3beta%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D5%26spage%3D1429%26epage%3D1433%26doi%3D10.1016%2Fj.bmcl.2011.01.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Gentile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozzan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernasconi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bax, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belyanskaya, S.</span><span> </span><span class="NLM_article-title">5-Aryl-4-carboxamide-1,3-oxazoles: potent and selective GSK-3 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1989</span><span class="NLM_x">–</span> <span class="NLM_lpage">1994</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.01.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1016%2Fj.bmcl.2012.01.034" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1989-1994&issue=5&author=G.+Gentileauthor=G.+Merloauthor=A.+Pozzanauthor=G.+Bernasconiauthor=B.+Baxauthor=P.+Bamboroughauthor=A.+Bridgesauthor=P.+Carterauthor=M.+Neuauthor=G.+Yaoauthor=C.+Broughauthor=G.+Cutlerauthor=A.+Coffinauthor=S.+Belyanskaya&title=5-Aryl-4-carboxamide-1%2C3-oxazoles%3A+potent+and+selective+GSK-3+inhibitors&doi=10.1016%2Fj.bmcl.2012.01.034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.01.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.01.034%26sid%3Dliteratum%253Aachs%26aulast%3DGentile%26aufirst%3DG.%26aulast%3DMerlo%26aufirst%3DG.%26aulast%3DPozzan%26aufirst%3DA.%26aulast%3DBernasconi%26aufirst%3DG.%26aulast%3DBax%26aufirst%3DB.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DBridges%26aufirst%3DA.%26aulast%3DCarter%26aufirst%3DP.%26aulast%3DNeu%26aufirst%3DM.%26aulast%3DYao%26aufirst%3DG.%26aulast%3DBrough%26aufirst%3DC.%26aulast%3DCutler%26aufirst%3DG.%26aulast%3DCoffin%26aufirst%3DA.%26aulast%3DBelyanskaya%26aufirst%3DS.%26atitle%3D5-Aryl-4-carboxamide-1%252C3-oxazoles%253A%2520potent%2520and%2520selective%2520GSK-3%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26issue%3D5%26spage%3D1989%26epage%3D1994%26doi%3D10.1016%2Fj.bmcl.2012.01.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaisina, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petukhov, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blond, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedolak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldarone, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGonigle, P.</span><span> </span><span class="NLM_article-title">Structure-based design leads to the identification of lithium mimetics that block mania-like effects in rodents. Possible new GSK-3beta therapies for bipolar disorders</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">8328</span><span class="NLM_x">–</span> <span class="NLM_lpage">8332</span><span class="refDoi"> DOI: 10.1021/ja068969w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja068969w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=8328-8332&issue=26&author=A.+P.+Kozikowskiauthor=I.+N.+Gaisinaauthor=H.+Yuanauthor=P.+A.+Petukhovauthor=S.+Y.+Blondauthor=A.+Fedolakauthor=B.+Caldaroneauthor=P.+McGonigle&title=Structure-based+design+leads+to+the+identification+of+lithium+mimetics+that+block+mania-like+effects+in+rodents.+Possible+new+GSK-3beta+therapies+for+bipolar+disorders&doi=10.1021%2Fja068969w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fja068969w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja068969w%26sid%3Dliteratum%253Aachs%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DGaisina%26aufirst%3DI.%2BN.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DPetukhov%26aufirst%3DP.%2BA.%26aulast%3DBlond%26aufirst%3DS.%2BY.%26aulast%3DFedolak%26aufirst%3DA.%26aulast%3DCaldarone%26aufirst%3DB.%26aulast%3DMcGonigle%26aufirst%3DP.%26atitle%3DStructure-based%2520design%2520leads%2520to%2520the%2520identification%2520of%2520lithium%2520mimetics%2520that%2520block%2520mania-like%2520effects%2520in%2520rodents.%2520Possible%2520new%2520GSK-3beta%2520therapies%2520for%2520bipolar%2520disorders%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26issue%3D26%26spage%3D8328%26epage%3D8332%26doi%3D10.1021%2Fja068969w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaisina, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunosewoyo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malekiani, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanania, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Structure-guided design of a highly selective glycogen synthase kinase-3beta inhibitor: a superior neuroprotective pyrazolone showing antimania effects</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1587</span><span class="NLM_x">–</span> <span class="NLM_lpage">1592</span><span class="refDoi"> DOI: 10.1002/cmdc.201100231</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1002%2Fcmdc.201100231" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1587-1592&issue=9&author=W.+Chenauthor=I.+N.+Gaisinaauthor=H.+Gunosewoyoauthor=S.+A.+Malekianiauthor=T.+Hananiaauthor=A.+P.+Kozikowski&title=Structure-guided+design+of+a+highly+selective+glycogen+synthase+kinase-3beta+inhibitor%3A+a+superior+neuroprotective+pyrazolone+showing+antimania+effects&doi=10.1002%2Fcmdc.201100231"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100231%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DGaisina%26aufirst%3DI.%2BN.%26aulast%3DGunosewoyo%26aufirst%3DH.%26aulast%3DMalekiani%26aufirst%3DS.%2BA.%26aulast%3DHanania%26aufirst%3DT.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DStructure-guided%2520design%2520of%2520a%2520highly%2520selective%2520glycogen%2520synthase%2520kinase-3beta%2520inhibitor%253A%2520a%2520superior%2520neuroprotective%2520pyrazolone%2520showing%2520antimania%2520effects%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26issue%3D9%26spage%3D1587%26epage%3D1592%26doi%3D10.1002%2Fcmdc.201100231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Kalinichev, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, L. A.</span><span> </span><span class="NLM_article-title">Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK3) inhibitors in a strain-specific model of acute mania</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1051</span><span class="NLM_x">–</span> <span class="NLM_lpage">1067</span><span class="refDoi"> DOI: 10.1017/S1461145710001495</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1017%2FS1461145710001495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=21208504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A528%3ADC%252BC3MXps1eitLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=1051-1067&issue=8&author=M.+Kalinichevauthor=L.+A.+Dawson&title=Evidence+for+antimanic+efficacy+of+glycogen+synthase+kinase-3+%28GSK3%29+inhibitors+in+a+strain-specific+model+of+acute+mania&doi=10.1017%2FS1461145710001495"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK3) inhibitors in a strain-specific model of acute mania</span></div><div class="casAuthors">Kalinichev, Mikhail; Dawson, Lee A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1051-1067</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">There is a growing body of evidence suggesting that animal models can be developed to probe the specific domains of bipolar disorder (BD) using the endophenotype approach.  Here we tested clin. active antimanic drugs to validate amphetamine-induced hyperactivity in Black Swiss mice as a putative model of the manic phase of BD.  We also co-administered a mood stabilizer and an atypical antipsychotic drug in a manner akin to the clin. treatment regimens.  Since lithium has been shown to potentially act through glycogen synthase kinase-3 (GSK3) inhibition, we evaluated the efficacy of selective GSK3 inhibitors in this model.  Habituated animals were pretreated with a compd. of interest before being challenged with amphetamine (2.0 mg/kg) and returned to activity cages for an addnl. 1.5 h.  We tested lithium, sodium valproate, carbamazepine, olanzapine, ziprasidone as well as co-administered lithium and olanzapine at sub-efficacious doses.  The GSK3 inhibitors tested included indirubin, alsterpaullone, TDZD-8, AR-A014418, SB-216763, and SB-627772.  All mood stabilizers and antipsychotic drugs reduced hyperactivity without affecting spontaneous locomotion.  While subactive doses of lithium and olanzapine were without effect, their co-administration produced robust redns. in hyperactivity.  All GSK3 inhibitors were active in the model, producing selective inhibition of rearing hyperactivity.  These data support the predictive validity of the model for the acute manic phase of BD and may have utility as an in-vivo model for identifying novel antimanic therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5B0hy-ESJIrVg90H21EOLACvtfcHk0lhrJiXw9fg7AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXps1eitLc%253D&md5=afab413eb631fdd646c8d34d55d982df</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1017%2FS1461145710001495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145710001495%26sid%3Dliteratum%253Aachs%26aulast%3DKalinichev%26aufirst%3DM.%26aulast%3DDawson%26aufirst%3DL.%2BA.%26atitle%3DEvidence%2520for%2520antimanic%2520efficacy%2520of%2520glycogen%2520synthase%2520kinase-3%2520%2528GSK3%2529%2520inhibitors%2520in%2520a%2520strain-specific%2520model%2520of%2520acute%2520mania%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2011%26volume%3D14%26issue%3D8%26spage%3D1051%26epage%3D1067%26doi%3D10.1017%2FS1461145710001495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Ombrato, R.; Mancini, F.; Mangano, G.</span>, unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Ombrato%2C+R.%3B+Mancini%2C+F.%3B+Mangano%2C+G.%2C+unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DOmbrato%26aufirst%3DR." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Alisi, M. A.; Nicola, C.; Guglielmotti, A.; Furlotti, G.; Luna, G.; Polenzani, L.</span><span> </span><span class="NLM_article-title">Indazolamides with Analgesic Activity, Process and Intermediates for Their Preparation, and Their Pharmaceutical Compositions</span>. WO 2004074275 A1,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+A.+Alisi&author=C.+Nicola&author=A.+Guglielmotti&author=G.+Furlotti&author=G.+Luna&author=L.+Polenzani&title=Indazolamides+with+Analgesic+Activity%2C+Process+and+Intermediates+for+Their+Preparation%2C+and+Their+Pharmaceutical+Compositions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlisi%26aufirst%3DM.%2BA.%26atitle%3DIndazolamides%2520with%2520Analgesic%2520Activity%252C%2520Process%2520and%2520Intermediates%2520for%2520Their%2520Preparation%252C%2520and%2520Their%2520Pharmaceutical%2520Compositions%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Witherington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaiba, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawlings, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slingsby, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takle, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, R. W.</span><span> </span><span class="NLM_article-title">6-Heteroaryl-pyrazolo[3,4-b]pyridines: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">3059</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span><span class="refDoi"> DOI: 10.1016/S0960-894X(03)00646-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1016%2FS0960-894X%2803%2900646-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=3059-62&issue=18&author=J.+Witheringtonauthor=V.+Bordasauthor=A.+Gaibaauthor=A.+Naylorauthor=A.+D.+Rawlingsauthor=B.+P.+Slingsbyauthor=D.+G.+Smithauthor=A.+K.+Takleauthor=R.+W.+Ward&title=6-Heteroaryl-pyrazolo%5B3%2C4-b%5Dpyridines%3A+potent+and+selective+inhibitors+of+glycogen+synthase+kinase-3+%28GSK-3%29&doi=10.1016%2FS0960-894X%2803%2900646-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900646-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900646-2%26sid%3Dliteratum%253Aachs%26aulast%3DWitherington%26aufirst%3DJ.%26aulast%3DBordas%26aufirst%3DV.%26aulast%3DGaiba%26aufirst%3DA.%26aulast%3DNaylor%26aufirst%3DA.%26aulast%3DRawlings%26aufirst%3DA.%2BD.%26aulast%3DSlingsby%26aufirst%3DB.%2BP.%26aulast%3DSmith%26aufirst%3DD.%2BG.%26aulast%3DTakle%26aufirst%3DA.%2BK.%26aulast%3DWard%26aufirst%3DR.%2BW.%26atitle%3D6-Heteroaryl-pyrazolo%255B3%252C4-b%255Dpyridines%253A%2520potent%2520and%2520selective%2520inhibitors%2520of%2520glycogen%2520synthase%2520kinase-3%2520%2528GSK-3%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26issue%3D18%26spage%3D3059%26epage%3D62%26doi%3D10.1016%2FS0960-894X%2803%2900646-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Witherington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haigh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ife, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawlings, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slingsby, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, R. W.</span><span> </span><span class="NLM_article-title">5-Aryl-pyrazolo[3,4-b]pyridazines: potent inhibitors of glycogen synthase kinase-3 (GSK-3)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1581</span><span class="NLM_x">–</span> <span class="NLM_lpage">1584</span><span class="refDoi"> DOI: 10.1016/S0960-894X(03)00135-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1016%2FS0960-894X%2803%2900135-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1581-1584&issue=9&author=J.+Witheringtonauthor=V.+Bordasauthor=D.+Haighauthor=D.+M.+Hickeyauthor=R.+J.+Ifeauthor=A.+D.+Rawlingsauthor=B.+P.+Slingsbyauthor=D.+G.+Smithauthor=R.+W.+Ward&title=5-Aryl-pyrazolo%5B3%2C4-b%5Dpyridazines%3A+potent+inhibitors+of+glycogen+synthase+kinase-3+%28GSK-3%29&doi=10.1016%2FS0960-894X%2803%2900135-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900135-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900135-5%26sid%3Dliteratum%253Aachs%26aulast%3DWitherington%26aufirst%3DJ.%26aulast%3DBordas%26aufirst%3DV.%26aulast%3DHaigh%26aufirst%3DD.%26aulast%3DHickey%26aufirst%3DD.%2BM.%26aulast%3DIfe%26aufirst%3DR.%2BJ.%26aulast%3DRawlings%26aufirst%3DA.%2BD.%26aulast%3DSlingsby%26aufirst%3DB.%2BP.%26aulast%3DSmith%26aufirst%3DD.%2BG.%26aulast%3DWard%26aufirst%3DR.%2BW.%26atitle%3D5-Aryl-pyrazolo%255B3%252C4-b%255Dpyridazines%253A%2520potent%2520inhibitors%2520of%2520glycogen%2520synthase%2520kinase-3%2520%2528GSK-3%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26issue%3D9%26spage%3D1581%26epage%3D1584%26doi%3D10.1016%2FS0960-894X%2803%2900135-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skaltsounis, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magiatis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polychronopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knockaert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leost, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vonica, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brivanlou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dajani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crovace, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarricone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musacchio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greengard, P.</span><span> </span><span class="NLM_article-title">GSK-3-selective inhibitors derived from Tyrian purple indirubins. BMC</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1255</span><span class="NLM_x">–</span> <span class="NLM_lpage">1266</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2003.11.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1016%2Fj.chembiol.2003.11.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=14700633" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVWis73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=1255-1266&issue=12&author=L.+Meijerauthor=A.+L.+Skaltsounisauthor=P.+Magiatisauthor=P.+Polychronopoulosauthor=M.+Knockaertauthor=M.+Leostauthor=X.+P.+Ryanauthor=C.+A.+Vonicaauthor=A.+Brivanlouauthor=R.+Dajaniauthor=C.+Crovaceauthor=C.+Tarriconeauthor=A.+Musacchioauthor=S.+M.+Roeauthor=L.+Pearlauthor=P.+Greengard&title=GSK-3-selective+inhibitors+derived+from+Tyrian+purple+indirubins.+BMC&doi=10.1016%2Fj.chembiol.2003.11.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">GSK-3-Selective Inhibitors Derived from Tyrian Purple Indirubins</span></div><div class="casAuthors">Meijer, Laurent; Skaltsounis, Alexios-Leandros; Magiatis, Prokopios; Polychronopoulos, Panagiotis; Knockaert, Marie; Leost, Maryse; Ryan, Xiaozhou P.; Vonica, Claudia Alin; Brivanlou, Ali; Dajani, Rana; Crovace, Claudia; Tarricone, Cataldo; Musacchio, Andrea; Roe, S. Mark; Pearl, Laurence; Greengard, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1255-1266</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Gastropod mollusks have been used for over 2500 yr to produce the "Tyrian purple" dye made famous by the Phoenicians.  This dye is constituted of mixed bromine-substituted indigo and indirubin isomers.  Among these, the new natural product 6-bromoindirubin and its synthetic, cell-permeable deriv., 6-bromoindirubin-3'-oxime (BIO), display remarkable selective inhibition of glycogen synthase kinase-3 (GSK-3).  Cocrystal structure of GSK-3β/BIO and CDK5/p25/indirubin-3'-oxime were resolved, providing a detailed view of indirubins' interactions within the ATP binding pocket of these kinases.  BIO but not 1-methyl-BIO, its kinase inactive analog, also inhibited the phosphorylation on Tyr276/216, a GSK-3α/β activation site.  BIO but not 1-methyl-BIO reduced β-catenin phosphorylation on a GSK-3-specific site in cellular models.  BIO but not 1-methyl-BIO closely mimicked Wnt signaling in Xenopus embryos.  6-Bromoindirubins thus provide a new scaffold for the development of selective and potent pharmacol. inhibitors of GSK-3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol3sG1_xDZJ7Vg90H21EOLACvtfcHk0lhrJiXw9fg7AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVWis73O&md5=0fbc4fc974a3bea0db8c63d97eada58f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2003.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2003.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DSkaltsounis%26aufirst%3DA.%2BL.%26aulast%3DMagiatis%26aufirst%3DP.%26aulast%3DPolychronopoulos%26aufirst%3DP.%26aulast%3DKnockaert%26aufirst%3DM.%26aulast%3DLeost%26aufirst%3DM.%26aulast%3DRyan%26aufirst%3DX.%2BP.%26aulast%3DVonica%26aufirst%3DC.%2BA.%26aulast%3DBrivanlou%26aufirst%3DA.%26aulast%3DDajani%26aufirst%3DR.%26aulast%3DCrovace%26aufirst%3DC.%26aulast%3DTarricone%26aufirst%3DC.%26aulast%3DMusacchio%26aufirst%3DA.%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DPearl%26aufirst%3DL.%26aulast%3DGreengard%26aufirst%3DP.%26atitle%3DGSK-3-selective%2520inhibitors%2520derived%2520from%2520Tyrian%2520purple%2520indirubins.%2520BMC%26jtitle%3DChem.%2520Biol.%26date%3D2003%26volume%3D10%26issue%3D12%26spage%3D1255%26epage%3D1266%26doi%3D10.1016%2Fj.chembiol.2003.11.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Copeland, R. A.</span><span> </span><span class="NLM_article-title">Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists</span> <span class="citation_source-journal">Methods Biochem. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=16350889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A280%3ADC%252BD2MnmtlyjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=1-265&author=R.+A.+Copeland&title=Evaluation+of+enzyme+inhibitors+in+drug+discovery.+A+guide+for+medicinal+chemists+and+pharmacologists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists</span></div><div class="casAuthors">Copeland Robert A</div><div class="citationInfo"><span class="NLM_cas:title">Methods of biochemical analysis</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-265</span>
        ISSN:<span class="NLM_cas:issn">0076-6941</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSR7_ubfiC0DK2q3xNe7a7QfW6udTcc2eYtAhkuXkB7Obntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MnmtlyjsA%253D%253D&md5=4bb6759b5155aa6c2b6a462432afda7f</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26atitle%3DEvaluation%2520of%2520enzyme%2520inhibitors%2520in%2520drug%2520discovery.%2520A%2520guide%2520for%2520medicinal%2520chemists%2520and%2520pharmacologists%26jtitle%3DMethods%2520Biochem.%2520Anal.%26date%3D2005%26volume%3D46%26spage%3D1%26epage%3D265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Becker, W.</span><span> </span><span class="NLM_article-title">Emerging role of DYRK family protein kinases as regulators of protein stability in cell cycle control</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">3389</span><span class="NLM_x">–</span> <span class="NLM_lpage">3394</span><span class="refDoi"> DOI: 10.4161/cc.21404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.4161%2Fcc.21404" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=3389-3394&issue=18&author=W.+Becker&title=Emerging+role+of+DYRK+family+protein+kinases+as+regulators+of+protein+stability+in+cell+cycle+control&doi=10.4161%2Fcc.21404"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.4161%2Fcc.21404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.21404%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DEmerging%2520role%2520of%2520DYRK%2520family%2520protein%2520kinases%2520as%2520regulators%2520of%2520protein%2520stability%2520in%2520cell%2520cycle%2520control%26jtitle%3DCell%2520Cycle%26date%3D2012%26volume%3D11%26issue%3D18%26spage%3D3389%26epage%3D3394%26doi%3D10.4161%2Fcc.21404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Noll, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Planque, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ripoll, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guedj, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ducros, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duchon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Freminville, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grattau, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bléhaut, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herault, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delabar, J. M.</span><span> </span><span class="NLM_article-title">DYRK1A, a novel determinant of the methionine-homocysteine cycle in different mouse models overexpressing this Down-syndrome-associated kinase</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">e7540</span><span class="refDoi"> DOI: 10.1371/journal.pone.0007540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1371%2Fjournal.pone.0007540" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=e7540&issue=10&author=C.+Nollauthor=C.+Planqueauthor=C.+Ripollauthor=F.+Guedjauthor=A.+Diezauthor=V.+Ducrosauthor=N.+Belinauthor=A.+Duchonauthor=J.+L.+Paulauthor=A.+Badelauthor=B.+de+Freminvilleauthor=Y.+Grattauauthor=H.+Bl%C3%A9hautauthor=Y.+Heraultauthor=N.+Janelauthor=J.+M.+Delabar&title=DYRK1A%2C+a+novel+determinant+of+the+methionine-homocysteine+cycle+in+different+mouse+models+overexpressing+this+Down-syndrome-associated+kinase&doi=10.1371%2Fjournal.pone.0007540"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0007540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0007540%26sid%3Dliteratum%253Aachs%26aulast%3DNoll%26aufirst%3DC.%26aulast%3DPlanque%26aufirst%3DC.%26aulast%3DRipoll%26aufirst%3DC.%26aulast%3DGuedj%26aufirst%3DF.%26aulast%3DDiez%26aufirst%3DA.%26aulast%3DDucros%26aufirst%3DV.%26aulast%3DBelin%26aufirst%3DN.%26aulast%3DDuchon%26aufirst%3DA.%26aulast%3DPaul%26aufirst%3DJ.%2BL.%26aulast%3DBadel%26aufirst%3DA.%26aulast%3Dde%2BFreminville%26aufirst%3DB.%26aulast%3DGrattau%26aufirst%3DY.%26aulast%3DBl%25C3%25A9haut%26aufirst%3DH.%26aulast%3DHerault%26aufirst%3DY.%26aulast%3DJanel%26aufirst%3DN.%26aulast%3DDelabar%26aufirst%3DJ.%2BM.%26atitle%3DDYRK1A%252C%2520a%2520novel%2520determinant%2520of%2520the%2520methionine-homocysteine%2520cycle%2520in%2520different%2520mouse%2520models%2520overexpressing%2520this%2520Down-syndrome-associated%2520kinase%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26issue%3D10%26spage%3De7540%26doi%3D10.1371%2Fjournal.pone.0007540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Menegay, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moeslein, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landreth, G. E.</span><span> </span><span class="NLM_article-title">Biochemical characterization and localization of the dual specificity kinase CLK1</span> <span class="citation_source-journal">J. Cell. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">3241</span><span class="NLM_x">–</span> <span class="NLM_lpage">3253</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10954422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsVyltb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2000&pages=3241-3253&issue=18&author=H.+J.+Menegayauthor=M.+P.+Myersauthor=F.+M.+Moesleinauthor=G.+E.+Landreth&title=Biochemical+characterization+and+localization+of+the+dual+specificity+kinase+CLK1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical characterization and localization of the dual specificity kinase CLK1</span></div><div class="casAuthors">Menegay, Harry J.; Myers, Michael P.; Moeslein, Fred M.; Landreth, Gary E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3241-3253</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">CLK1 kinase was one of the 1st identified dual specificity kinases and is the founding member of the "LAMMER" family of kinases.  THe authors previously established the substrate site specificity of CLK1.  Here, the authors report that truncation of the N-terminus of CLK1 resulted in a dramatic increase in CLK1 enzymic activity, indicating that the N-terminus acts as a neg. regulatory domain.  The N-terminal truncation resulted in a 45-fold increase in Vmax, suggesting that this domain does not contain a pseudo-substrate motif, but may act to conformationally constrain the catalytic activity of CLK1.  Tyrosine-phosphorylation has been proposed to be crit. for CLK1 activity, however, CLK1 activity was unaffected by exposure to tyrosine phosphatases.  Treatment of CLK1 with the serine/threonine-specific phosphophosphatase PP2A, resulted in a 2- to 6-fold increase in enzymic activity.  Incubation of CLK1 with tyrosine phosphatases in combination with PP2A abolished CLK1 activity.  These data suggest that CLK1 is regulated by 3 distinct mechanisms that serve to both pos. and neg. regulate CLK1 activity.  CLK1 activity is pos. regulated by phosphorylation on either Tyr residues or Ser/Thr residues, and is neg. regulated by steric constraints mediated by the N-terminal domain, as well as, by phosphorylation on a subset of Ser/Thr residues within the catalytic domain.  CLK1 mRNA was expressed at low levels in all tissues and cell lines examd.  The full-length and truncated splice forms were expressed at roughly equiv. levels in most tissues.  The ratio of the 2 splice variants of CLK1 could be altered by treatment with cycloheximide.  CLK1 protein expression was limited to a small subset of highly localized neuronal populations in the rat brain.  Contrary to previous studies using overexpression systems, it was shown that CLK1 protein was primarily found in the cytoplasm of these cells, with only a small fraction localized to the nucleus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro5fsug852p7Vg90H21EOLACvtfcHk0li6-FWs7YYW_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsVyltb4%253D&md5=a90c2dcf6aad8518a017190c549925b3</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMenegay%26aufirst%3DH.%2BJ.%26aulast%3DMyers%26aufirst%3DM.%2BP.%26aulast%3DMoeslein%26aufirst%3DF.%2BM.%26aulast%3DLandreth%26aufirst%3DG.%2BE.%26atitle%3DBiochemical%2520characterization%2520and%2520localization%2520of%2520the%2520dual%2520specificity%2520kinase%2520CLK1%26jtitle%3DJ.%2520Cell.%2520Sci.%26date%3D2000%26volume%3D113%26issue%3D18%26spage%3D3241%26epage%3D3253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Hartmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rujescu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannakouros, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolakaki, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goedert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Q. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreadis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamm, S.</span><span> </span><span class="NLM_article-title">Regulation of Alternative Splicing of Human Tau Exon 10 by Phosphorylation of Splicing Factors</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span><span class="refDoi"> DOI: 10.1006/mcne.2001.1000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1006%2Fmcne.2001.1000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=11461155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlt1Cmur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2001&pages=80-90&author=A.+Hartmannauthor=D.+Rujescuauthor=T.+Giannakourosauthor=E.+Nikolakakiauthor=M.+Goedertauthor=E.+Mandelkowauthor=Q.+S.+Gaoauthor=A.+Andreadisauthor=S.+Stamm&title=Regulation+of+Alternative+Splicing+of+Human+Tau+Exon+10+by+Phosphorylation+of+Splicing+Factors&doi=10.1006%2Fmcne.2001.1000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of Alternative Splicing of Human Tau Exon 10 by Phosphorylation of Splicing Factors</span></div><div class="casAuthors">Hartmann, Annette M.; Rujescu, Dan; Giannakouros, Thomas; Nikolakaki, Eleni; Goedert, Michel; Mandelkow, Eva-Maria; Gao, Qing Sheng; Andreadis, Athena; Stamm, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">80-90</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Tau is a microtubule-assocd. protein whose transcript undergoes regulated splicing in the mammalian nervous system.  Exon 10 of the gene is an alternatively spliced cassette that is adult-specific and encodes a microtubule-binding domain.  Mutations increasing the inclusion of exon 10 result in the prodn. of tau protein which predominantly contains four microtubule-binding repeats and were shown to cause frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).  Here we show that exon 10 usage is regulated by CDC2-like kinases CLK1, 2, 3, and 4 that phosphorylate serine-arginine-rich proteins, which in turn regulate pre-mRNA splicing.  Cotransfection expts. suggest that CLKs achieve this effect by releasing specific proteins from nuclear storage sites.  Our results show that changing pre-mRNA-processing pathways through phosphorylation could be a new therapeutic concept for tauopathies.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF56T2cyktgLVg90H21EOLACvtfcHk0ljGPeMK9Jhw8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlt1Cmur4%253D&md5=c5fc041adf6f212feb59f277aec9aa4b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1006%2Fmcne.2001.1000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmcne.2001.1000%26sid%3Dliteratum%253Aachs%26aulast%3DHartmann%26aufirst%3DA.%26aulast%3DRujescu%26aufirst%3DD.%26aulast%3DGiannakouros%26aufirst%3DT.%26aulast%3DNikolakaki%26aufirst%3DE.%26aulast%3DGoedert%26aufirst%3DM.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DGao%26aufirst%3DQ.%2BS.%26aulast%3DAndreadis%26aufirst%3DA.%26aulast%3DStamm%26aufirst%3DS.%26atitle%3DRegulation%2520of%2520Alternative%2520Splicing%2520of%2520Human%2520Tau%2520Exon%252010%2520by%2520Phosphorylation%2520of%2520Splicing%2520Factors%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D2001%26volume%3D18%26spage%3D80%26epage%3D90%26doi%3D10.1006%2Fmcne.2001.1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Yamanashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyoshima, K.</span><span> </span><span class="NLM_article-title">Selective expression of a protein-tyrosine kinase, p56lyn, in hematopoietic cells and association with production of human T-cell lymphotropic virus type I</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">6538</span><span class="NLM_x">–</span> <span class="NLM_lpage">6542</span><span class="refDoi"> DOI: 10.1073/pnas.86.17.6538</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1073%2Fpnas.86.17.6538" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1989&pages=6538-6542&issue=17&author=Y.+Yamanashiauthor=S.+Moriauthor=M.+Yoshidaauthor=T.+Kishimotoauthor=K.+Inoueauthor=T.+Yamamotoauthor=K.+Toyoshima&title=Selective+expression+of+a+protein-tyrosine+kinase%2C+p56lyn%2C+in+hematopoietic+cells+and+association+with+production+of+human+T-cell+lymphotropic+virus+type+I&doi=10.1073%2Fpnas.86.17.6538"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1073%2Fpnas.86.17.6538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.86.17.6538%26sid%3Dliteratum%253Aachs%26aulast%3DYamanashi%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DS.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DKishimoto%26aufirst%3DT.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DToyoshima%26aufirst%3DK.%26atitle%3DSelective%2520expression%2520of%2520a%2520protein-tyrosine%2520kinase%252C%2520p56lyn%252C%2520in%2520hematopoietic%2520cells%2520and%2520association%2520with%2520production%2520of%2520human%2520T-cell%2520lymphotropic%2520virus%2520type%2520I%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1989%26volume%3D86%26issue%3D17%26spage%3D6538%26epage%3D6542%26doi%3D10.1073%2Fpnas.86.17.6538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Tsantikos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oracki, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quilici, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarlinton, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibbs, M. L.</span><span> </span><span class="NLM_article-title">Autoimmune disease in Lyn-deficient mice is dependent on an inflammatory environment established by IL-6</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">184</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1348</span><span class="NLM_x">–</span> <span class="NLM_lpage">1360</span><span class="refDoi"> DOI: 10.4049/jimmunol.0901878</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.4049%2Fjimmunol.0901878" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=2010&pages=1348-1360&issue=3&author=E.+Tsantikosauthor=S.+A.+Orackiauthor=C.+Quiliciauthor=G.+P.+Andersonauthor=D.+M.+Tarlintonauthor=M.+L.+Hibbs&title=Autoimmune+disease+in+Lyn-deficient+mice+is+dependent+on+an+inflammatory+environment+established+by+IL-6&doi=10.4049%2Fjimmunol.0901878"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.0901878&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.0901878%26sid%3Dliteratum%253Aachs%26aulast%3DTsantikos%26aufirst%3DE.%26aulast%3DOracki%26aufirst%3DS.%2BA.%26aulast%3DQuilici%26aufirst%3DC.%26aulast%3DAnderson%26aufirst%3DG.%2BP.%26aulast%3DTarlinton%26aufirst%3DD.%2BM.%26aulast%3DHibbs%26aufirst%3DM.%2BL.%26atitle%3DAutoimmune%2520disease%2520in%2520Lyn-deficient%2520mice%2520is%2520dependent%2520on%2520an%2520inflammatory%2520environment%2520established%2520by%2520IL-6%26jtitle%3DJ.%2520Immunol.%26date%3D2010%26volume%3D184%26issue%3D3%26spage%3D1348%26epage%3D1360%26doi%3D10.4049%2Fjimmunol.0901878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Nishimoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishida, E.</span><span> </span><span class="NLM_article-title">MAPK signalling: ERK5 versus ERK1/2</span> <span class="citation_source-journal">EMBO Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">782</span><span class="NLM_x">–</span> <span class="NLM_lpage">786</span><span class="refDoi"> DOI: 10.1038/sj.embor.7400755</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1038%2Fsj.embor.7400755" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=16880823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsFajsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=782-786&issue=8&author=S.+Nishimotoauthor=E.+Nishida&title=MAPK+signalling%3A+ERK5+versus+ERK1%2F2&doi=10.1038%2Fsj.embor.7400755"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">MAPK signaling: ERK5 versus ERK1/2</span></div><div class="casAuthors">Nishimoto, Satoko; Nishida, Eisuke</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Reports</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">782-786</span>CODEN:
                <span class="NLM_cas:coden">ERMEAX</span>;
        ISSN:<span class="NLM_cas:issn">1469-221X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Extracellular-signal-regulated kinase 5 (ERK5) is a member of the mitogen-activated protein kinase (MAPK) family and, similar to ERK1/2, has the Thr-Glu-Tyr (TEY) activation motif.  Both ERK5 and ERK1/2 are activated by growth factors and have an important role in the regulation of cell proliferation and cell differentiation.  Moreover, both the ERK5 and the ERK1/2 pathways are sensitive to PD98059 and U0126, which are two well-known inhibitors of the ERK pathway.  Despite these similarities, recent studies have revealed distinctive features of the ERK5 pathway: ERK5 has a key role in cardiovascular development and neural differentiation; ERK5 nuclear translocation is controlled by its own nuclear localizing and nuclear export activities; and the carboxy-terminal half of ERK5, which follows its kinase catalytic domain, has a unique function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxGAyxrdcDGrVg90H21EOLACvtfcHk0ljGPeMK9Jhw8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsFajsrw%253D&md5=f0e4ffe6cf70f29a8867da4a86e46940</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fsj.embor.7400755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.embor.7400755%26sid%3Dliteratum%253Aachs%26aulast%3DNishimoto%26aufirst%3DS.%26aulast%3DNishida%26aufirst%3DE.%26atitle%3DMAPK%2520signalling%253A%2520ERK5%2520versus%2520ERK1%252F2%26jtitle%3DEMBO%2520Rep.%26date%3D2006%26volume%3D7%26issue%3D8%26spage%3D782%26epage%3D786%26doi%3D10.1038%2Fsj.embor.7400755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Ribas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penela, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murga, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salcedo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Hoz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurado-Pueyo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aymerich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayor, F.</span><span> </span><span class="NLM_article-title">The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signaling</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Biomembr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1768</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">913</span><span class="NLM_x">–</span> <span class="NLM_lpage">922</span><span class="refDoi"> DOI: 10.1016/j.bbamem.2006.09.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1016%2Fj.bbamem.2006.09.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=17084806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsVWhsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1768&publication_year=2007&pages=913-922&issue=4&author=C.+Ribasauthor=P.+Penelaauthor=C.+Murgaauthor=A.+Salcedoauthor=C.+Garc%C3%ADa-Hozauthor=M.+Jurado-Pueyoauthor=I.+Aymerichauthor=F.+Mayor&title=The+G+protein-coupled+receptor+kinase+%28GRK%29+interactome%3A+role+of+GRKs+in+GPCR+regulation+and+signaling&doi=10.1016%2Fj.bbamem.2006.09.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The G protein-coupled receptor kinase (GRK) interactome: Role of GRKs in GPCR regulation and signaling</span></div><div class="casAuthors">Ribas, Catalina; Penela, Petronila; Murga, Cristina; Salcedo, Alicia; Garcia-Hoz, Carlota; Jurado-Pueyo, Maria; Aymerich, Ivette; Mayor, Federico</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1768</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">913-922</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptor kinases (GRKs) and arrestins are key participants in the canonical pathways leading to phosphorylation-dependent GPCR desensitization, endocytosis, intracellular trafficking and resensitization as well as in the modulation of important intracellular signaling cascades by GPCR.  Novel studies have revealed a phosphorylation-independent desensitization mechanism operating through their RGS-homol. (RH) domain and the recent detn. of the crystal structures of GRK2 and GRK6 has uncovered interesting details on the structure-function relationships of these kinases.  Emerging evidence indicates that the activity of GRKs is tightly modulated by mechanisms including phosphorylation by different kinases and interaction with several cellular proteins such as calmodulin, caveolin or RKIP.  In addn., GRKs are involved in multiple interactions with non-receptor proteins (PI3K, Akt, GIT or MEK) that point to novel GRK cellular roles.  In this article, the authors' purpose is to describe the ever increasing map of functional interactions for GRK proteins as a basis to better understand its contribution to cellular processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVEb4zP9V6WbVg90H21EOLACvtfcHk0libpJGfUqCq3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsVWhsLs%253D&md5=7bcb46279c2781485f8b4b20c58656cf</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2006.09.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2006.09.019%26sid%3Dliteratum%253Aachs%26aulast%3DRibas%26aufirst%3DC.%26aulast%3DPenela%26aufirst%3DP.%26aulast%3DMurga%26aufirst%3DC.%26aulast%3DSalcedo%26aufirst%3DA.%26aulast%3DGarc%25C3%25ADa-Hoz%26aufirst%3DC.%26aulast%3DJurado-Pueyo%26aufirst%3DM.%26aulast%3DAymerich%26aufirst%3DI.%26aulast%3DMayor%26aufirst%3DF.%26atitle%3DThe%2520G%2520protein-coupled%2520receptor%2520kinase%2520%2528GRK%2529%2520interactome%253A%2520role%2520of%2520GRKs%2520in%2520GPCR%2520regulation%2520and%2520signaling%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2007%26volume%3D1768%26issue%3D4%26spage%3D913%26epage%3D922%26doi%3D10.1016%2Fj.bbamem.2006.09.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4a','cit4b','cit4c'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8a','cit8b','cit8c','cit8d','cit8e','cit8f'],'ref9':['cit9a','cit9b','cit9c'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12a','cit12b','cit12c'],'ref13':['cit13a','cit13b','cit13c','cit13d'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20a','cit20b'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 21 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Federica Prati, Rosa Buonfiglio, Guido Furlotti, Claudia Cavarischia, Giorgina Mangano, Rossella Picollo, Laura Oggianu, Anna di Matteo, Silvana Olivieri, Graziella Bovi, Pier Francesca Porceddu, Angelo Reggiani, Beatrice Garrone, Francesco Paolo Di Giorgio, <span class="NLM_string-name hlFld-ContribAuthor">Rosella Ombrato</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of Indazole-Based GSK-3 Inhibitors with Mitigated hERG Issue and In Vivo Activity in a Mood Disorder Model. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (5)
                                     , 825-831. <a href="https://doi.org/10.1021/acsmedchemlett.9b00633" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00633</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00633%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DOptimization%252Bof%252BIndazole-Based%252BGSK-3%252BInhibitors%252Bwith%252BMitigated%252BhERG%252BIssue%252Band%252BIn%252BVivo%252BActivity%252Bin%252Ba%252BMood%252BDisorder%252BModel%26aulast%3DPrati%26aufirst%3DFederica%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D20122019%26date%3D24032020%26date%3D27032020%26date%3D24032020%26volume%3D11%26issue%3D5%26spage%3D825%26epage%3D831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Somayeh Motevalli, Michelle T. Nguyen, Jiacheng Tan, <span class="NLM_string-name hlFld-ContribAuthor">Amelia A. Fuller</span>. </span><span class="cited-content_cbyCitation_article-title">Diverse N-Substituted Azole-Containing Amino Acids as Building Blocks for Cyclopeptides. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2020,</strong> <em>5 </em>
                                    (2)
                                     , 1214-1220. <a href="https://doi.org/10.1021/acsomega.9b03682" title="DOI URL">https://doi.org/10.1021/acsomega.9b03682</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.9b03682&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.9b03682%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DDiverse%252BN-Substituted%252BAzole-Containing%252BAmino%252BAcids%252Bas%252BBuilding%252BBlocks%252Bfor%252BCyclopeptides%26aulast%3DMotevalli%26aufirst%3DSomayeh%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D31102019%26date%3D24122019%26date%3D08012020%26volume%3D5%26issue%3D2%26spage%3D1214%26epage%3D1220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Cheng Zhang, Sailan Chang, Shanliang Dong, Lihua Qiu, <span class="NLM_string-name hlFld-ContribAuthor">Xinfang Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Acid-Promoted Bicyclization of Diaryl Alkynes: Synthesis of 2H-Indazoles with in Situ Generated Diazonium Salt as Nitrogen Source. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (16)
                                     , 9125-9136. <a href="https://doi.org/10.1021/acs.joc.8b01199" title="DOI URL">https://doi.org/10.1021/acs.joc.8b01199</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b01199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b01199%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAcid-Promoted%252BBicyclization%252Bof%252BDiaryl%252BAlkynes%25253A%252BSynthesis%252Bof%252B2H-Indazoles%252Bwith%252Bin%252BSitu%252BGenerated%252BDiazonium%252BSalt%252Bas%252BNitrogen%252BSource%26aulast%3DZhang%26aufirst%3DCheng%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D10052018%26date%3D21062018%26date%3D08062018%26volume%3D83%26issue%3D16%26spage%3D9125%26epage%3D9136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hwangseo  Park</span>, <span class="hlFld-ContribAuthor ">Yongje  Shin</span>, <span class="hlFld-ContribAuthor ">Jinhee  Kim</span>, and <span class="hlFld-ContribAuthor ">Sungwoo  Hong</span>  . </span><span class="cited-content_cbyCitation_article-title">Application of Fragment-Based de Novo Design to the Discovery of Selective Picomolar Inhibitors of Glycogen Synthase Kinase-3 Beta. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (19)
                                     , 9018-9034. <a href="https://doi.org/10.1021/acs.jmedchem.6b00944" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00944</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00944&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00944%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DApplication%252Bof%252BFragment-Based%252Bde%252BNovo%252BDesign%252Bto%252Bthe%252BDiscovery%252Bof%252BSelective%252BPicomolar%252BInhibitors%252Bof%252BGlycogen%252BSynthase%252BKinase-3%252BBeta%26aulast%3DPark%26aufirst%3DHwangseo%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D28062016%26date%3D30092016%26date%3D13102016%26date%3D27092016%26volume%3D59%26issue%3D19%26spage%3D9018%26epage%3D9034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xueyang  Jiang</span>, <span class="hlFld-ContribAuthor ">Chang  Liu</span>, <span class="hlFld-ContribAuthor ">Manxing  Zou</span>, <span class="hlFld-ContribAuthor ">Huanfang  Xie</span>, <span class="hlFld-ContribAuthor ">Tailiang  Lin</span>, <span class="hlFld-ContribAuthor ">Weiping  Lyu</span>, <span class="hlFld-ContribAuthor ">Jian  Xu</span>, <span class="hlFld-ContribAuthor ">Yuan  Li</span>, <span class="hlFld-ContribAuthor ">Feng  Feng</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>, <span class="hlFld-ContribAuthor ">Wenyuan  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 2-(cyclopropanecarboxamido)-N-(5-((1-(4-fluorobenzyl)piperidin-4-yl)methoxy)pyridin-3-yl)isonicotinamide as a potent dual AChE/GSK3β inhibitor for the treatment of Alzheimer's disease: Significantly increasing the level of acetylcholine in the brain without affecting that in intestine. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>223 </em>, 113663. <a href="https://doi.org/10.1016/j.ejmech.2021.113663" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113663</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113663%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B2-%252528cyclopropanecarboxamido%252529-N-%2525285-%252528%2525281-%2525284-fluorobenzyl%252529piperidin-4-yl%252529methoxy%252529pyridin-3-yl%252529isonicotinamide%252Bas%252Ba%252Bpotent%252Bdual%252BAChE%25252FGSK3%2525CE%2525B2%252Binhibitor%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%25253A%252BSignificantly%252Bincreasing%252Bthe%252Blevel%252Bof%252Bacetylcholine%252Bin%252Bthe%252Bbrain%252Bwithout%252Baffecting%252Bthat%252Bin%252Bintestine%26aulast%3DJiang%26aufirst%3DXueyang%26date%3D2021%26volume%3D223%26spage%3D113663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nitin  Tandon</span>, <span class="hlFld-ContribAuthor ">Vijay  Luxami</span>, <span class="hlFld-ContribAuthor ">Divya  Kant</span>, <span class="hlFld-ContribAuthor ">Runjhun  Tandon</span>, <span class="hlFld-ContribAuthor ">Kamaldeep  Paul</span>. </span><span class="cited-content_cbyCitation_article-title">Current progress, challenges and future prospects of indazoles as protein kinase inhibitors for the treatment of cancer. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2021,</strong> <em>11 </em>
                                    (41)
                                     , 25228-25257. <a href="https://doi.org/10.1039/D1RA03979B" title="DOI URL">https://doi.org/10.1039/D1RA03979B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1RA03979B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1RA03979B%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DCurrent%252Bprogress%25252C%252Bchallenges%252Band%252Bfuture%252Bprospects%252Bof%252Bindazoles%252Bas%252Bprotein%252Bkinase%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bcancer%26aulast%3DTandon%26aufirst%3DNitin%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D41%26spage%3D25228%26epage%3D25257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shan-Kui  Liu</span>, <span class="hlFld-ContribAuthor ">Hong-Xu  Xie</span>, <span class="hlFld-ContribAuthor ">Yong-Xi  Ge</span>, <span class="hlFld-ContribAuthor ">Juan  Zhang</span>, <span class="hlFld-ContribAuthor ">Cheng-Shi  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">An updated research of glycogen synthase kinase-3β inhibitors: a review. </span><span class="cited-content_cbyCitation_journal-name">Monatshefte für Chemie - Chemical Monthly</span><span> <strong>2021,</strong> <em>152 </em>
                                    (1)
                                     , 19-33. <a href="https://doi.org/10.1007/s00706-020-02718-y" title="DOI URL">https://doi.org/10.1007/s00706-020-02718-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00706-020-02718-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00706-020-02718-y%26sid%3Dliteratum%253Aachs%26jtitle%3DMonatshefte%2520f%25C3%25BCr%2520Chemie%2520-%2520Chemical%2520Monthly%26atitle%3DAn%252Bupdated%252Bresearch%252Bof%252Bglycogen%252Bsynthase%252Bkinase-3%2525CE%2525B2%252Binhibitors%25253A%252Ba%252Breview%26aulast%3DLiu%26aufirst%3DShan-Kui%26date%3D2021%26date%3D2021%26volume%3D152%26issue%3D1%26spage%3D19%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sumit  Ghosh</span>, <span class="hlFld-ContribAuthor ">Susmita  Mondal</span>, <span class="hlFld-ContribAuthor ">Alakananda  Hajra</span>. </span><span class="cited-content_cbyCitation_article-title">Direct Catalytic Functionalization of Indazole Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2020,</strong> <em>362 </em>
                                    (18)
                                     , 3768-3794. <a href="https://doi.org/10.1002/adsc.202000423" title="DOI URL">https://doi.org/10.1002/adsc.202000423</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202000423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202000423%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DDirect%252BCatalytic%252BFunctionalization%252Bof%252BIndazole%252BDerivatives%26aulast%3DGhosh%26aufirst%3DSumit%26date%3D2020%26date%3D2020%26volume%3D362%26issue%3D18%26spage%3D3768%26epage%3D3794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valeria  Capurro</span>, <span class="hlFld-ContribAuthor ">Massimiliano  Lanfranco</span>, <span class="hlFld-ContribAuthor ">Maria  Summa</span>, <span class="hlFld-ContribAuthor ">Pier Francesca  Porceddu</span>, <span class="hlFld-ContribAuthor ">Mariasole  Ciampoli</span>, <span class="hlFld-ContribAuthor ">Natasha  Margaroli</span>, <span class="hlFld-ContribAuthor ">Lucia  Durando</span>, <span class="hlFld-ContribAuthor ">Beatrice  Garrone</span>, <span class="hlFld-ContribAuthor ">Rosella  Ombrato</span>, <span class="hlFld-ContribAuthor ">Serena  Tongiani</span>, <span class="hlFld-ContribAuthor ">Angelo  Reggiani</span>. </span><span class="cited-content_cbyCitation_article-title">The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2020,</strong> <em>128 </em>, 110249. <a href="https://doi.org/10.1016/j.biopha.2020.110249" title="DOI URL">https://doi.org/10.1016/j.biopha.2020.110249</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2020.110249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2020.110249%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DThe%252Bmood%252Bstabilizing%252Bproperties%252Bof%252BAF3581%25252C%252Ba%252Bnovel%252Bpotent%252BGSK-3%2525CE%2525B2%252Binhibitor%26aulast%3DCapurro%26aufirst%3DValeria%26date%3D2020%26volume%3D128%26spage%3D110249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Santosh  Raut</span>, <span class="hlFld-ContribAuthor ">Atul  Tidke</span>, <span class="hlFld-ContribAuthor ">Bharat  Dhotre</span>, <span class="hlFld-ContribAuthor ">Pathan Mohd  Arif</span>. </span><span class="cited-content_cbyCitation_article-title">Different Strategies to the Synthesis of Indazole and its Derivatives: A Review. </span><span class="cited-content_cbyCitation_journal-name">Mini-Reviews in Organic Chemistry</span><span> <strong>2020,</strong> <em>17 </em>
                                    (4)
                                     , 363-404. <a href="https://doi.org/10.2174/1570193X16666190430160324" title="DOI URL">https://doi.org/10.2174/1570193X16666190430160324</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570193X16666190430160324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570193X16666190430160324%26sid%3Dliteratum%253Aachs%26jtitle%3DMini-Reviews%2520in%2520Organic%2520Chemistry%26atitle%3DDifferent%252BStrategies%252Bto%252Bthe%252BSynthesis%252Bof%252BIndazole%252Band%252Bits%252BDerivatives%25253A%252BA%252BReview%26aulast%3DRaut%26aufirst%3DSantosh%26date%3D2020%26volume%3D17%26issue%3D4%26spage%3D363%26epage%3D404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rosa  Buonfiglio</span>, <span class="hlFld-ContribAuthor ">Federica  Prati</span>, <span class="hlFld-ContribAuthor ">Martina  Bischetti</span>, <span class="hlFld-ContribAuthor ">Claudia  Cavarischia</span>, <span class="hlFld-ContribAuthor ">Guido  Furlotti</span>, <span class="hlFld-ContribAuthor ">Rosella  Ombrato</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Imidazopyridine GSK-3β Inhibitors Supported by Computational Approaches. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (9)
                                     , 2163. <a href="https://doi.org/10.3390/molecules25092163" title="DOI URL">https://doi.org/10.3390/molecules25092163</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25092163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25092163%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDiscovery%252Bof%252BNovel%252BImidazopyridine%252BGSK-3%2525CE%2525B2%252BInhibitors%252BSupported%252Bby%252BComputational%252BApproaches%26aulast%3DBuonfiglio%26aufirst%3DRosa%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D9%26spage%3D2163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohammed  Eddahmi</span>, <span class="hlFld-ContribAuthor ">Nuno M. M.  Moura</span>, <span class="hlFld-ContribAuthor ">Latifa  Bouissane</span>, <span class="hlFld-ContribAuthor ">Maria A. F.  Faustino</span>, <span class="hlFld-ContribAuthor ">José A. S.  Cavaleiro</span>, <span class="hlFld-ContribAuthor ">Filipe A. A.  Paz</span>, <span class="hlFld-ContribAuthor ">Ricardo F.  Mendes</span>, <span class="hlFld-ContribAuthor ">Joana  Figueiredo</span>, <span class="hlFld-ContribAuthor ">Josué  Carvalho</span>, <span class="hlFld-ContribAuthor ">Carla  Cruz</span>, <span class="hlFld-ContribAuthor ">Maria G. P. M. S.  Neves</span>, <span class="hlFld-ContribAuthor ">El Mostapha  Rakib</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of New Functionalized Nitroindazolylacetonitrile Derivatives. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (48)
                                     , 14335-14342. <a href="https://doi.org/10.1002/slct.201904344" title="DOI URL">https://doi.org/10.1002/slct.201904344</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201904344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201904344%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BNew%252BFunctionalized%252BNitroindazolylacetonitrile%252BDerivatives%26aulast%3DEddahmi%26aufirst%3DMohammed%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D48%26spage%3D14335%26epage%3D14342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanxing  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaodong  Dou</span>, <span class="hlFld-ContribAuthor ">Lan  Jiang</span>, <span class="hlFld-ContribAuthor ">Hongwei  Jin</span>, <span class="hlFld-ContribAuthor ">Lihe  Zhang</span>, <span class="hlFld-ContribAuthor ">Liangren  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhenming  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel glycogen synthase kinase-3α inhibitors: Structure-based virtual screening, preliminary SAR and biological evaluation for treatment of acute myeloid leukemia. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>171 </em>, 221-234. <a href="https://doi.org/10.1016/j.ejmech.2019.03.039" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.03.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.03.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.03.039%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252Bglycogen%252Bsynthase%252Bkinase-3%2525CE%2525B1%252Binhibitors%25253A%252BStructure-based%252Bvirtual%252Bscreening%25252C%252Bpreliminary%252BSAR%252Band%252Bbiological%252Bevaluation%252Bfor%252Btreatment%252Bof%252Bacute%252Bmyeloid%252Bleukemia%26aulast%3DWang%26aufirst%3DYanxing%26date%3D2019%26volume%3D171%26spage%3D221%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pravin  Ambure</span>, <span class="hlFld-ContribAuthor ">Jyotsna  Bhat</span>, <span class="hlFld-ContribAuthor ">Tomasz  Puzyn</span>, <span class="hlFld-ContribAuthor ">Kunal  Roy</span>. </span><span class="cited-content_cbyCitation_article-title">Identifying natural compounds as multi-target-directed ligands against Alzheimer’s disease: an
              in silico
              approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2019,</strong> <em>37 </em>
                                    (5)
                                     , 1282-1306. <a href="https://doi.org/10.1080/07391102.2018.1456975" title="DOI URL">https://doi.org/10.1080/07391102.2018.1456975</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2018.1456975&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2018.1456975%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DIdentifying%252Bnatural%252Bcompounds%252Bas%252Bmulti-target-directed%252Bligands%252Bagainst%252BAlzheimer%2525E2%252580%252599s%252Bdisease%25253A%252Ban%252Bin%252Bsilico%252Bapproach%26aulast%3DAmbure%26aufirst%3DPravin%26date%3D2019%26date%3D2018%26volume%3D37%26issue%3D5%26spage%3D1282%26epage%3D1306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.  Xu</span>, <span class="hlFld-ContribAuthor ">S.L.  Wang</span>, <span class="hlFld-ContribAuthor ">L.  Zhu</span>, <span class="hlFld-ContribAuthor ">P.Y.  Wu</span>, <span class="hlFld-ContribAuthor ">W.B.  Dai</span>, <span class="hlFld-ContribAuthor ">K.P.  Rakesh</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-activity relationship (SAR) studies of synthetic glycogen synthase kinase-3β inhibitors: A critical review. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>164 </em>, 448-470. <a href="https://doi.org/10.1016/j.ejmech.2018.12.073" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.12.073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.12.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.12.073%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-activity%252Brelationship%252B%252528SAR%252529%252Bstudies%252Bof%252Bsynthetic%252Bglycogen%252Bsynthase%252Bkinase-3%2525CE%2525B2%252Binhibitors%25253A%252BA%252Bcritical%252Breview%26aulast%3DXu%26aufirst%3DM.%26date%3D2019%26volume%3D164%26spage%3D448%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaodong  Dou</span>, <span class="hlFld-ContribAuthor ">Lan  Jiang</span>, <span class="hlFld-ContribAuthor ">Yanxing  Wang</span>, <span class="hlFld-ContribAuthor ">Hongwei  Jin</span>, <span class="hlFld-ContribAuthor ">Zhenming  Liu</span>, <span class="hlFld-ContribAuthor ">Liangren  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of new GSK-3β inhibitors through structure-based virtual screening. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (2)
                                     , 160-166. <a href="https://doi.org/10.1016/j.bmcl.2017.11.036" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.11.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.11.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.11.036%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnew%252BGSK-3%2525CE%2525B2%252Binhibitors%252Bthrough%252Bstructure-based%252Bvirtual%252Bscreening%26aulast%3DDou%26aufirst%3DXiaodong%26date%3D2018%26volume%3D28%26issue%3D2%26spage%3D160%26epage%3D166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valle  Palomo</span>, <span class="hlFld-ContribAuthor ">Ana  Martinez</span>. </span><span class="cited-content_cbyCitation_article-title">Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2014-2015). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2017,</strong> <em>27 </em>
                                    (6)
                                     , 657-666. <a href="https://doi.org/10.1080/13543776.2017.1259412" title="DOI URL">https://doi.org/10.1080/13543776.2017.1259412</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2017.1259412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2017.1259412%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DGlycogen%252Bsynthase%252Bkinase%252B3%252B%252528GSK-3%252529%252Binhibitors%25253A%252Ba%252Bpatent%252Bupdate%252B%2525282014-2015%252529%26aulast%3DPalomo%26aufirst%3DValle%26date%3D2017%26date%3D2016%26volume%3D27%26issue%3D6%26spage%3D657%26epage%3D666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ather  Muneer</span>. </span><span class="cited-content_cbyCitation_article-title">Wnt and GSK3 Signaling Pathways in Bipolar Disorder: Clinical and Therapeutic Implications. </span><span class="cited-content_cbyCitation_journal-name">Clinical Psychopharmacology and Neuroscience</span><span> <strong>2017,</strong> <em>15 </em>
                                    (2)
                                     , 100-114. <a href="https://doi.org/10.9758/cpn.2017.15.2.100" title="DOI URL">https://doi.org/10.9758/cpn.2017.15.2.100</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.9758/cpn.2017.15.2.100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.9758%2Fcpn.2017.15.2.100%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Psychopharmacology%2520and%2520Neuroscience%26atitle%3DWnt%252Band%252BGSK3%252BSignaling%252BPathways%252Bin%252BBipolar%252BDisorder%25253A%252BClinical%252Band%252BTherapeutic%252BImplications%26aulast%3DMuneer%26aufirst%3DAther%26date%3D2017%26volume%3D15%26issue%3D2%26spage%3D100%26epage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinhee  Kim</span>, <span class="hlFld-ContribAuthor ">Yonghoon  Moon</span>, <span class="hlFld-ContribAuthor ">Sungwoo  Hong</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of lead small molecule inhibitors of glycogen synthase kinase-3 beta using a fragment-linking strategy. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (23)
                                     , 5669-5673. <a href="https://doi.org/10.1016/j.bmcl.2016.10.060" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.10.060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.10.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.10.060%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252Blead%252Bsmall%252Bmolecule%252Binhibitors%252Bof%252Bglycogen%252Bsynthase%252Bkinase-3%252Bbeta%252Busing%252Ba%252Bfragment-linking%252Bstrategy%26aulast%3DKim%26aufirst%3DJinhee%26date%3D2016%26volume%3D26%26issue%3D23%26spage%3D5669%26epage%3D5673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saïd  El Kazzouli</span>, <span class="hlFld-ContribAuthor ">Gérald  Guillaumet</span>. </span><span class="cited-content_cbyCitation_article-title">Functionalization of indazoles by means of transition metal-catalyzed cross-coupling reactions. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2016,</strong> <em>72 </em>
                                    (43)
                                     , 6711-6727. <a href="https://doi.org/10.1016/j.tet.2016.08.031" title="DOI URL">https://doi.org/10.1016/j.tet.2016.08.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2016.08.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2016.08.031%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DFunctionalization%252Bof%252Bindazoles%252Bby%252Bmeans%252Bof%252Btransition%252Bmetal-catalyzed%252Bcross-coupling%252Breactions%26aulast%3DEl%2BKazzouli%26aufirst%3DSa%25C3%25AFd%26date%3D2016%26volume%3D72%26issue%3D43%26spage%3D6711%26epage%3D6727" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/medium/jm-2015-01208k_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01208&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/medium/jm-2015-01208k_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0016.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Structures of GSK-3β Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01208&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/medium/jm-2015-01208k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0001.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. X-ray crystal structure of compound <b>5</b> in the GSK-3β ATP binding site: (A) view of the hinge region interactions; (B) view from the inner cavity toward the hinge region and solvent accessible area.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01208&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/medium/jm-2015-01208k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0005.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Indazole-3-carboxamide Derivatives <b>9a</b>, <b>c</b>, <b>f</b>, <b>g</b>, <b>n</b>–<b>q</b>, <b>u</b>, <b>v</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01208&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HOBt, DCC, DMF, r.t., 39–67%; (b) H<sub>2</sub>, 10% Pd/C, 80 °C, 37%.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/medium/jm-2015-01208k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0006.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Indazole-3-carboxamide Derivatives <b>9b</b>, <b>d</b>, <b>e</b>, <b>m</b>, <b>t</b>, <b>w</b>–<b>z</b>, and <b>aa</b>–<b>ah</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01208&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) HOBt, DCC, DMF, 0 °C, 2 h → r. t., o.n., 87–96%; (b) 2 M HCl-EtOH, MeOH, r.t., 3 h, 76–89%; (c) R<sub>1</sub>-X, K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 1 h, 11–59%; (d) acq. NaOH, MeOH, Δ, o.n., 43–87%.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/medium/jm-2015-01208k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0007.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Amide Derivatives <b>9h</b>–<b>l</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01208&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) BOC-NH(CH<sub>2</sub>)<sub>3</sub>Br, TEA, MEK, 80 °C, 1 h; (b) TFA, DCM, r. t.; o.n., 63%; (c) R-COCl, DMSO, DCM, r. t., 2 h, 17–69%.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/medium/jm-2015-01208k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0008.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. <sup>a</sup> Synthesis of Derivatives <b>13</b>–<b>17</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01208&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R<sub>1</sub>-X, K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C, 1 h, 16–62%; (b) R<sub>2</sub>B(OH)<sub>2</sub> or R<sub>2</sub>B(OR)<sub>2</sub>, Pd(dppf)Cl<sub>2</sub>, Cs<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O (3:1), μ-wave (45’@ T = 160 °C, max power 300 W), 15–45%.</p></p></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/medium/jm-2015-01208k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0002.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Docking study of compound <b>9z</b> in the GSK-3β ATP site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01208&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/medium/jm-2015-01208k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0003.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Docking study of compound <b>14n</b> in the GSK-3β ATP site: (A) view of the hinge region interactions; (B) view from the inner cavity toward the hinge region and solvent accessible area.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01208&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/medium/jm-2015-01208k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0004.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effect of lithium chloride (A), TDZD-8 (B), and <b>14i</b> (C) on spontaneous motility (saline) and on amphetamine hyperactivity (amphetamine). Each bar is the average ± SEM (<i>n</i> = 8 each group). °°°<i>p</i> < 0.001 vs saline; *<i>p</i> < 0.05, **<i>p</i> < 0.01, and ***<i>p</i> < 0.001 vs amphetamine. Two way ANOVA, Bonferroni post-test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-22/acs.jmedchem.5b01208/20151119/images/large/jm-2015-01208k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01208&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i118">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12805" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12805" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 30 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Merikangas, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kessler, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampson, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viana, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrade, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karam, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ladea, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina-Mora, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Posada-Villa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sagar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarkov, Z.</span><span> </span><span class="NLM_article-title">Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">251</span><span class="refDoi"> DOI: 10.1001/archgenpsychiatry.2011.12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1001%2Farchgenpsychiatry.2011.12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=21383262" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A280%3ADC%252BC3M3kvVWjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2011&pages=241-251&issue=3&author=K.+R.+Merikangasauthor=R.+Jinauthor=J.+P.+Heauthor=R.+C.+Kesslerauthor=S.+Leeauthor=N.+A.+Sampsonauthor=M.+C.+Vianaauthor=L.+H.+Andradeauthor=C.+Huauthor=E.+G.+Karamauthor=M.+Ladeaauthor=M.+E.+Medina-Moraauthor=Y.+Onoauthor=J.+Posada-Villaauthor=R.+Sagarauthor=J.+E.+Wellsauthor=Z.+Zarkov&title=Prevalence+and+correlates+of+bipolar+spectrum+disorder+in+the+world+mental+health+survey+initiative&doi=10.1001%2Farchgenpsychiatry.2011.12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative</span></div><div class="casAuthors">Merikangas Kathleen R; Jin Robert; He Jian-Ping; Kessler Ronald C; Lee Sing; Sampson Nancy A; Viana Maria Carmen; Andrade Laura Helena; Hu Chiyi; Karam Elie G; Ladea Maria; Medina-Mora Maria Elena; Ono Yutaka; Posada-Villa Jose; Sagar Rajesh; Wells J Elisabeth; Zarkov Zahari</div><div class="citationInfo"><span class="NLM_cas:title">Archives of general psychiatry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">241-51</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">CONTEXT:  There is limited information on the prevalence and correlates of bipolar spectrum disorder in international population-based studies using common methods.  OBJECTIVES:  To describe the prevalence, impact, patterns of comorbidity, and patterns of service utilization for bipolar spectrum disorder (BPS) in the World Health Organization World Mental Health Survey Initiative.  DESIGN, SETTING, AND PARTICIPANTS:  Cross-sectional, face-to-face, household surveys of 61,392 community adults in 11 countries in the Americas, Europe, and Asia assessed with the World Mental Health version of the World Health Organization Composite International Diagnostic Interview, version 3.0, a fully structured, lay-administered psychiatric diagnostic interview.  MAIN OUTCOME MEASURES:  Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) disorders, severity, and treatment.  RESULTS:  The aggregate lifetime prevalences were 0.6% for bipolar type I disorder (BP-I), 0.4% for BP-II, 1.4% for subthreshold BP, and 2.4% for BPS.  Twelve-month prevalences were 0.4% for BP-I, 0.3% for BP-II, 0.8% for subthreshold BP, and 1.5% for BPS.  Severity of both manic and depressive symptoms as well as suicidal behavior increased monotonically from subthreshold BP to BP-I.  By contrast, role impairment was similar across BP subtypes.  Symptom severity was greater for depressive episodes than manic episodes, with approximately 74.0% of respondents with depression and 50.9% of respondents with mania reporting severe role impairment.  Three-quarters of those with BPS met criteria for at least 1 other disorder, with anxiety disorders (particularly panic attacks) being the most common comorbid condition.  Less than half of those with lifetime BPS received mental health treatment, particularly in low-income countries, where only 25.2% reported contact with the mental health system.  CONCLUSIONS:  Despite cross-site variation in the prevalence rates of BPS, the severity, impact, and patterns of comorbidity were remarkably similar internationally.  The uniform increases in clinical correlates, suicidal behavior, and comorbidity across each diagnostic category provide evidence for the validity of the concept of BPS.  Treatment needs for BPS are often unmet, particularly in low-income countries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTMABAeAsogHHELvajU9pjPfW6udTcc2eZ8Rd8Zd1xZ_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3kvVWjtA%253D%253D&md5=37d524cfd194d45407095c3b2b3b9af3</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1001%2Farchgenpsychiatry.2011.12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchgenpsychiatry.2011.12%26sid%3Dliteratum%253Aachs%26aulast%3DMerikangas%26aufirst%3DK.%2BR.%26aulast%3DJin%26aufirst%3DR.%26aulast%3DHe%26aufirst%3DJ.%2BP.%26aulast%3DKessler%26aufirst%3DR.%2BC.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DSampson%26aufirst%3DN.%2BA.%26aulast%3DViana%26aufirst%3DM.%2BC.%26aulast%3DAndrade%26aufirst%3DL.%2BH.%26aulast%3DHu%26aufirst%3DC.%26aulast%3DKaram%26aufirst%3DE.%2BG.%26aulast%3DLadea%26aufirst%3DM.%26aulast%3DMedina-Mora%26aufirst%3DM.%2BE.%26aulast%3DOno%26aufirst%3DY.%26aulast%3DPosada-Villa%26aufirst%3DJ.%26aulast%3DSagar%26aufirst%3DR.%26aulast%3DWells%26aufirst%3DJ.%2BE.%26aulast%3DZarkov%26aufirst%3DZ.%26atitle%3DPrevalence%2520and%2520correlates%2520of%2520bipolar%2520spectrum%2520disorder%2520in%2520the%2520world%2520mental%2520health%2520survey%2520initiative%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D2011%26volume%3D68%26issue%3D3%26spage%3D241%26epage%3D251%26doi%3D10.1001%2Farchgenpsychiatry.2011.12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Mao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koehler, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doud, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tassa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berry, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biechele, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petryshen, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moon, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haggarty, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, L. H.</span><span> </span><span class="NLM_article-title">Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">136</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1017</span><span class="NLM_x">–</span> <span class="NLM_lpage">1031</span><span class="refDoi"> DOI: 10.1016/j.cell.2008.12.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1016%2Fj.cell.2008.12.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=19303846" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltFSntrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2009&pages=1017-1031&issue=6&author=Y.+Maoauthor=X.+Geauthor=C.+L.+Frankauthor=J.+M.+Madisonauthor=A.+N.+Koehlerauthor=M.+K.+Doudauthor=C.+Tassaauthor=E.+M.+Berryauthor=T.+Sodaauthor=K.+K.+Singhauthor=T.+Biecheleauthor=T.+L.+Petryshenauthor=R.+T.+Moonauthor=S.+J.+Haggartyauthor=L.+H.+Tsai&title=Disrupted+in+schizophrenia+1+regulates+neuronal+progenitor+proliferation+via+modulation+of+GSK3beta%2Fbeta-catenin+signaling&doi=10.1016%2Fj.cell.2008.12.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3β/β-catenin signaling</span></div><div class="casAuthors">Mao, Yingwei; Ge, Xuecai; Frank, Christopher L.; Madison, Jon M.; Koehler, Angela N.; Doud, Mary Kathryn; Tassa, Carlos; Berry, Erin M.; Soda, Takahiro; Singh, Karun K.; Biechele, Travis; Petryshen, Tracey L.; Moon, Randall T.; Haggarty, Stephen J.; Tsai, Li-Huei</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1017-1031</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The Disrupted in Schizophrenia 1 (DISC1) gene is disrupted by a balanced chromosomal translocation (1; 11) (q42; q14.3) in a Scottish family with a high incidence of major depression, schizophrenia, and bipolar disorder.  Subsequent studies provided indications that DISC1 plays a role in brain development.  Here, we demonstrate that suppression of DISC1 expression reduces neural progenitor proliferation, leading to premature cell cycle exit and differentiation.  Several lines of evidence suggest that DISC1 mediates this function by regulating GSK3β.  First, DISC1 inhibits GSK3β activity through direct phys. interaction, which reduces β-catenin phosphorylation and stabilizes β-catenin.  Importantly, expression of stabilized β-catenin overrides the impairment of progenitor proliferation caused by DISC1 loss of function.  Furthermore, GSK3 inhibitors normalize progenitor proliferation and behavioral defects caused by DISC1 loss of function.  Together, these results implicate DISC1 in GSK3β/β-catenin signaling pathways and provide a framework for understanding how alterations in this pathway may contribute to the etiol. of psychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpy05n-L5CETbVg90H21EOLACvtfcHk0lj0EFSbrqDd5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltFSntrs%253D&md5=c049804aefd16bf1ebb760af8d82c469</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2008.12.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2008.12.044%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DY.%26aulast%3DGe%26aufirst%3DX.%26aulast%3DFrank%26aufirst%3DC.%2BL.%26aulast%3DMadison%26aufirst%3DJ.%2BM.%26aulast%3DKoehler%26aufirst%3DA.%2BN.%26aulast%3DDoud%26aufirst%3DM.%2BK.%26aulast%3DTassa%26aufirst%3DC.%26aulast%3DBerry%26aufirst%3DE.%2BM.%26aulast%3DSoda%26aufirst%3DT.%26aulast%3DSingh%26aufirst%3DK.%2BK.%26aulast%3DBiechele%26aufirst%3DT.%26aulast%3DPetryshen%26aufirst%3DT.%2BL.%26aulast%3DMoon%26aufirst%3DR.%2BT.%26aulast%3DHaggarty%26aufirst%3DS.%2BJ.%26aulast%3DTsai%26aufirst%3DL.%2BH.%26atitle%3DDisrupted%2520in%2520schizophrenia%25201%2520regulates%2520neuronal%2520progenitor%2520proliferation%2520via%2520modulation%2520of%2520GSK3beta%252Fbeta-catenin%2520signaling%26jtitle%3DCell%26date%3D2009%26volume%3D136%26issue%3D6%26spage%3D1017%26epage%3D1031%26doi%3D10.1016%2Fj.cell.2008.12.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">De Sarno, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jope, R. S.</span><span> </span><span class="NLM_article-title">Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1158</span><span class="NLM_x">–</span> <span class="NLM_lpage">1164</span><span class="refDoi"> DOI: 10.1016/S0028-3908(02)00215-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1016%2FS0028-3908%2802%2900215-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2002&pages=1158-1164&issue=7&author=P.+De+Sarnoauthor=X.+Liauthor=R.+S.+Jope&title=Regulation+of+Akt+and+glycogen+synthase+kinase-3+beta+phosphorylation+by+sodium+valproate+and+lithium&doi=10.1016%2FS0028-3908%2802%2900215-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2802%2900215-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252802%252900215-0%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BSarno%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DJope%26aufirst%3DR.%2BS.%26atitle%3DRegulation%2520of%2520Akt%2520and%2520glycogen%2520synthase%2520kinase-3%2520beta%2520phosphorylation%2520by%2520sodium%2520valproate%2520and%2520lithium%26jtitle%3DNeuropharmacology%26date%3D2002%26volume%3D43%26issue%3D7%26spage%3D1158%26epage%3D1164%26doi%3D10.1016%2FS0028-3908%2802%2900215-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manji, H. K.</span><span> </span><span class="NLM_article-title">The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1327</span><span class="NLM_x">–</span> <span class="NLM_lpage">1330</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.2000.0721327.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1046%2Fj.1471-4159.2000.0721327.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10037507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A528%3ADyaK1MXhsFWgtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1999&pages=1327-1330&issue=3&author=G.+Chenauthor=L.+D.+Huangauthor=Y.+M.+Jiangauthor=H.+K.+Manji&title=The+mood-stabilizing+agent+valproate+inhibits+the+activity+of+glycogen+synthase+kinase-3&doi=10.1046%2Fj.1471-4159.2000.0721327.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3</span></div><div class="casAuthors">Chen, Guang; Huang, Li-Dong; Jiang, Yi-Ming; Manji, Husseini K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1327-1330</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Valproic acid (VPA) is a potent broad-spectrum anti-epileptic with demonstrated efficacy in the treatment of bipolar affective disorder.  It has previously been demonstrated that both VPA and lithium increase activator protein-1 (AP-1) DNA binding activity, but the mechanisms underlying these effects have not been elucidated.  However, it is known that phosphorylation of c-jun by glycogen synthase kinase (GSK)-3β inhibits AP-1 DNA binding activity, and lithium has recently been demonstrated to inhibit GSK-3β.  These results suggest that lithium may increase AP-1 DNA binding activity by inhibiting GSK-3β.  In the present study, we sought to det. if VPA, like lithium, regulates GSK-3.  We have found that VPA concn.-dependently inhibits both GSK-3α and -3β, with significant effects obsd. at concns. of VPA similar to those attained clin.  Incubation of intact human neuroblastoma SH-SY5Y cells with VPA results in an increase in the subsequent in vitro recombinant GSK-3β-mediated 32P incorporation into two putative GSK-3 substrates (∼85 and 200 kDa), compatible with inhibition of endogenous GSK-3β by VPA.  Consistent with GSK-3β inhibition, incubation of SH-SY5Y cells with VPA results in a significant time-dependent increase in both cytosolic and nuclear β-catenin levels.  GSK-3β plays a crit. role in the CNS by regulating various cytoskeletal processes as well as long-term nuclear events and is a common target for both lithium and VPA; inhibition of GSK-3β in the CNS may thus underlie some of the long-term therapeutic effects of mood-stabilizing agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoivImxXJEehrVg90H21EOLACvtfcHk0lj0EFSbrqDd5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhsFWgtrs%253D&md5=c33e39007f1180b9282080a62fa18ae3</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2000.0721327.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2000.0721327.x%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DL.%2BD.%26aulast%3DJiang%26aufirst%3DY.%2BM.%26aulast%3DManji%26aufirst%3DH.%2BK.%26atitle%3DThe%2520mood-stabilizing%2520agent%2520valproate%2520inhibits%2520the%2520activity%2520of%2520glycogen%2520synthase%2520kinase-3%26jtitle%3DJ.%2520Neurochem.%26date%3D1999%26volume%3D72%26issue%3D3%26spage%3D1327%26epage%3D1330%26doi%3D10.1046%2Fj.1471-4159.2000.0721327.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Klein, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melton, D. A.</span><span> </span><span class="NLM_article-title">A molecular mechanism for the effect of lithium on development</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">93</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">8455</span><span class="NLM_x">–</span> <span class="NLM_lpage">8459</span><span class="refDoi"> DOI: 10.1073/pnas.93.16.8455</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1073%2Fpnas.93.16.8455" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=93&publication_year=1996&pages=8455-8459&issue=16&author=P.+S.+Kleinauthor=D.+A.+Melton&title=A+molecular+mechanism+for+the+effect+of+lithium+on+development&doi=10.1073%2Fpnas.93.16.8455"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1073%2Fpnas.93.16.8455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.93.16.8455%26sid%3Dliteratum%253Aachs%26aulast%3DKlein%26aufirst%3DP.%2BS.%26aulast%3DMelton%26aufirst%3DD.%2BA.%26atitle%3DA%2520molecular%2520mechanism%2520for%2520the%2520effect%2520of%2520lithium%2520on%2520development%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1996%26volume%3D93%26issue%3D16%26spage%3D8455%26epage%3D8459%26doi%3D10.1073%2Fpnas.93.16.8455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Silva, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesquita, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bessa, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sousa, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotiropoulos, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leao, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almeida, O. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sousa, N.</span><span> </span><span class="NLM_article-title">Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthase-kinase-3beta</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">656</span><span class="NLM_x">–</span> <span class="NLM_lpage">669</span><span class="refDoi"> DOI: 10.1016/j.neuroscience.2007.12.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1016%2Fj.neuroscience.2007.12.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2008&pages=656-669&issue=3&author=R.+Silvaauthor=A.+R.+Mesquitaauthor=J.+Bessaauthor=J.+C.+Sousaauthor=I.+Sotiropoulosauthor=P.+Leaoauthor=O.+F.+Almeidaauthor=N.+Sousa&title=Lithium+blocks+stress-induced+changes+in+depressive-like+behavior+and+hippocampal+cell+fate%3A+the+role+of+glycogen-synthase-kinase-3beta&doi=10.1016%2Fj.neuroscience.2007.12.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2007.12.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2007.12.026%26sid%3Dliteratum%253Aachs%26aulast%3DSilva%26aufirst%3DR.%26aulast%3DMesquita%26aufirst%3DA.%2BR.%26aulast%3DBessa%26aufirst%3DJ.%26aulast%3DSousa%26aufirst%3DJ.%2BC.%26aulast%3DSotiropoulos%26aufirst%3DI.%26aulast%3DLeao%26aufirst%3DP.%26aulast%3DAlmeida%26aufirst%3DO.%2BF.%26aulast%3DSousa%26aufirst%3DN.%26atitle%3DLithium%2520blocks%2520stress-induced%2520changes%2520in%2520depressive-like%2520behavior%2520and%2520hippocampal%2520cell%2520fate%253A%2520the%2520role%2520of%2520glycogen-synthase-kinase-3beta%26jtitle%3DNeuroscience%26date%3D2008%26volume%3D152%26issue%3D3%26spage%3D656%26epage%3D669%26doi%3D10.1016%2Fj.neuroscience.2007.12.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bijur, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jope, R. S.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection</span> <span class="citation_source-journal">Bipolar Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">137</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span><span class="refDoi"> DOI: 10.1034/j.1399-5618.2002.40201.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1034%2Fj.1399-5618.2002.40201.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=12071511" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnsFKhtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=137-144&issue=2&author=X.+Liauthor=G.+N.+Bijurauthor=R.+S.+Jope&title=Glycogen+synthase+kinase-3beta%2C+mood+stabilizers%2C+and+neuroprotection&doi=10.1034%2Fj.1399-5618.2002.40201.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Glycogen synthase kinase-3β, mood stabilizers, and neuroprotection</span></div><div class="casAuthors">Li, Xiaohua; Bijur, Gautam N.; Jope, Richard S.</div><div class="citationInfo"><span class="NLM_cas:title">Bipolar Disorders</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">137-144</span>CODEN:
                <span class="NLM_cas:coden">BDIIAU</span>;
        ISSN:<span class="NLM_cas:issn">1398-5647</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Glycogen synthase kinase-3β (GSK-3β) is a central component in many crit. intracellular signaling mechanisms.  These include the phosphatidylinositol 3-kinase/Akt cell survival pathway, which inhibits GSK-3β activity.  GSK-3β itself inhibits the activation of several transcription factors, which are important cell survival factors, such as heat shock factor 1.  These factors likely contribute to the recent revelation that GSK-3β is a pro-apoptotic enzyme.  Recently, Li was identified as a selective and direct inhibitor of GSK-3β.  Based on these findings, the authors have proposed that part of the neuroprotectant properties of Li is due to its ability to inhibit GSK-3β, and thus block the facilitation of apoptosis produced by GSK-3β.  Since several anticonvulsants recently were shown to be effective mood stabilizers, the authors examd. if these agents are capable of protecting cells from GSK-3β-facilitated apoptosis.  In addn. to Li, both valproic acid and lamotrigine, but not carbamazepine, provided protection from GSK-3β-facilitated apoptosis in human neuroblastoma SH-SY5Y cells.  These results demonstrate that several drugs therapeutic for bipolar disorder can provide neuroprotection by inhibiting the pro-apoptotic effects of GSK-3β, providing new evidence that dysregulation of GSK-3β may contribute to the pathophysiol. of bipolar disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ2qmOneZ5o7Vg90H21EOLACvtfcHk0lhU0uQlFwqmHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnsFKhtLs%253D&md5=5102f8775d227684c490d1e63835bd7b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1034%2Fj.1399-5618.2002.40201.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1034%252Fj.1399-5618.2002.40201.x%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DBijur%26aufirst%3DG.%2BN.%26aulast%3DJope%26aufirst%3DR.%2BS.%26atitle%3DGlycogen%2520synthase%2520kinase-3beta%252C%2520mood%2520stabilizers%252C%2520and%2520neuroprotection%26jtitle%3DBipolar%2520Disord.%26date%3D2002%26volume%3D4%26issue%3D2%26spage%3D137%26epage%3D144%26doi%3D10.1034%2Fj.1399-5618.2002.40201.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">The hormonal control of glycogen metabolism in mammalian muscle by multivalent phosphorylation</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">480</span><span class="refDoi"> DOI: 10.1042/bst0070459</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1042%2Fbst0070459" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=221283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A528%3ADyaL3cXjsFWm" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1979&pages=459-480&issue=3&author=P.+Cohen&title=The+hormonal+control+of+glycogen+metabolism+in+mammalian+muscle+by+multivalent+phosphorylation&doi=10.1042%2Fbst0070459"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The hormonal control of glycogen metabolism in mammalian muscle by multivalent phosphorylation</span></div><div class="casAuthors">Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">459-80</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    </div><div class="casAbstract">A review with 56 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWmnH8oWNdq7Vg90H21EOLACvtfcHk0lhU0uQlFwqmHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXjsFWm&md5=438f34e4fe2ba252bcf4a4008fce300a</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1042%2Fbst0070459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbst0070459%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520hormonal%2520control%2520of%2520glycogen%2520metabolism%2520in%2520mammalian%2520muscle%2520by%2520multivalent%2520phosphorylation%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D1979%26volume%3D7%26issue%3D3%26spage%3D459%26epage%3D480%26doi%3D10.1042%2Fbst0070459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Benedetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serretti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorenzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tubazio, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smeraldi, E.</span><span> </span><span class="NLM_article-title">A glycogen synthase kinase 3-beta promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">368</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span><span class="refDoi"> DOI: 10.1016/j.neulet.2004.06.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1016%2Fj.neulet.2004.06.050" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2004&pages=123-126&issue=2&author=F.+Benedettiauthor=A.+Serrettiauthor=C.+Colomboauthor=C.+Lorenziauthor=V.+Tubazioauthor=E.+Smeraldi&title=A+glycogen+synthase+kinase+3-beta+promoter+gene+single+nucleotide+polymorphism+is+associated+with+age+at+onset+and+response+to+total+sleep+deprivation+in+bipolar+depression&doi=10.1016%2Fj.neulet.2004.06.050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.neulet.2004.06.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neulet.2004.06.050%26sid%3Dliteratum%253Aachs%26aulast%3DBenedetti%26aufirst%3DF.%26aulast%3DSerretti%26aufirst%3DA.%26aulast%3DColombo%26aufirst%3DC.%26aulast%3DLorenzi%26aufirst%3DC.%26aulast%3DTubazio%26aufirst%3DV.%26aulast%3DSmeraldi%26aufirst%3DE.%26atitle%3DA%2520glycogen%2520synthase%2520kinase%25203-beta%2520promoter%2520gene%2520single%2520nucleotide%2520polymorphism%2520is%2520associated%2520with%2520age%2520at%2520onset%2520and%2520response%2520to%2520total%2520sleep%2520deprivation%2520in%2520bipolar%2520depression%26jtitle%3DNeurosci.%2520Lett.%26date%3D2004%26volume%3D368%26issue%3D2%26spage%3D123%26epage%3D126%26doi%3D10.1016%2Fj.neulet.2004.06.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hanger, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hughes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodgett, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brion, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderton, B. H.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase-3 induces Alzheimer’s disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">147</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">58</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span><span class="refDoi"> DOI: 10.1016/0304-3940(92)90774-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1016%2F0304-3940%2892%2990774-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=147&publication_year=1992&pages=58-62&issue=1&author=D.+P.+Hangerauthor=K.+Hughesauthor=J.+R.+Woodgettauthor=J.+P.+Brionauthor=B.+H.+Anderton&title=Glycogen+synthase+kinase-3+induces+Alzheimer%E2%80%99s+disease-like+phosphorylation+of+tau%3A+generation+of+paired+helical+filament+epitopes+and+neuronal+localisation+of+the+kinase&doi=10.1016%2F0304-3940%2892%2990774-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1016%2F0304-3940%2892%2990774-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0304-3940%252892%252990774-2%26sid%3Dliteratum%253Aachs%26aulast%3DHanger%26aufirst%3DD.%2BP.%26aulast%3DHughes%26aufirst%3DK.%26aulast%3DWoodgett%26aufirst%3DJ.%2BR.%26aulast%3DBrion%26aufirst%3DJ.%2BP.%26aulast%3DAnderton%26aufirst%3DB.%2BH.%26atitle%3DGlycogen%2520synthase%2520kinase-3%2520induces%2520Alzheimer%25E2%2580%2599s%2520disease-like%2520phosphorylation%2520of%2520tau%253A%2520generation%2520of%2520paired%2520helical%2520filament%2520epitopes%2520and%2520neuronal%2520localisation%2520of%2520the%2520kinase%26jtitle%3DNeurosci.%2520Lett.%26date%3D1992%26volume%3D147%26issue%3D1%26spage%3D58%26epage%3D62%26doi%3D10.1016%2F0304-3940%2892%2990774-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mazanetz, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, P. M.</span><span> </span><span class="NLM_article-title">Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">464</span><span class="NLM_x">–</span> <span class="NLM_lpage">479</span><span class="refDoi"> DOI: 10.1038/nrd2111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1038%2Fnrd2111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=17541419" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmtVSmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=464-479&issue=6&author=M.+P.+Mazanetzauthor=P.+M.+Fischer&title=Untangling+tau+hyperphosphorylation+in+drug+design+for+neurodegenerative+diseases&doi=10.1038%2Fnrd2111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases</span></div><div class="casAuthors">Mazanetz, Michael P.; Fischer, Peter M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">464-479</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Aggregation of hyperphosphorylated tau is one of the characteristic neuropathol. lesions of Alzheimer's disease and other neurodegenerative disorders.  Pharmacol. modulation of tau hyperphosphorylation might represent a valid and feasible therapeutic strategy for such disorders.  Here, we consider recent evidence supporting the validity of the three most relevant kinases affecting tau hyperphosphorylation - GSK3β, CDK5 and ERK2 - as drug targets and describe progress in the design of inhibitors for these kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvocBJpueNO7Vg90H21EOLACvtfcHk0ljYfZaKLFIzRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmtVSmtbg%253D&md5=7b8dc32d05340020a38be985c5838c0a</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1038%2Fnrd2111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2111%26sid%3Dliteratum%253Aachs%26aulast%3DMazanetz%26aufirst%3DM.%2BP.%26aulast%3DFischer%26aufirst%3DP.%2BM.%26atitle%3DUntangling%2520tau%2520hyperphosphorylation%2520in%2520drug%2520design%2520for%2520neurodegenerative%2520diseases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26issue%3D6%26spage%3D464%26epage%3D479%26doi%3D10.1038%2Fnrd2111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hong, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span> </span><span class="NLM_article-title">Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">272</span><span class="NLM_x"> (</span><span class="NLM_issue">40</span><span class="NLM_x">) </span> <span class="NLM_fpage">25326</span><span class="NLM_x">–</span> <span class="NLM_lpage">15332</span><span class="refDoi"> DOI: 10.1074/jbc.272.40.25326</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1074%2Fjbc.272.40.25326" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1997&pages=25326-15332&issue=40&author=M.+Hongauthor=D.+C.+Chenauthor=P.+S.+Kleinauthor=V.+M.+Lee&title=Lithium+reduces+tau+phosphorylation+by+inhibition+of+glycogen+synthase+kinase-3&doi=10.1074%2Fjbc.272.40.25326"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1074%2Fjbc.272.40.25326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.272.40.25326%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DD.%2BC.%26aulast%3DKlein%26aufirst%3DP.%2BS.%26aulast%3DLee%26aufirst%3DV.%2BM.%26atitle%3DLithium%2520reduces%2520tau%2520phosphorylation%2520by%2520inhibition%2520of%2520glycogen%2520synthase%2520kinase-3%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1997%26volume%3D272%26issue%3D40%26spage%3D25326%26epage%3D15332%26doi%3D10.1074%2Fjbc.272.40.25326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Cedazo-Minguez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popescu, B. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanco-Millan, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akterin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pei, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winblad, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowburn, R. F.</span><span> </span><span class="NLM_article-title">Apolipoprotein E and beta-amyloid (1–42) regulation of glycogen synthase kinase-3beta</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">87</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1152</span><span class="NLM_x">–</span> <span class="NLM_lpage">1164</span><span class="refDoi"> DOI: 10.1046/j.1471-4159.2003.02088.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1046%2Fj.1471-4159.2003.02088.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=14622095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps1Ohs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2003&pages=1152-1164&issue=5&author=A.+Cedazo-Minguezauthor=B.+O.+Popescuauthor=J.+M.+Blanco-Millanauthor=S.+Akterinauthor=J.+J.+Peiauthor=B.+Winbladauthor=R.+F.+Cowburn&title=Apolipoprotein+E+and+beta-amyloid+%281%E2%80%9342%29+regulation+of+glycogen+synthase+kinase-3beta&doi=10.1046%2Fj.1471-4159.2003.02088.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8dR"><div class="casContent"><span class="casTitleNuber">8d</span><div class="casTitle"><span class="NLM_cas:atitle">Apolipoprotein E and β-amyloid (1-42) regulation of glycogen synthase kinase-3β</span></div><div class="casAuthors">Cedazo-minguez, A.; Popescu, B. O.; Blanco-millan, J. M.; Akterin, S.; Pei, J. -J.; Winblad, B.; Cowburn, R. F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1152-1164</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Glycogen synthase kinase-3β (GSK-3β) is implicated in regulating apoptosis and tau protein hyperphosphorylation in Alzheimer's disease (AD).  We investigated the effects of two key AD mols., namely apoE (E3 and E4 isoforms) and β-amyloid (Aβ) 1-42 on GSK-3β and its major upstream regulators, intracellular calcium and protein kinases C and B (PKC and PKB) in human SH-SY5Y neuroblastoma cells.  ApoE3 induced a mild, transient, Ca2+-independent and early activation of GSK-3β.  ApoE4 effects were biphasic, with an early strong GSK-3β activation that was partially dependent on extracellular Ca2+, followed by a GSK-3β inactivation.  ApoE4 also activated PKC-α and PKB possibly giving the subsequent GSK-3β inhibition.  Aβ(1-42) effects were also biphasic with a strong activation dependent partially on extracellular Ca2+ followed by an inactivation.  Aβ(1-42) induced an early and potent activation of PKC-α and a late decrease of PKB activity.  ApoE4 and Aβ(1-42) were more toxic than apoE3 as shown by MTT redn. assays and generation of activated caspase-3.  ApoE4 and Aβ(1-42)-induced early activation of GSK-3β could lead to apoptosis and tau hyperphosphorylation.  A late inhibition of GSK-3β through activation of upstream kinases likely compensates the effects of apoE4 and Aβ(1-42) on GSK-3β, the unbalanced regulation of which may contribute to AD pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVieJURTy-3bVg90H21EOLACvtfcHk0ljYfZaKLFIzRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps1Ohs7g%253D&md5=8258b17760e825285e4c3c73738bcf0b</span></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2003.02088.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2003.02088.x%26sid%3Dliteratum%253Aachs%26aulast%3DCedazo-Minguez%26aufirst%3DA.%26aulast%3DPopescu%26aufirst%3DB.%2BO.%26aulast%3DBlanco-Millan%26aufirst%3DJ.%2BM.%26aulast%3DAkterin%26aufirst%3DS.%26aulast%3DPei%26aufirst%3DJ.%2BJ.%26aulast%3DWinblad%26aufirst%3DB.%26aulast%3DCowburn%26aufirst%3DR.%2BF.%26atitle%3DApolipoprotein%2520E%2520and%2520beta-amyloid%2520%25281%25E2%2580%259342%2529%2520regulation%2520of%2520glycogen%2520synthase%2520kinase-3beta%26jtitle%3DJ.%2520Neurochem.%26date%3D2003%26volume%3D87%26issue%3D5%26spage%3D1152%26epage%3D1164%26doi%3D10.1046%2Fj.1471-4159.2003.02088.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Anderson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hampton, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pryce, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowther, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franklin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giovannoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compston, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spillantini, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandran, S.</span><span> </span><span class="NLM_article-title">Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x"> (</span><span class="NLM_issue">Pt 7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1736</span><span class="NLM_x">–</span> <span class="NLM_lpage">1748</span><span class="refDoi"> DOI: 10.1093/brain/awn119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1093%2Fbrain%2Fawn119" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2008&pages=1736-1748&issue=Pt+7&author=J.+M.+Andersonauthor=D.+W.+Hamptonauthor=R.+Pataniauthor=G.+Pryceauthor=R.+A.+Crowtherauthor=R.+Reynoldsauthor=R.+J.+Franklinauthor=G.+Giovannoniauthor=D.+A.+Compstonauthor=D.+Bakerauthor=M.+G.+Spillantiniauthor=S.+Chandran&title=Abnormally+phosphorylated+tau+is+associated+with+neuronal+and+axonal+loss+in+experimental+autoimmune+encephalomyelitis+and+multiple+sclerosis&doi=10.1093%2Fbrain%2Fawn119"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8e&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawn119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawn119%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DJ.%2BM.%26aulast%3DHampton%26aufirst%3DD.%2BW.%26aulast%3DPatani%26aufirst%3DR.%26aulast%3DPryce%26aufirst%3DG.%26aulast%3DCrowther%26aufirst%3DR.%2BA.%26aulast%3DReynolds%26aufirst%3DR.%26aulast%3DFranklin%26aufirst%3DR.%2BJ.%26aulast%3DGiovannoni%26aufirst%3DG.%26aulast%3DCompston%26aufirst%3DD.%2BA.%26aulast%3DBaker%26aufirst%3DD.%26aulast%3DSpillantini%26aufirst%3DM.%2BG.%26aulast%3DChandran%26aufirst%3DS.%26atitle%3DAbnormally%2520phosphorylated%2520tau%2520is%2520associated%2520with%2520neuronal%2520and%2520axonal%2520loss%2520in%2520experimental%2520autoimmune%2520encephalomyelitis%2520and%2520multiple%2520sclerosis%26jtitle%3DBrain%26date%3D2008%26volume%3D131%26issue%3DPt%25207%26spage%3D1736%26epage%3D1748%26doi%3D10.1093%2Fbrain%2Fawn119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Anderson, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicholas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Compston, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spillantini, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandran, S.</span><span> </span><span class="NLM_article-title">Abnormal tau phosphorylation in primary progressive multiple sclerosis</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">591</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span><span class="refDoi"> DOI: 10.1007/s00401-010-0671-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1007%2Fs00401-010-0671-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=20306268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1WqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2010&pages=591-600&issue=5&author=J.+M.+Andersonauthor=R.+Pataniauthor=R.+Reynoldsauthor=R.+Nicholasauthor=A.+Compstonauthor=M.+G.+Spillantiniauthor=S.+Chandran&title=Abnormal+tau+phosphorylation+in+primary+progressive+multiple+sclerosis&doi=10.1007%2Fs00401-010-0671-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8fR"><div class="casContent"><span class="casTitleNuber">8f</span><div class="casTitle"><span class="NLM_cas:atitle">Abnormal tau phosphorylation in primary progressive multiple sclerosis</span></div><div class="casAuthors">Anderson, Jane Marian; Patani, Rickie; Reynolds, Richard; Nicholas, Richard; Compston, Alastair; Spillantini, Maria Grazia; Chandran, Siddharthan</div><div class="citationInfo"><span class="NLM_cas:title">Acta Neuropathologica</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">591-600</span>CODEN:
                <span class="NLM_cas:coden">ANPTAL</span>;
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Although neurodegeneration is the pathol. substrate of progression in multiple sclerosis (MS), the underlying mechanisms remain unresolved.  Abnormal phosphorylation of tau, implicated in the aetiopathogenesis of a no. of classic neurodegenerative disorders, has also recently been described in secondary progressive MS (SPMS).  In contrast to SPMS, primary progressive MS (PPMS) represents a significant subset of patients with accumulating neurol. disability from onset.  The neuropathol. relationship between SPMS and PPMS is unknown.  Against this background, we investigated tau phosphorylation status in five cases of PPMS using immunohistochem. and biochem. methods.  We report widespread abnormal tau hyperphosphorylation of the classic tau phospho-epitopes occurring in multiple cell types but with a clear immunohistochem. glial bias.  In addn., biochem. anal. revealed abnormally phosphorylated insol. tau in all cases.  These findings establish a platform for further study of the role of insol. tau formation, including detg. the relevance of glial tau pathol., in the neurodegenerative phase of MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0XOfQkcpz8bVg90H21EOLACvtfcHk0lh7QrVBPvxv3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1WqsrY%253D&md5=18ebc2cf2ca2ae8b4740d164798832df</span></div><a href="/servlet/linkout?suffix=cit8f&amp;dbid=16384&amp;doi=10.1007%2Fs00401-010-0671-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00401-010-0671-4%26sid%3Dliteratum%253Aachs%26aulast%3DAnderson%26aufirst%3DJ.%2BM.%26aulast%3DPatani%26aufirst%3DR.%26aulast%3DReynolds%26aufirst%3DR.%26aulast%3DNicholas%26aufirst%3DR.%26aulast%3DCompston%26aufirst%3DA.%26aulast%3DSpillantini%26aufirst%3DM.%2BG.%26aulast%3DChandran%26aufirst%3DS.%26atitle%3DAbnormal%2520tau%2520phosphorylation%2520in%2520primary%2520progressive%2520multiple%2520sclerosis%26jtitle%3DActa%2520Neuropathol.%26date%3D2010%26volume%3D119%26issue%3D5%26spage%3D591%26epage%3D600%26doi%3D10.1007%2Fs00401-010-0671-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, M.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase 3 (GSK-3) and its inhibitors</span> <span class="citation_source-journal">Wiley Series in Drug Discovery and Development</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="refDoi"> DOI: 10.1002/0470052171.ch14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1002%2F0470052171.ch14" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=257&author=A.+Martinezauthor=A.+Castroauthor=M.+Medina&title=Glycogen+synthase+kinase+3+%28GSK-3%29+and+its+inhibitors&doi=10.1002%2F0470052171.ch14"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1002%2F0470052171.ch14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F0470052171.ch14%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DMedina%26aufirst%3DM.%26atitle%3DGlycogen%2520synthase%2520kinase%25203%2520%2528GSK-3%2529%2520and%2520its%2520inhibitors%26jtitle%3DWiley%2520Series%2520in%2520Drug%2520Discovery%2520and%2520Development%26date%3D2006%26spage%3D257%26doi%3D10.1002%2F0470052171.ch14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kramer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo Monte, F.</span><span> </span><span class="NLM_article-title">Small-Molecule Inhibitors of GSK-3: Structural insights and their application to Alzheimer’s disease models</span> <span class="citation_source-journal">Int. J. Alzheimer's Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="refDoi"> DOI: 10.1155/2012/381029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1155%2F2012%2F381029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=1&author=T.+Kramerauthor=B.+Schmidtauthor=F.+Lo+Monte&title=Small-Molecule+Inhibitors+of+GSK-3%3A+Structural+insights+and+their+application+to+Alzheimer%E2%80%99s+disease+models&doi=10.1155%2F2012%2F381029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1155%2F2012%2F381029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F381029%26sid%3Dliteratum%253Aachs%26aulast%3DKramer%26aufirst%3DT.%26aulast%3DSchmidt%26aufirst%3DB.%26aulast%3DLo%2BMonte%26aufirst%3DF.%26atitle%3DSmall-Molecule%2520Inhibitors%2520of%2520GSK-3%253A%2520Structural%2520insights%2520and%2520their%2520application%2520to%2520Alzheimer%25E2%2580%2599s%2520disease%2520models%26jtitle%3DInt.%2520J.%2520Alzheimer%2527s%2520Dis.%26date%3D2012%26volume%3D2012%26spage%3D1%26doi%3D10.1155%2F2012%2F381029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Eldar-Finkelman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, A.</span><span> </span><span class="NLM_article-title">GSK-3 Inhibitors: Preclinical and clinical focus on CNS</span> <span class="citation_source-journal">Front. Mol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">32</span><span class="refDoi"> DOI: 10.3389/fnmol.2011.00032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.3389%2Ffnmol.2011.00032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=22065134" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A528%3ADC%252BC38XovVyg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=32&author=H.+Eldar-Finkelmanauthor=A.+Martinez&title=GSK-3+Inhibitors%3A+Preclinical+and+clinical+focus+on+CNS&doi=10.3389%2Ffnmol.2011.00032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9cR"><div class="casContent"><span class="casTitleNuber">9c</span><div class="casTitle"><span class="NLM_cas:atitle">GSK-3 inhibitors: preclinical and clinical focus on CNS</span></div><div class="casAuthors">Eldar-Finkelman, Hagit; Martinez, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">Oct.</span>),
    <span class="NLM_cas:pages">32</span>CODEN:
                <span class="NLM_cas:coden">FMNRAJ</span>;
        ISSN:<span class="NLM_cas:issn">1662-5099</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  Inhibiting glycogen synthase kinase-3 (GSK-3) activity via pharmacol. intervention has become an important strategy for treating neurodegenerative and psychiatric disorders.  The known GSK-3 inhibitors are of diverse chemotypes and mechanisms of action and include compds. isolated from natural sources, cations, synthetic small-mol. ATP-competitive inhibitors, non-ATP-competitive inhibitors, and substrate-competitive inhibitors.  Here we describe the variety of GSK-3 inhibitors with a specific emphasis on their biol. activities in neurons and neurol. disorders.  We further highlight our current progress in the development of non-ATP-competitive inhibitors of GSK-3.  The available data raise the hope that one or more of these drug design approaches will prove successful at stabilizing or even reversing the aberrant neuropathol. and cognitive deficits of certain central nervous system disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh6s366QUVnLVg90H21EOLACvtfcHk0lh7QrVBPvxv3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XovVyg&md5=d497efe2ec600fc16f10260cd53d7103</span></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=10.3389%2Ffnmol.2011.00032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnmol.2011.00032%26sid%3Dliteratum%253Aachs%26aulast%3DEldar-Finkelman%26aufirst%3DH.%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DGSK-3%2520Inhibitors%253A%2520Preclinical%2520and%2520clinical%2520focus%2520on%2520CNS%26jtitle%3DFront.%2520Mol.%2520Neurosci.%26date%3D2011%26volume%3D4%26spage%3D32%26doi%3D10.3389%2Ffnmol.2011.00032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Lovestone, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hull, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rinne, J. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huppertz, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calero, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez-Carrillo, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leon, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Ser, T.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">A phase II trial of tideglusib in Alzheimer’s disease</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span><span class="refDoi"> DOI: 10.3233/JAD-141959</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.3233%2FJAD-141959" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=25537011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjslOltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2015&pages=75-88&issue=1&author=S.+Lovestoneauthor=M.+Boadaauthor=B.+Duboisauthor=M.+Hullauthor=J.+O.+Rinneauthor=H.+J.+Huppertzauthor=M.+Caleroauthor=M.+V.+Andresauthor=B.+Gomez-Carrilloauthor=T.+Leonauthor=T.+del+Ser&title=A+phase+II+trial+of+tideglusib+in+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-141959"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">A Phase II Trial of Tideglusib in Alzheimer's Disease</span></div><div class="casAuthors">Lovestone, Simon; Boada, Merce; Dubois, Bruno; Huell, Michael; Rinne, Juha O.; Huppertz, Hans-Juergen; Calero, Miguel; Andres, Maria V.; Gomez-Carrillo, Belen; Leon, Teresa; del Ser, Teodoro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-88</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Background: The ARGO study was a phase II, double-blind, placebo controlled, four parallel arm trial of tideglusib in Alzheimer's disease (AD).  Objective: To prove the clin. efficacy of an inhibitor of glycogen synthase kinase-3 (GSK-3), in AD.  Methods: Mild to moderate (Mini-Mental State Examn. (MMSE) score, 14-26) AD patients on cholinesterase inhibitor and/or memantine treatment were administered tideglusib or placebo for 26 wk.  The ADAS-cog15 was the primary efficacy measure; function, cognition, behavior, and quality of life were assessed as secondary measures; cerebral atrophy in MRI and the levels of tau, amyloid-β, and BACE1 in cerebrospinal fluid (CSF) were exploratory endpoints.  Results: 306 AD patients were randomized to active (1000 mg QD: n = 86, 1000 mg QOD: n = 90, and 500 mg QD: n = 50) or placebo (n = 85) in 55 sites in four European countries.  There were no statistically significant differences between either active and placebo arms in the efficacy variables.  However, BACE1 in CSF significantly decreased with treatment in a small subgroup of patients.  Participants with mild AD in the 500 mg QD group showed significant responses on ADAS-cog15, MMSE, and word fluency.  Diarrhea (14-18% in active, 11% placebo) and dose-dependent, mild to moderate, and fully reversible transaminase increase (9-16% in active, 3.5% placebo) were the most frequent adverse events.  Conclusions: Short term (26 wk) tideglusib was acceptably safe but produced no clin. benefit in this trial.  However, given the non-linear dose response, esp. in mildly affected patients, further dose finding studies in early disease stages and for longer duration are warranted to examine GSK-3 inhibition in AD patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru-ZlfznWkUbVg90H21EOLACvtfcHk0lh7QrVBPvxv3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjslOltb8%253D&md5=7a342ad28ad2cfbbc3dc768849fb73ef</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.3233%2FJAD-141959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-141959%26sid%3Dliteratum%253Aachs%26aulast%3DLovestone%26aufirst%3DS.%26aulast%3DBoada%26aufirst%3DM.%26aulast%3DDubois%26aufirst%3DB.%26aulast%3DHull%26aufirst%3DM.%26aulast%3DRinne%26aufirst%3DJ.%2BO.%26aulast%3DHuppertz%26aufirst%3DH.%2BJ.%26aulast%3DCalero%26aufirst%3DM.%26aulast%3DAndres%26aufirst%3DM.%2BV.%26aulast%3DGomez-Carrillo%26aufirst%3DB.%26aulast%3DLeon%26aufirst%3DT.%26aulast%3Ddel%2BSer%26aufirst%3DT.%26atitle%3DA%2520phase%2520II%2520trial%2520of%2520tideglusib%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2015%26volume%3D45%26issue%3D1%26spage%3D75%26epage%3D88%26doi%3D10.3233%2FJAD-141959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Bhat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ormo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radesater, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jerning, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markgren, P. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgegard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nylof, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gimenez-Cassina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz-Nido, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avila, J.</span><span> </span><span class="NLM_article-title">Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x"> (</span><span class="NLM_issue">46</span><span class="NLM_x">) </span> <span class="NLM_fpage">45937</span><span class="NLM_x">–</span> <span class="NLM_lpage">45945</span><span class="refDoi"> DOI: 10.1074/jbc.M306268200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1074%2Fjbc.M306268200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=45937-45945&issue=46&author=R.+Bhatauthor=Y.+Xueauthor=S.+Bergauthor=S.+Hellbergauthor=M.+Ormoauthor=Y.+Nilssonauthor=A.+C.+Radesaterauthor=E.+Jerningauthor=P.+O.+Markgrenauthor=T.+Borgegardauthor=M.+Nylofauthor=A.+Gimenez-Cassinaauthor=F.+Hernandezauthor=J.+J.+Lucasauthor=J.+Diaz-Nidoauthor=J.+Avila&title=Structural+insights+and+biological+effects+of+glycogen+synthase+kinase+3-specific+inhibitor+AR-A014418&doi=10.1074%2Fjbc.M306268200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M306268200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M306268200%26sid%3Dliteratum%253Aachs%26aulast%3DBhat%26aufirst%3DR.%26aulast%3DXue%26aufirst%3DY.%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DHellberg%26aufirst%3DS.%26aulast%3DOrmo%26aufirst%3DM.%26aulast%3DNilsson%26aufirst%3DY.%26aulast%3DRadesater%26aufirst%3DA.%2BC.%26aulast%3DJerning%26aufirst%3DE.%26aulast%3DMarkgren%26aufirst%3DP.%2BO.%26aulast%3DBorgegard%26aufirst%3DT.%26aulast%3DNylof%26aufirst%3DM.%26aulast%3DGimenez-Cassina%26aufirst%3DA.%26aulast%3DHernandez%26aufirst%3DF.%26aulast%3DLucas%26aufirst%3DJ.%2BJ.%26aulast%3DDiaz-Nido%26aufirst%3DJ.%26aulast%3DAvila%26aufirst%3DJ.%26atitle%3DStructural%2520insights%2520and%2520biological%2520effects%2520of%2520glycogen%2520synthase%2520kinase%25203-specific%2520inhibitor%2520AR-A014418%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26issue%3D46%26spage%3D45937%26epage%3D45945%26doi%3D10.1074%2Fjbc.M306268200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gaisina, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ougolkov, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurome, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holzle, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luchini, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blond, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billadeau, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">From a natural product lead to the identification of potent and selective benzofuran-3-yl-(indol-3-yl)maleimides as glycogen synthase kinase 3beta inhibitors that suppress proliferation and survival of pancreatic cancer cells</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1853</span><span class="NLM_x">–</span> <span class="NLM_lpage">1863</span><span class="refDoi"> DOI: 10.1021/jm801317h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801317h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1853-1863&issue=7&author=I.+N.+Gaisinaauthor=F.+Gallierauthor=A.+V.+Ougolkovauthor=K.+H.+Kimauthor=T.+Kuromeauthor=S.+Guoauthor=D.+Holzleauthor=D.+N.+Luchiniauthor=S.+Y.+Blondauthor=D.+D.+Billadeauauthor=A.+P.+Kozikowski&title=From+a+natural+product+lead+to+the+identification+of+potent+and+selective+benzofuran-3-yl-%28indol-3-yl%29maleimides+as+glycogen+synthase+kinase+3beta+inhibitors+that+suppress+proliferation+and+survival+of+pancreatic+cancer+cells&doi=10.1021%2Fjm801317h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1021%2Fjm801317h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801317h%26sid%3Dliteratum%253Aachs%26aulast%3DGaisina%26aufirst%3DI.%2BN.%26aulast%3DGallier%26aufirst%3DF.%26aulast%3DOugolkov%26aufirst%3DA.%2BV.%26aulast%3DKim%26aufirst%3DK.%2BH.%26aulast%3DKurome%26aufirst%3DT.%26aulast%3DGuo%26aufirst%3DS.%26aulast%3DHolzle%26aufirst%3DD.%26aulast%3DLuchini%26aufirst%3DD.%2BN.%26aulast%3DBlond%26aufirst%3DS.%2BY.%26aulast%3DBilladeau%26aufirst%3DD.%2BD.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DFrom%2520a%2520natural%2520product%2520lead%2520to%2520the%2520identification%2520of%2520potent%2520and%2520selective%2520benzofuran-3-yl-%2528indol-3-yl%2529maleimides%2520as%2520glycogen%2520synthase%2520kinase%25203beta%2520inhibitors%2520that%2520suppress%2520proliferation%2520and%2520survival%2520of%2520pancreatic%2520cancer%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26issue%3D7%26spage%3D1853%26epage%3D1863%26doi%3D10.1021%2Fjm801317h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kuo, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prouty, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeAngelis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connolly, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, W. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westover, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Look, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demarest, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emanuel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jolliffe, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beavers, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span> </span><span class="NLM_article-title">Synthesis and discovery of macrocyclic polyoxygenated bis-7-azaindolylmaleimides as a novel series of potent and highly selective glycogen synthase kinase-3beta inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">4021</span><span class="NLM_x">–</span> <span class="NLM_lpage">4031</span><span class="refDoi"> DOI: 10.1021/jm030115o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030115o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4021-4031&issue=19&author=G.+H.+Kuoauthor=C.+Proutyauthor=A.+DeAngelisauthor=L.+Shenauthor=D.+J.+O%E2%80%99Neillauthor=C.+Shahauthor=P.+J.+Connollyauthor=W.+V.+Murrayauthor=B.+R.+Conwayauthor=P.+Cheungauthor=L.+Westoverauthor=J.+Z.+Xuauthor=R.+A.+Lookauthor=K.+T.+Demarestauthor=S.+Emanuelauthor=S.+A.+Middletonauthor=L.+Jolliffeauthor=M.+P.+Beaversauthor=X.+Chen&title=Synthesis+and+discovery+of+macrocyclic+polyoxygenated+bis-7-azaindolylmaleimides+as+a+novel+series+of+potent+and+highly+selective+glycogen+synthase+kinase-3beta+inhibitors&doi=10.1021%2Fjm030115o"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1021%2Fjm030115o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030115o%26sid%3Dliteratum%253Aachs%26aulast%3DKuo%26aufirst%3DG.%2BH.%26aulast%3DProuty%26aufirst%3DC.%26aulast%3DDeAngelis%26aufirst%3DA.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DD.%2BJ.%26aulast%3DShah%26aufirst%3DC.%26aulast%3DConnolly%26aufirst%3DP.%2BJ.%26aulast%3DMurray%26aufirst%3DW.%2BV.%26aulast%3DConway%26aufirst%3DB.%2BR.%26aulast%3DCheung%26aufirst%3DP.%26aulast%3DWestover%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DJ.%2BZ.%26aulast%3DLook%26aufirst%3DR.%2BA.%26aulast%3DDemarest%26aufirst%3DK.%2BT.%26aulast%3DEmanuel%26aufirst%3DS.%26aulast%3DMiddleton%26aufirst%3DS.%2BA.%26aulast%3DJolliffe%26aufirst%3DL.%26aulast%3DBeavers%26aufirst%3DM.%2BP.%26aulast%3DChen%26aufirst%3DX.%26atitle%3DSynthesis%2520and%2520discovery%2520of%2520macrocyclic%2520polyoxygenated%2520bis-7-azaindolylmaleimides%2520as%2520a%2520novel%2520series%2520of%2520potent%2520and%2520highly%2520selective%2520glycogen%2520synthase%2520kinase-3beta%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26issue%3D19%26spage%3D4021%26epage%3D4031%26doi%3D10.1021%2Fjm030115o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">La Pietra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Regina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coluccia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Famiglini, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelliccia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plotkin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eldar-Finkelman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brancale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballatore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunden, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novellino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvestri, R.</span><span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of 1-phenylpyrazolo[3,4-e]pyrrolo[3,4-g]indolizine-4,6(1H,5H)-diones as new glycogen synthase kinase-3beta inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">10066</span><span class="NLM_x">–</span> <span class="NLM_lpage">10078</span><span class="refDoi"> DOI: 10.1021/jm401466v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401466v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=10066-10078&issue=24&author=V.+La+Pietraauthor=G.+La+Reginaauthor=A.+Colucciaauthor=V.+Famigliniauthor=S.+Pellicciaauthor=B.+Plotkinauthor=H.+Eldar-Finkelmanauthor=A.+Brancaleauthor=C.+Ballatoreauthor=A.+Croweauthor=K.+R.+Brundenauthor=L.+Marinelliauthor=E.+Novellinoauthor=R.+Silvestri&title=Design%2C+synthesis%2C+and+biological+evaluation+of+1-phenylpyrazolo%5B3%2C4-e%5Dpyrrolo%5B3%2C4-g%5Dindolizine-4%2C6%281H%2C5H%29-diones+as+new+glycogen+synthase+kinase-3beta+inhibitors&doi=10.1021%2Fjm401466v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=10.1021%2Fjm401466v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401466v%26sid%3Dliteratum%253Aachs%26aulast%3DLa%2BPietra%26aufirst%3DV.%26aulast%3DLa%2BRegina%26aufirst%3DG.%26aulast%3DColuccia%26aufirst%3DA.%26aulast%3DFamiglini%26aufirst%3DV.%26aulast%3DPelliccia%26aufirst%3DS.%26aulast%3DPlotkin%26aufirst%3DB.%26aulast%3DEldar-Finkelman%26aufirst%3DH.%26aulast%3DBrancale%26aufirst%3DA.%26aulast%3DBallatore%26aufirst%3DC.%26aulast%3DCrowe%26aufirst%3DA.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DMarinelli%26aufirst%3DL.%26aulast%3DNovellino%26aufirst%3DE.%26aulast%3DSilvestri%26aufirst%3DR.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%25201-phenylpyrazolo%255B3%252C4-e%255Dpyrrolo%255B3%252C4-g%255Dindolizine-4%252C6%25281H%252C5H%2529-diones%2520as%2520new%2520glycogen%2520synthase%2520kinase-3beta%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26issue%3D24%26spage%3D10066%26epage%3D10078%26doi%3D10.1021%2Fjm401466v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fukunaga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uehara, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aritomo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okuyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Usui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamakoshi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanano, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsuchiya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamagami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujimura, M.</span><span> </span><span class="NLM_article-title">2-(2-Phenylmorpholin-4-yl)pyrimidin-4(3H)-ones; a new class of potent, selective and orally active glycogen synthase kinase-3beta inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">6933</span><span class="NLM_x">–</span> <span class="NLM_lpage">6937</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.09.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1016%2Fj.bmcl.2013.09.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=24176395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1yqt7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6933-6937&issue=24&author=K.+Fukunagaauthor=F.+Ueharaauthor=K.+Aritomoauthor=A.+Shodaauthor=S.+Hikiauthor=M.+Okuyamaauthor=Y.+Usuiauthor=K.+Watanabeauthor=K.+Yamakoshiauthor=T.+Koharaauthor=T.+Hananoauthor=H.+Tanakaauthor=S.+Tsuchiyaauthor=S.+Sunadaauthor=K.+Saitoauthor=J.+Eguchiauthor=S.+Yukiauthor=S.+Asanoauthor=S.+Tanakaauthor=A.+Moriauthor=K.+Yamagamiauthor=H.+Babaauthor=T.+Horikawaauthor=M.+Fujimura&title=2-%282-Phenylmorpholin-4-yl%29pyrimidin-4%283H%29-ones%3B+a+new+class+of+potent%2C+selective+and+orally+active+glycogen+synthase+kinase-3beta+inhibitors&doi=10.1016%2Fj.bmcl.2013.09.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">2-(2-Phenylmorpholin-4-yl)pyrimidin-4(3H)-ones; A new class of potent, selective and orally active glycogen synthase kinase-3β inhibitors</span></div><div class="casAuthors">Fukunaga, Kenji; Uehara, Fumiaki; Aritomo, Keiichi; Shoda, Aya; Hiki, Shinsuke; Okuyama, Masahiro; Usui, Yoshihiro; Watanabe, Kazutoshi; Yamakoshi, Koichi; Kohara, Toshiyuki; Hanano, Tokushi; Tanaka, Hiroshi; Tsuchiya, Susumu; Sunada, Shinji; Saito, Ken-Ichi; Eguchi, Jun-ichi; Yuki, Satoshi; Asano, Shoichi; Tanaka, Shinji; Mori, Akiko; Yamagami, Keiji; Baba, Hiroshi; Horikawa, Takashi; Fujimura, Masatake</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6933-6937</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of 2-(2-phenylmorpholin-4-yl)pyrimidin-4(3H)-ones was synthesized and examd. for their inhibitory activity against glycogen synthase kinase-3β (GSK-3β).  We found compds. I (R = 4-F (II), 2,6-di-OMe, 2-F-6-Cl) to possess potent in vitro GSK-3β inhibitory activity with good in vitro PK profiles.  Compd. II demonstrated significant decrease of tau phosphorylation after oral administration in mice and excellent PK profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9woxQA77rTbVg90H21EOLACvtfcHk0lhYe7X9mhg4sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1yqt7vL&md5=6c8bc95e0ccb21078aff1837d83e649e</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.09.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.09.020%26sid%3Dliteratum%253Aachs%26aulast%3DFukunaga%26aufirst%3DK.%26aulast%3DUehara%26aufirst%3DF.%26aulast%3DAritomo%26aufirst%3DK.%26aulast%3DShoda%26aufirst%3DA.%26aulast%3DHiki%26aufirst%3DS.%26aulast%3DOkuyama%26aufirst%3DM.%26aulast%3DUsui%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DYamakoshi%26aufirst%3DK.%26aulast%3DKohara%26aufirst%3DT.%26aulast%3DHanano%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DTsuchiya%26aufirst%3DS.%26aulast%3DSunada%26aufirst%3DS.%26aulast%3DSaito%26aufirst%3DK.%26aulast%3DEguchi%26aufirst%3DJ.%26aulast%3DYuki%26aufirst%3DS.%26aulast%3DAsano%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DMori%26aufirst%3DA.%26aulast%3DYamagami%26aufirst%3DK.%26aulast%3DBaba%26aufirst%3DH.%26aulast%3DHorikawa%26aufirst%3DT.%26aulast%3DFujimura%26aufirst%3DM.%26atitle%3D2-%25282-Phenylmorpholin-4-yl%2529pyrimidin-4%25283H%2529-ones%253B%2520a%2520new%2520class%2520of%2520potent%252C%2520selective%2520and%2520orally%2520active%2520glycogen%2520synthase%2520kinase-3beta%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26issue%3D24%26spage%3D6933%26epage%3D6937%26doi%3D10.1016%2Fj.bmcl.2013.09.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Uehara, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aritomo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukunaga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinoda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueno, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kubodera, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asano, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoneyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niwa, T.</span><span> </span><span class="NLM_article-title">6-(4-Pyridyl)pyrimidin-4(3H)-ones as CNS penetrant glycogen synthase kinase-3beta inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">6928</span><span class="NLM_x">–</span> <span class="NLM_lpage">6932</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2013.09.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1016%2Fj.bmcl.2013.09.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6928-6932&issue=24&author=F.+Ueharaauthor=A.+Shodaauthor=K.+Aritomoauthor=K.+Fukunagaauthor=K.+Watanabeauthor=R.+Andoauthor=M.+Shinodaauthor=H.+Uenoauthor=H.+Kuboderaauthor=S.+Sunadaauthor=K.+Saitoauthor=T.+Kajiauthor=S.+Asanoauthor=J.+Eguchiauthor=S.+Yukiauthor=S.+Tanakaauthor=Y.+Yoneyamaauthor=T.+Niwa&title=6-%284-Pyridyl%29pyrimidin-4%283H%29-ones+as+CNS+penetrant+glycogen+synthase+kinase-3beta+inhibitors&doi=10.1016%2Fj.bmcl.2013.09.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.09.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.09.021%26sid%3Dliteratum%253Aachs%26aulast%3DUehara%26aufirst%3DF.%26aulast%3DShoda%26aufirst%3DA.%26aulast%3DAritomo%26aufirst%3DK.%26aulast%3DFukunaga%26aufirst%3DK.%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DAndo%26aufirst%3DR.%26aulast%3DShinoda%26aufirst%3DM.%26aulast%3DUeno%26aufirst%3DH.%26aulast%3DKubodera%26aufirst%3DH.%26aulast%3DSunada%26aufirst%3DS.%26aulast%3DSaito%26aufirst%3DK.%26aulast%3DKaji%26aufirst%3DT.%26aulast%3DAsano%26aufirst%3DS.%26aulast%3DEguchi%26aufirst%3DJ.%26aulast%3DYuki%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DYoneyama%26aufirst%3DY.%26aulast%3DNiwa%26aufirst%3DT.%26atitle%3D6-%25284-Pyridyl%2529pyrimidin-4%25283H%2529-ones%2520as%2520CNS%2520penetrant%2520glycogen%2520synthase%2520kinase-3beta%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26issue%3D24%26spage%3D6928%26epage%3D6932%26doi%3D10.1016%2Fj.bmcl.2013.09.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Fukunaga, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabeno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eguchi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inazawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horikawa, T.</span><span> </span><span class="NLM_article-title">Discovery of novel 2-(alkylmorpholin-4-yl)-6-(3-fluoropyridin-4-yl)-pyrimidin-4(3H)-ones as orally-active GSK-3beta inhibitors for Alzheimer’s disease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1086</span><span class="NLM_x">–</span> <span class="NLM_lpage">1091</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.01.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1016%2Fj.bmcl.2015.01.005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=1086-1091&issue=5&author=K.+Fukunagaauthor=D.+Sakaiauthor=K.+Watanabeauthor=K.+Nakayamaauthor=T.+Koharaauthor=H.+Tanakaauthor=S.+Sunadaauthor=M.+Nabenoauthor=M.+Okamotoauthor=K.+Saitoauthor=J.+Eguchiauthor=A.+Moriauthor=S.+Tanakaauthor=K.+Inazawaauthor=T.+Horikawa&title=Discovery+of+novel+2-%28alkylmorpholin-4-yl%29-6-%283-fluoropyridin-4-yl%29-pyrimidin-4%283H%29-ones+as+orally-active+GSK-3beta+inhibitors+for+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmcl.2015.01.005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DFukunaga%26aufirst%3DK.%26aulast%3DSakai%26aufirst%3DD.%26aulast%3DWatanabe%26aufirst%3DK.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DKohara%26aufirst%3DT.%26aulast%3DTanaka%26aufirst%3DH.%26aulast%3DSunada%26aufirst%3DS.%26aulast%3DNabeno%26aufirst%3DM.%26aulast%3DOkamoto%26aufirst%3DM.%26aulast%3DSaito%26aufirst%3DK.%26aulast%3DEguchi%26aufirst%3DJ.%26aulast%3DMori%26aufirst%3DA.%26aulast%3DTanaka%26aufirst%3DS.%26aulast%3DInazawa%26aufirst%3DK.%26aulast%3DHorikawa%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520novel%25202-%2528alkylmorpholin-4-yl%2529-6-%25283-fluoropyridin-4-yl%2529-pyrimidin-4%25283H%2529-ones%2520as%2520orally-active%2520GSK-3beta%2520inhibitors%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26issue%3D5%26spage%3D1086%26epage%3D1091%26doi%3D10.1016%2Fj.bmcl.2015.01.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Coffman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanyon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schachter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng-Lovering, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wessel, M.</span><span> </span><span class="NLM_article-title">6-Amino-4-(pyrimidin-4-yl)pyridones: novel glycogen synthase kinase-3beta inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1429</span><span class="NLM_x">–</span> <span class="NLM_lpage">1433</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.01.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1016%2Fj.bmcl.2011.01.017" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=1429-1433&issue=5&author=K.+Coffmanauthor=M.+Brodneyauthor=J.+Cookauthor=L.+Lanyonauthor=J.+Panditauthor=S.+Sakyaauthor=J.+Schachterauthor=E.+Tseng-Loveringauthor=M.+Wessel&title=6-Amino-4-%28pyrimidin-4-yl%29pyridones%3A+novel+glycogen+synthase+kinase-3beta+inhibitors&doi=10.1016%2Fj.bmcl.2011.01.017"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13d&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.01.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.01.017%26sid%3Dliteratum%253Aachs%26aulast%3DCoffman%26aufirst%3DK.%26aulast%3DBrodney%26aufirst%3DM.%26aulast%3DCook%26aufirst%3DJ.%26aulast%3DLanyon%26aufirst%3DL.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DSakya%26aufirst%3DS.%26aulast%3DSchachter%26aufirst%3DJ.%26aulast%3DTseng-Lovering%26aufirst%3DE.%26aulast%3DWessel%26aufirst%3DM.%26atitle%3D6-Amino-4-%2528pyrimidin-4-yl%2529pyridones%253A%2520novel%2520glycogen%2520synthase%2520kinase-3beta%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D5%26spage%3D1429%26epage%3D1433%26doi%3D10.1016%2Fj.bmcl.2011.01.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Gentile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pozzan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernasconi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bax, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridges, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brough, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cutler, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coffin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belyanskaya, S.</span><span> </span><span class="NLM_article-title">5-Aryl-4-carboxamide-1,3-oxazoles: potent and selective GSK-3 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1989</span><span class="NLM_x">–</span> <span class="NLM_lpage">1994</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.01.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1016%2Fj.bmcl.2012.01.034" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1989-1994&issue=5&author=G.+Gentileauthor=G.+Merloauthor=A.+Pozzanauthor=G.+Bernasconiauthor=B.+Baxauthor=P.+Bamboroughauthor=A.+Bridgesauthor=P.+Carterauthor=M.+Neuauthor=G.+Yaoauthor=C.+Broughauthor=G.+Cutlerauthor=A.+Coffinauthor=S.+Belyanskaya&title=5-Aryl-4-carboxamide-1%2C3-oxazoles%3A+potent+and+selective+GSK-3+inhibitors&doi=10.1016%2Fj.bmcl.2012.01.034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.01.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.01.034%26sid%3Dliteratum%253Aachs%26aulast%3DGentile%26aufirst%3DG.%26aulast%3DMerlo%26aufirst%3DG.%26aulast%3DPozzan%26aufirst%3DA.%26aulast%3DBernasconi%26aufirst%3DG.%26aulast%3DBax%26aufirst%3DB.%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DBridges%26aufirst%3DA.%26aulast%3DCarter%26aufirst%3DP.%26aulast%3DNeu%26aufirst%3DM.%26aulast%3DYao%26aufirst%3DG.%26aulast%3DBrough%26aufirst%3DC.%26aulast%3DCutler%26aufirst%3DG.%26aulast%3DCoffin%26aufirst%3DA.%26aulast%3DBelyanskaya%26aufirst%3DS.%26atitle%3D5-Aryl-4-carboxamide-1%252C3-oxazoles%253A%2520potent%2520and%2520selective%2520GSK-3%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26issue%3D5%26spage%3D1989%26epage%3D1994%26doi%3D10.1016%2Fj.bmcl.2012.01.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaisina, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petukhov, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blond, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedolak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldarone, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGonigle, P.</span><span> </span><span class="NLM_article-title">Structure-based design leads to the identification of lithium mimetics that block mania-like effects in rodents. Possible new GSK-3beta therapies for bipolar disorders</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">8328</span><span class="NLM_x">–</span> <span class="NLM_lpage">8332</span><span class="refDoi"> DOI: 10.1021/ja068969w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja068969w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=8328-8332&issue=26&author=A.+P.+Kozikowskiauthor=I.+N.+Gaisinaauthor=H.+Yuanauthor=P.+A.+Petukhovauthor=S.+Y.+Blondauthor=A.+Fedolakauthor=B.+Caldaroneauthor=P.+McGonigle&title=Structure-based+design+leads+to+the+identification+of+lithium+mimetics+that+block+mania-like+effects+in+rodents.+Possible+new+GSK-3beta+therapies+for+bipolar+disorders&doi=10.1021%2Fja068969w"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fja068969w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja068969w%26sid%3Dliteratum%253Aachs%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DGaisina%26aufirst%3DI.%2BN.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DPetukhov%26aufirst%3DP.%2BA.%26aulast%3DBlond%26aufirst%3DS.%2BY.%26aulast%3DFedolak%26aufirst%3DA.%26aulast%3DCaldarone%26aufirst%3DB.%26aulast%3DMcGonigle%26aufirst%3DP.%26atitle%3DStructure-based%2520design%2520leads%2520to%2520the%2520identification%2520of%2520lithium%2520mimetics%2520that%2520block%2520mania-like%2520effects%2520in%2520rodents.%2520Possible%2520new%2520GSK-3beta%2520therapies%2520for%2520bipolar%2520disorders%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26issue%3D26%26spage%3D8328%26epage%3D8332%26doi%3D10.1021%2Fja068969w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Chen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaisina, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunosewoyo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malekiani, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanania, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozikowski, A. P.</span><span> </span><span class="NLM_article-title">Structure-guided design of a highly selective glycogen synthase kinase-3beta inhibitor: a superior neuroprotective pyrazolone showing antimania effects</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1587</span><span class="NLM_x">–</span> <span class="NLM_lpage">1592</span><span class="refDoi"> DOI: 10.1002/cmdc.201100231</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1002%2Fcmdc.201100231" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1587-1592&issue=9&author=W.+Chenauthor=I.+N.+Gaisinaauthor=H.+Gunosewoyoauthor=S.+A.+Malekianiauthor=T.+Hananiaauthor=A.+P.+Kozikowski&title=Structure-guided+design+of+a+highly+selective+glycogen+synthase+kinase-3beta+inhibitor%3A+a+superior+neuroprotective+pyrazolone+showing+antimania+effects&doi=10.1002%2Fcmdc.201100231"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201100231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201100231%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DW.%26aulast%3DGaisina%26aufirst%3DI.%2BN.%26aulast%3DGunosewoyo%26aufirst%3DH.%26aulast%3DMalekiani%26aufirst%3DS.%2BA.%26aulast%3DHanania%26aufirst%3DT.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DStructure-guided%2520design%2520of%2520a%2520highly%2520selective%2520glycogen%2520synthase%2520kinase-3beta%2520inhibitor%253A%2520a%2520superior%2520neuroprotective%2520pyrazolone%2520showing%2520antimania%2520effects%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26issue%3D9%26spage%3D1587%26epage%3D1592%26doi%3D10.1002%2Fcmdc.201100231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Kalinichev, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, L. A.</span><span> </span><span class="NLM_article-title">Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK3) inhibitors in a strain-specific model of acute mania</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1051</span><span class="NLM_x">–</span> <span class="NLM_lpage">1067</span><span class="refDoi"> DOI: 10.1017/S1461145710001495</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1017%2FS1461145710001495" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=21208504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A528%3ADC%252BC3MXps1eitLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=1051-1067&issue=8&author=M.+Kalinichevauthor=L.+A.+Dawson&title=Evidence+for+antimanic+efficacy+of+glycogen+synthase+kinase-3+%28GSK3%29+inhibitors+in+a+strain-specific+model+of+acute+mania&doi=10.1017%2FS1461145710001495"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for antimanic efficacy of glycogen synthase kinase-3 (GSK3) inhibitors in a strain-specific model of acute mania</span></div><div class="casAuthors">Kalinichev, Mikhail; Dawson, Lee A.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1051-1067</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">There is a growing body of evidence suggesting that animal models can be developed to probe the specific domains of bipolar disorder (BD) using the endophenotype approach.  Here we tested clin. active antimanic drugs to validate amphetamine-induced hyperactivity in Black Swiss mice as a putative model of the manic phase of BD.  We also co-administered a mood stabilizer and an atypical antipsychotic drug in a manner akin to the clin. treatment regimens.  Since lithium has been shown to potentially act through glycogen synthase kinase-3 (GSK3) inhibition, we evaluated the efficacy of selective GSK3 inhibitors in this model.  Habituated animals were pretreated with a compd. of interest before being challenged with amphetamine (2.0 mg/kg) and returned to activity cages for an addnl. 1.5 h.  We tested lithium, sodium valproate, carbamazepine, olanzapine, ziprasidone as well as co-administered lithium and olanzapine at sub-efficacious doses.  The GSK3 inhibitors tested included indirubin, alsterpaullone, TDZD-8, AR-A014418, SB-216763, and SB-627772.  All mood stabilizers and antipsychotic drugs reduced hyperactivity without affecting spontaneous locomotion.  While subactive doses of lithium and olanzapine were without effect, their co-administration produced robust redns. in hyperactivity.  All GSK3 inhibitors were active in the model, producing selective inhibition of rearing hyperactivity.  These data support the predictive validity of the model for the acute manic phase of BD and may have utility as an in-vivo model for identifying novel antimanic therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5B0hy-ESJIrVg90H21EOLACvtfcHk0ljkc8yB-uFhHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXps1eitLc%253D&md5=afab413eb631fdd646c8d34d55d982df</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1017%2FS1461145710001495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145710001495%26sid%3Dliteratum%253Aachs%26aulast%3DKalinichev%26aufirst%3DM.%26aulast%3DDawson%26aufirst%3DL.%2BA.%26atitle%3DEvidence%2520for%2520antimanic%2520efficacy%2520of%2520glycogen%2520synthase%2520kinase-3%2520%2528GSK3%2529%2520inhibitors%2520in%2520a%2520strain-specific%2520model%2520of%2520acute%2520mania%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2011%26volume%3D14%26issue%3D8%26spage%3D1051%26epage%3D1067%26doi%3D10.1017%2FS1461145710001495" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Ombrato, R.; Mancini, F.; Mangano, G.</span>, unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Ombrato%2C+R.%3B+Mancini%2C+F.%3B+Mangano%2C+G.%2C+unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DOmbrato%26aufirst%3DR." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Alisi, M. A.; Nicola, C.; Guglielmotti, A.; Furlotti, G.; Luna, G.; Polenzani, L.</span><span> </span><span class="NLM_article-title">Indazolamides with Analgesic Activity, Process and Intermediates for Their Preparation, and Their Pharmaceutical Compositions</span>. WO 2004074275 A1,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+A.+Alisi&author=C.+Nicola&author=A.+Guglielmotti&author=G.+Furlotti&author=G.+Luna&author=L.+Polenzani&title=Indazolamides+with+Analgesic+Activity%2C+Process+and+Intermediates+for+Their+Preparation%2C+and+Their+Pharmaceutical+Compositions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlisi%26aufirst%3DM.%2BA.%26atitle%3DIndazolamides%2520with%2520Analgesic%2520Activity%252C%2520Process%2520and%2520Intermediates%2520for%2520Their%2520Preparation%252C%2520and%2520Their%2520Pharmaceutical%2520Compositions%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Witherington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaiba, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawlings, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slingsby, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takle, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, R. W.</span><span> </span><span class="NLM_article-title">6-Heteroaryl-pyrazolo[3,4-b]pyridines: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">3059</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span><span class="refDoi"> DOI: 10.1016/S0960-894X(03)00646-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1016%2FS0960-894X%2803%2900646-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=3059-62&issue=18&author=J.+Witheringtonauthor=V.+Bordasauthor=A.+Gaibaauthor=A.+Naylorauthor=A.+D.+Rawlingsauthor=B.+P.+Slingsbyauthor=D.+G.+Smithauthor=A.+K.+Takleauthor=R.+W.+Ward&title=6-Heteroaryl-pyrazolo%5B3%2C4-b%5Dpyridines%3A+potent+and+selective+inhibitors+of+glycogen+synthase+kinase-3+%28GSK-3%29&doi=10.1016%2FS0960-894X%2803%2900646-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900646-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900646-2%26sid%3Dliteratum%253Aachs%26aulast%3DWitherington%26aufirst%3DJ.%26aulast%3DBordas%26aufirst%3DV.%26aulast%3DGaiba%26aufirst%3DA.%26aulast%3DNaylor%26aufirst%3DA.%26aulast%3DRawlings%26aufirst%3DA.%2BD.%26aulast%3DSlingsby%26aufirst%3DB.%2BP.%26aulast%3DSmith%26aufirst%3DD.%2BG.%26aulast%3DTakle%26aufirst%3DA.%2BK.%26aulast%3DWard%26aufirst%3DR.%2BW.%26atitle%3D6-Heteroaryl-pyrazolo%255B3%252C4-b%255Dpyridines%253A%2520potent%2520and%2520selective%2520inhibitors%2520of%2520glycogen%2520synthase%2520kinase-3%2520%2528GSK-3%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26issue%3D18%26spage%3D3059%26epage%3D62%26doi%3D10.1016%2FS0960-894X%2803%2900646-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Witherington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bordas, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haigh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ife, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawlings, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slingsby, B. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, R. W.</span><span> </span><span class="NLM_article-title">5-Aryl-pyrazolo[3,4-b]pyridazines: potent inhibitors of glycogen synthase kinase-3 (GSK-3)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1581</span><span class="NLM_x">–</span> <span class="NLM_lpage">1584</span><span class="refDoi"> DOI: 10.1016/S0960-894X(03)00135-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1016%2FS0960-894X%2803%2900135-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1581-1584&issue=9&author=J.+Witheringtonauthor=V.+Bordasauthor=D.+Haighauthor=D.+M.+Hickeyauthor=R.+J.+Ifeauthor=A.+D.+Rawlingsauthor=B.+P.+Slingsbyauthor=D.+G.+Smithauthor=R.+W.+Ward&title=5-Aryl-pyrazolo%5B3%2C4-b%5Dpyridazines%3A+potent+inhibitors+of+glycogen+synthase+kinase-3+%28GSK-3%29&doi=10.1016%2FS0960-894X%2803%2900135-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900135-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900135-5%26sid%3Dliteratum%253Aachs%26aulast%3DWitherington%26aufirst%3DJ.%26aulast%3DBordas%26aufirst%3DV.%26aulast%3DHaigh%26aufirst%3DD.%26aulast%3DHickey%26aufirst%3DD.%2BM.%26aulast%3DIfe%26aufirst%3DR.%2BJ.%26aulast%3DRawlings%26aufirst%3DA.%2BD.%26aulast%3DSlingsby%26aufirst%3DB.%2BP.%26aulast%3DSmith%26aufirst%3DD.%2BG.%26aulast%3DWard%26aufirst%3DR.%2BW.%26atitle%3D5-Aryl-pyrazolo%255B3%252C4-b%255Dpyridazines%253A%2520potent%2520inhibitors%2520of%2520glycogen%2520synthase%2520kinase-3%2520%2528GSK-3%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26issue%3D9%26spage%3D1581%26epage%3D1584%26doi%3D10.1016%2FS0960-894X%2803%2900135-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skaltsounis, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magiatis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polychronopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knockaert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leost, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vonica, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brivanlou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dajani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crovace, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarricone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musacchio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roe, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearl, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greengard, P.</span><span> </span><span class="NLM_article-title">GSK-3-selective inhibitors derived from Tyrian purple indirubins. BMC</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1255</span><span class="NLM_x">–</span> <span class="NLM_lpage">1266</span><span class="refDoi"> DOI: 10.1016/j.chembiol.2003.11.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1016%2Fj.chembiol.2003.11.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=14700633" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVWis73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=1255-1266&issue=12&author=L.+Meijerauthor=A.+L.+Skaltsounisauthor=P.+Magiatisauthor=P.+Polychronopoulosauthor=M.+Knockaertauthor=M.+Leostauthor=X.+P.+Ryanauthor=C.+A.+Vonicaauthor=A.+Brivanlouauthor=R.+Dajaniauthor=C.+Crovaceauthor=C.+Tarriconeauthor=A.+Musacchioauthor=S.+M.+Roeauthor=L.+Pearlauthor=P.+Greengard&title=GSK-3-selective+inhibitors+derived+from+Tyrian+purple+indirubins.+BMC&doi=10.1016%2Fj.chembiol.2003.11.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">GSK-3-Selective Inhibitors Derived from Tyrian Purple Indirubins</span></div><div class="casAuthors">Meijer, Laurent; Skaltsounis, Alexios-Leandros; Magiatis, Prokopios; Polychronopoulos, Panagiotis; Knockaert, Marie; Leost, Maryse; Ryan, Xiaozhou P.; Vonica, Claudia Alin; Brivanlou, Ali; Dajani, Rana; Crovace, Claudia; Tarricone, Cataldo; Musacchio, Andrea; Roe, S. Mark; Pearl, Laurence; Greengard, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1255-1266</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Gastropod mollusks have been used for over 2500 yr to produce the "Tyrian purple" dye made famous by the Phoenicians.  This dye is constituted of mixed bromine-substituted indigo and indirubin isomers.  Among these, the new natural product 6-bromoindirubin and its synthetic, cell-permeable deriv., 6-bromoindirubin-3'-oxime (BIO), display remarkable selective inhibition of glycogen synthase kinase-3 (GSK-3).  Cocrystal structure of GSK-3β/BIO and CDK5/p25/indirubin-3'-oxime were resolved, providing a detailed view of indirubins' interactions within the ATP binding pocket of these kinases.  BIO but not 1-methyl-BIO, its kinase inactive analog, also inhibited the phosphorylation on Tyr276/216, a GSK-3α/β activation site.  BIO but not 1-methyl-BIO reduced β-catenin phosphorylation on a GSK-3-specific site in cellular models.  BIO but not 1-methyl-BIO closely mimicked Wnt signaling in Xenopus embryos.  6-Bromoindirubins thus provide a new scaffold for the development of selective and potent pharmacol. inhibitors of GSK-3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGol3sG1_xDZJ7Vg90H21EOLACvtfcHk0lhEpNO0aS8i1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVWis73O&md5=0fbc4fc974a3bea0db8c63d97eada58f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2003.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2003.11.010%26sid%3Dliteratum%253Aachs%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DSkaltsounis%26aufirst%3DA.%2BL.%26aulast%3DMagiatis%26aufirst%3DP.%26aulast%3DPolychronopoulos%26aufirst%3DP.%26aulast%3DKnockaert%26aufirst%3DM.%26aulast%3DLeost%26aufirst%3DM.%26aulast%3DRyan%26aufirst%3DX.%2BP.%26aulast%3DVonica%26aufirst%3DC.%2BA.%26aulast%3DBrivanlou%26aufirst%3DA.%26aulast%3DDajani%26aufirst%3DR.%26aulast%3DCrovace%26aufirst%3DC.%26aulast%3DTarricone%26aufirst%3DC.%26aulast%3DMusacchio%26aufirst%3DA.%26aulast%3DRoe%26aufirst%3DS.%2BM.%26aulast%3DPearl%26aufirst%3DL.%26aulast%3DGreengard%26aufirst%3DP.%26atitle%3DGSK-3-selective%2520inhibitors%2520derived%2520from%2520Tyrian%2520purple%2520indirubins.%2520BMC%26jtitle%3DChem.%2520Biol.%26date%3D2003%26volume%3D10%26issue%3D12%26spage%3D1255%26epage%3D1266%26doi%3D10.1016%2Fj.chembiol.2003.11.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Copeland, R. A.</span><span> </span><span class="NLM_article-title">Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists</span> <span class="citation_source-journal">Methods Biochem. Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=16350889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A280%3ADC%252BD2MnmtlyjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=1-265&author=R.+A.+Copeland&title=Evaluation+of+enzyme+inhibitors+in+drug+discovery.+A+guide+for+medicinal+chemists+and+pharmacologists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists</span></div><div class="casAuthors">Copeland Robert A</div><div class="citationInfo"><span class="NLM_cas:title">Methods of biochemical analysis</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-265</span>
        ISSN:<span class="NLM_cas:issn">0076-6941</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSR7_ubfiC0DK2q3xNe7a7QfW6udTcc2eaT-nuKqQX-7rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MnmtlyjsA%253D%253D&md5=4bb6759b5155aa6c2b6a462432afda7f</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26atitle%3DEvaluation%2520of%2520enzyme%2520inhibitors%2520in%2520drug%2520discovery.%2520A%2520guide%2520for%2520medicinal%2520chemists%2520and%2520pharmacologists%26jtitle%3DMethods%2520Biochem.%2520Anal.%26date%3D2005%26volume%3D46%26spage%3D1%26epage%3D265" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Becker, W.</span><span> </span><span class="NLM_article-title">Emerging role of DYRK family protein kinases as regulators of protein stability in cell cycle control</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">3389</span><span class="NLM_x">–</span> <span class="NLM_lpage">3394</span><span class="refDoi"> DOI: 10.4161/cc.21404</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.4161%2Fcc.21404" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=3389-3394&issue=18&author=W.+Becker&title=Emerging+role+of+DYRK+family+protein+kinases+as+regulators+of+protein+stability+in+cell+cycle+control&doi=10.4161%2Fcc.21404"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.4161%2Fcc.21404&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcc.21404%26sid%3Dliteratum%253Aachs%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DEmerging%2520role%2520of%2520DYRK%2520family%2520protein%2520kinases%2520as%2520regulators%2520of%2520protein%2520stability%2520in%2520cell%2520cycle%2520control%26jtitle%3DCell%2520Cycle%26date%3D2012%26volume%3D11%26issue%3D18%26spage%3D3389%26epage%3D3394%26doi%3D10.4161%2Fcc.21404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Noll, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Planque, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ripoll, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guedj, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ducros, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duchon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paul, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Badel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Freminville, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grattau, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bléhaut, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herault, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janel, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delabar, J. M.</span><span> </span><span class="NLM_article-title">DYRK1A, a novel determinant of the methionine-homocysteine cycle in different mouse models overexpressing this Down-syndrome-associated kinase</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">e7540</span><span class="refDoi"> DOI: 10.1371/journal.pone.0007540</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1371%2Fjournal.pone.0007540" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=e7540&issue=10&author=C.+Nollauthor=C.+Planqueauthor=C.+Ripollauthor=F.+Guedjauthor=A.+Diezauthor=V.+Ducrosauthor=N.+Belinauthor=A.+Duchonauthor=J.+L.+Paulauthor=A.+Badelauthor=B.+de+Freminvilleauthor=Y.+Grattauauthor=H.+Bl%C3%A9hautauthor=Y.+Heraultauthor=N.+Janelauthor=J.+M.+Delabar&title=DYRK1A%2C+a+novel+determinant+of+the+methionine-homocysteine+cycle+in+different+mouse+models+overexpressing+this+Down-syndrome-associated+kinase&doi=10.1371%2Fjournal.pone.0007540"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0007540&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0007540%26sid%3Dliteratum%253Aachs%26aulast%3DNoll%26aufirst%3DC.%26aulast%3DPlanque%26aufirst%3DC.%26aulast%3DRipoll%26aufirst%3DC.%26aulast%3DGuedj%26aufirst%3DF.%26aulast%3DDiez%26aufirst%3DA.%26aulast%3DDucros%26aufirst%3DV.%26aulast%3DBelin%26aufirst%3DN.%26aulast%3DDuchon%26aufirst%3DA.%26aulast%3DPaul%26aufirst%3DJ.%2BL.%26aulast%3DBadel%26aufirst%3DA.%26aulast%3Dde%2BFreminville%26aufirst%3DB.%26aulast%3DGrattau%26aufirst%3DY.%26aulast%3DBl%25C3%25A9haut%26aufirst%3DH.%26aulast%3DHerault%26aufirst%3DY.%26aulast%3DJanel%26aufirst%3DN.%26aulast%3DDelabar%26aufirst%3DJ.%2BM.%26atitle%3DDYRK1A%252C%2520a%2520novel%2520determinant%2520of%2520the%2520methionine-homocysteine%2520cycle%2520in%2520different%2520mouse%2520models%2520overexpressing%2520this%2520Down-syndrome-associated%2520kinase%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26issue%3D10%26spage%3De7540%26doi%3D10.1371%2Fjournal.pone.0007540" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Menegay, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moeslein, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landreth, G. E.</span><span> </span><span class="NLM_article-title">Biochemical characterization and localization of the dual specificity kinase CLK1</span> <span class="citation_source-journal">J. Cell. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">3241</span><span class="NLM_x">–</span> <span class="NLM_lpage">3253</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10954422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsVyltb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2000&pages=3241-3253&issue=18&author=H.+J.+Menegayauthor=M.+P.+Myersauthor=F.+M.+Moesleinauthor=G.+E.+Landreth&title=Biochemical+characterization+and+localization+of+the+dual+specificity+kinase+CLK1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical characterization and localization of the dual specificity kinase CLK1</span></div><div class="casAuthors">Menegay, Harry J.; Myers, Michael P.; Moeslein, Fred M.; Landreth, Gary E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3241-3253</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">CLK1 kinase was one of the 1st identified dual specificity kinases and is the founding member of the "LAMMER" family of kinases.  THe authors previously established the substrate site specificity of CLK1.  Here, the authors report that truncation of the N-terminus of CLK1 resulted in a dramatic increase in CLK1 enzymic activity, indicating that the N-terminus acts as a neg. regulatory domain.  The N-terminal truncation resulted in a 45-fold increase in Vmax, suggesting that this domain does not contain a pseudo-substrate motif, but may act to conformationally constrain the catalytic activity of CLK1.  Tyrosine-phosphorylation has been proposed to be crit. for CLK1 activity, however, CLK1 activity was unaffected by exposure to tyrosine phosphatases.  Treatment of CLK1 with the serine/threonine-specific phosphophosphatase PP2A, resulted in a 2- to 6-fold increase in enzymic activity.  Incubation of CLK1 with tyrosine phosphatases in combination with PP2A abolished CLK1 activity.  These data suggest that CLK1 is regulated by 3 distinct mechanisms that serve to both pos. and neg. regulate CLK1 activity.  CLK1 activity is pos. regulated by phosphorylation on either Tyr residues or Ser/Thr residues, and is neg. regulated by steric constraints mediated by the N-terminal domain, as well as, by phosphorylation on a subset of Ser/Thr residues within the catalytic domain.  CLK1 mRNA was expressed at low levels in all tissues and cell lines examd.  The full-length and truncated splice forms were expressed at roughly equiv. levels in most tissues.  The ratio of the 2 splice variants of CLK1 could be altered by treatment with cycloheximide.  CLK1 protein expression was limited to a small subset of highly localized neuronal populations in the rat brain.  Contrary to previous studies using overexpression systems, it was shown that CLK1 protein was primarily found in the cytoplasm of these cells, with only a small fraction localized to the nucleus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro5fsug852p7Vg90H21EOLACvtfcHk0lib_QGajLjvMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsVyltb4%253D&md5=a90c2dcf6aad8518a017190c549925b3</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMenegay%26aufirst%3DH.%2BJ.%26aulast%3DMyers%26aufirst%3DM.%2BP.%26aulast%3DMoeslein%26aufirst%3DF.%2BM.%26aulast%3DLandreth%26aufirst%3DG.%2BE.%26atitle%3DBiochemical%2520characterization%2520and%2520localization%2520of%2520the%2520dual%2520specificity%2520kinase%2520CLK1%26jtitle%3DJ.%2520Cell.%2520Sci.%26date%3D2000%26volume%3D113%26issue%3D18%26spage%3D3241%26epage%3D3253" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Hartmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rujescu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannakouros, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolakaki, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goedert, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Q. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreadis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamm, S.</span><span> </span><span class="NLM_article-title">Regulation of Alternative Splicing of Human Tau Exon 10 by Phosphorylation of Splicing Factors</span> <span class="citation_source-journal">Mol. Cell. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span><span class="NLM_x">–</span> <span class="NLM_lpage">90</span><span class="refDoi"> DOI: 10.1006/mcne.2001.1000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1006%2Fmcne.2001.1000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=11461155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlt1Cmur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2001&pages=80-90&author=A.+Hartmannauthor=D.+Rujescuauthor=T.+Giannakourosauthor=E.+Nikolakakiauthor=M.+Goedertauthor=E.+Mandelkowauthor=Q.+S.+Gaoauthor=A.+Andreadisauthor=S.+Stamm&title=Regulation+of+Alternative+Splicing+of+Human+Tau+Exon+10+by+Phosphorylation+of+Splicing+Factors&doi=10.1006%2Fmcne.2001.1000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of Alternative Splicing of Human Tau Exon 10 by Phosphorylation of Splicing Factors</span></div><div class="casAuthors">Hartmann, Annette M.; Rujescu, Dan; Giannakouros, Thomas; Nikolakaki, Eleni; Goedert, Michel; Mandelkow, Eva-Maria; Gao, Qing Sheng; Andreadis, Athena; Stamm, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">80-90</span>CODEN:
                <span class="NLM_cas:coden">MOCNED</span>;
        ISSN:<span class="NLM_cas:issn">1044-7431</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Tau is a microtubule-assocd. protein whose transcript undergoes regulated splicing in the mammalian nervous system.  Exon 10 of the gene is an alternatively spliced cassette that is adult-specific and encodes a microtubule-binding domain.  Mutations increasing the inclusion of exon 10 result in the prodn. of tau protein which predominantly contains four microtubule-binding repeats and were shown to cause frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).  Here we show that exon 10 usage is regulated by CDC2-like kinases CLK1, 2, 3, and 4 that phosphorylate serine-arginine-rich proteins, which in turn regulate pre-mRNA splicing.  Cotransfection expts. suggest that CLKs achieve this effect by releasing specific proteins from nuclear storage sites.  Our results show that changing pre-mRNA-processing pathways through phosphorylation could be a new therapeutic concept for tauopathies.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF56T2cyktgLVg90H21EOLACvtfcHk0lib_QGajLjvMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlt1Cmur4%253D&md5=c5fc041adf6f212feb59f277aec9aa4b</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1006%2Fmcne.2001.1000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fmcne.2001.1000%26sid%3Dliteratum%253Aachs%26aulast%3DHartmann%26aufirst%3DA.%26aulast%3DRujescu%26aufirst%3DD.%26aulast%3DGiannakouros%26aufirst%3DT.%26aulast%3DNikolakaki%26aufirst%3DE.%26aulast%3DGoedert%26aufirst%3DM.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DGao%26aufirst%3DQ.%2BS.%26aulast%3DAndreadis%26aufirst%3DA.%26aulast%3DStamm%26aufirst%3DS.%26atitle%3DRegulation%2520of%2520Alternative%2520Splicing%2520of%2520Human%2520Tau%2520Exon%252010%2520by%2520Phosphorylation%2520of%2520Splicing%2520Factors%26jtitle%3DMol.%2520Cell.%2520Neurosci.%26date%3D2001%26volume%3D18%26spage%3D80%26epage%3D90%26doi%3D10.1006%2Fmcne.2001.1000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Yamanashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyoshima, K.</span><span> </span><span class="NLM_article-title">Selective expression of a protein-tyrosine kinase, p56lyn, in hematopoietic cells and association with production of human T-cell lymphotropic virus type I</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">6538</span><span class="NLM_x">–</span> <span class="NLM_lpage">6542</span><span class="refDoi"> DOI: 10.1073/pnas.86.17.6538</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1073%2Fpnas.86.17.6538" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=1989&pages=6538-6542&issue=17&author=Y.+Yamanashiauthor=S.+Moriauthor=M.+Yoshidaauthor=T.+Kishimotoauthor=K.+Inoueauthor=T.+Yamamotoauthor=K.+Toyoshima&title=Selective+expression+of+a+protein-tyrosine+kinase%2C+p56lyn%2C+in+hematopoietic+cells+and+association+with+production+of+human+T-cell+lymphotropic+virus+type+I&doi=10.1073%2Fpnas.86.17.6538"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1073%2Fpnas.86.17.6538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.86.17.6538%26sid%3Dliteratum%253Aachs%26aulast%3DYamanashi%26aufirst%3DY.%26aulast%3DMori%26aufirst%3DS.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DKishimoto%26aufirst%3DT.%26aulast%3DInoue%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DToyoshima%26aufirst%3DK.%26atitle%3DSelective%2520expression%2520of%2520a%2520protein-tyrosine%2520kinase%252C%2520p56lyn%252C%2520in%2520hematopoietic%2520cells%2520and%2520association%2520with%2520production%2520of%2520human%2520T-cell%2520lymphotropic%2520virus%2520type%2520I%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1989%26volume%3D86%26issue%3D17%26spage%3D6538%26epage%3D6542%26doi%3D10.1073%2Fpnas.86.17.6538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Tsantikos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oracki, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quilici, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarlinton, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibbs, M. L.</span><span> </span><span class="NLM_article-title">Autoimmune disease in Lyn-deficient mice is dependent on an inflammatory environment established by IL-6</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">184</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1348</span><span class="NLM_x">–</span> <span class="NLM_lpage">1360</span><span class="refDoi"> DOI: 10.4049/jimmunol.0901878</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.4049%2Fjimmunol.0901878" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=184&publication_year=2010&pages=1348-1360&issue=3&author=E.+Tsantikosauthor=S.+A.+Orackiauthor=C.+Quiliciauthor=G.+P.+Andersonauthor=D.+M.+Tarlintonauthor=M.+L.+Hibbs&title=Autoimmune+disease+in+Lyn-deficient+mice+is+dependent+on+an+inflammatory+environment+established+by+IL-6&doi=10.4049%2Fjimmunol.0901878"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.0901878&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.0901878%26sid%3Dliteratum%253Aachs%26aulast%3DTsantikos%26aufirst%3DE.%26aulast%3DOracki%26aufirst%3DS.%2BA.%26aulast%3DQuilici%26aufirst%3DC.%26aulast%3DAnderson%26aufirst%3DG.%2BP.%26aulast%3DTarlinton%26aufirst%3DD.%2BM.%26aulast%3DHibbs%26aufirst%3DM.%2BL.%26atitle%3DAutoimmune%2520disease%2520in%2520Lyn-deficient%2520mice%2520is%2520dependent%2520on%2520an%2520inflammatory%2520environment%2520established%2520by%2520IL-6%26jtitle%3DJ.%2520Immunol.%26date%3D2010%26volume%3D184%26issue%3D3%26spage%3D1348%26epage%3D1360%26doi%3D10.4049%2Fjimmunol.0901878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Nishimoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishida, E.</span><span> </span><span class="NLM_article-title">MAPK signalling: ERK5 versus ERK1/2</span> <span class="citation_source-journal">EMBO Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">782</span><span class="NLM_x">–</span> <span class="NLM_lpage">786</span><span class="refDoi"> DOI: 10.1038/sj.embor.7400755</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1038%2Fsj.embor.7400755" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=16880823" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A528%3ADC%252BD28XnsFajsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=782-786&issue=8&author=S.+Nishimotoauthor=E.+Nishida&title=MAPK+signalling%3A+ERK5+versus+ERK1%2F2&doi=10.1038%2Fsj.embor.7400755"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">MAPK signaling: ERK5 versus ERK1/2</span></div><div class="casAuthors">Nishimoto, Satoko; Nishida, Eisuke</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Reports</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">782-786</span>CODEN:
                <span class="NLM_cas:coden">ERMEAX</span>;
        ISSN:<span class="NLM_cas:issn">1469-221X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Extracellular-signal-regulated kinase 5 (ERK5) is a member of the mitogen-activated protein kinase (MAPK) family and, similar to ERK1/2, has the Thr-Glu-Tyr (TEY) activation motif.  Both ERK5 and ERK1/2 are activated by growth factors and have an important role in the regulation of cell proliferation and cell differentiation.  Moreover, both the ERK5 and the ERK1/2 pathways are sensitive to PD98059 and U0126, which are two well-known inhibitors of the ERK pathway.  Despite these similarities, recent studies have revealed distinctive features of the ERK5 pathway: ERK5 has a key role in cardiovascular development and neural differentiation; ERK5 nuclear translocation is controlled by its own nuclear localizing and nuclear export activities; and the carboxy-terminal half of ERK5, which follows its kinase catalytic domain, has a unique function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxGAyxrdcDGrVg90H21EOLACvtfcHk0licERFkLz83lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnsFajsrw%253D&md5=f0e4ffe6cf70f29a8867da4a86e46940</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fsj.embor.7400755&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.embor.7400755%26sid%3Dliteratum%253Aachs%26aulast%3DNishimoto%26aufirst%3DS.%26aulast%3DNishida%26aufirst%3DE.%26atitle%3DMAPK%2520signalling%253A%2520ERK5%2520versus%2520ERK1%252F2%26jtitle%3DEMBO%2520Rep.%26date%3D2006%26volume%3D7%26issue%3D8%26spage%3D782%26epage%3D786%26doi%3D10.1038%2Fsj.embor.7400755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Ribas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penela, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murga, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salcedo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Hoz, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jurado-Pueyo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aymerich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayor, F.</span><span> </span><span class="NLM_article-title">The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signaling</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Biomembr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1768</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">913</span><span class="NLM_x">–</span> <span class="NLM_lpage">922</span><span class="refDoi"> DOI: 10.1016/j.bbamem.2006.09.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=10.1016%2Fj.bbamem.2006.09.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=17084806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjsVWhsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1768&publication_year=2007&pages=913-922&issue=4&author=C.+Ribasauthor=P.+Penelaauthor=C.+Murgaauthor=A.+Salcedoauthor=C.+Garc%C3%ADa-Hozauthor=M.+Jurado-Pueyoauthor=I.+Aymerichauthor=F.+Mayor&title=The+G+protein-coupled+receptor+kinase+%28GRK%29+interactome%3A+role+of+GRKs+in+GPCR+regulation+and+signaling&doi=10.1016%2Fj.bbamem.2006.09.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The G protein-coupled receptor kinase (GRK) interactome: Role of GRKs in GPCR regulation and signaling</span></div><div class="casAuthors">Ribas, Catalina; Penela, Petronila; Murga, Cristina; Salcedo, Alicia; Garcia-Hoz, Carlota; Jurado-Pueyo, Maria; Aymerich, Ivette; Mayor, Federico</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1768</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">913-922</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptor kinases (GRKs) and arrestins are key participants in the canonical pathways leading to phosphorylation-dependent GPCR desensitization, endocytosis, intracellular trafficking and resensitization as well as in the modulation of important intracellular signaling cascades by GPCR.  Novel studies have revealed a phosphorylation-independent desensitization mechanism operating through their RGS-homol. (RH) domain and the recent detn. of the crystal structures of GRK2 and GRK6 has uncovered interesting details on the structure-function relationships of these kinases.  Emerging evidence indicates that the activity of GRKs is tightly modulated by mechanisms including phosphorylation by different kinases and interaction with several cellular proteins such as calmodulin, caveolin or RKIP.  In addn., GRKs are involved in multiple interactions with non-receptor proteins (PI3K, Akt, GIT or MEK) that point to novel GRK cellular roles.  In this article, the authors' purpose is to describe the ever increasing map of functional interactions for GRK proteins as a basis to better understand its contribution to cellular processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVEb4zP9V6WbVg90H21EOLACvtfcHk0licERFkLz83lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjsVWhsLs%253D&md5=7bcb46279c2781485f8b4b20c58656cf</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2006.09.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2006.09.019%26sid%3Dliteratum%253Aachs%26aulast%3DRibas%26aufirst%3DC.%26aulast%3DPenela%26aufirst%3DP.%26aulast%3DMurga%26aufirst%3DC.%26aulast%3DSalcedo%26aufirst%3DA.%26aulast%3DGarc%25C3%25ADa-Hoz%26aufirst%3DC.%26aulast%3DJurado-Pueyo%26aufirst%3DM.%26aulast%3DAymerich%26aufirst%3DI.%26aulast%3DMayor%26aufirst%3DF.%26atitle%3DThe%2520G%2520protein-coupled%2520receptor%2520kinase%2520%2528GRK%2529%2520interactome%253A%2520role%2520of%2520GRKs%2520in%2520GPCR%2520regulation%2520and%2520signaling%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2007%26volume%3D1768%26issue%3D4%26spage%3D913%26epage%3D922%26doi%3D10.1016%2Fj.bbamem.2006.09.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i114"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01208">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_26276"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b01208">10.1021/acs.jmedchem.5b01208</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">SMILES data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01208/suppl_file/jm5b01208_si_001.csv">CSV</a>)</p></li><li><p class="inline">Experimental description of the synthetic preparation of (piperidin-4-yl)methan-amines <b>6o</b>–<b>q</b> and <b>u</b>, with their analytical characterizations, <i>in vivo</i> pharmacokinetic assessment procedures, full lists of enzymatic and cellular GSK-3β assay results, full list of the kinase selectivity results for <b>14i</b>, and crystallization conditions and X-ray data collection (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01208/suppl_file/jm5b01208_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01208/suppl_file/jm5b01208_si_001.csv">jm5b01208_si_001.csv (3.75 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01208/suppl_file/jm5b01208_si_002.pdf">jm5b01208_si_002.pdf (665.29 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b01208&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-22%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b01208%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b01208" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679ac02e3f862362","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
